
<html lang="en"     class="pb-page"  data-request-id="bb4d7ac7-810e-4410-b7f6-72dc55802146"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.6b00636;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2016.59.issue-18"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents" /></meta><meta name="dc.Creator" content="Xiaokang  Li" /></meta><meta name="dc.Creator" content="Huan  Wang" /></meta><meta name="dc.Creator" content="Zhengyu  Lu" /></meta><meta name="dc.Creator" content="Xinyu  Zheng" /></meta><meta name="dc.Creator" content="Wei  Ni" /></meta><meta name="dc.Creator" content="Jin  Zhu" /></meta><meta name="dc.Creator" content="Yan  Fu" /></meta><meta name="dc.Creator" content="Fulin  Lian" /></meta><meta name="dc.Creator" content="Naixia  Zhang" /></meta><meta name="dc.Creator" content="Jian  Li" /></meta><meta name="dc.Creator" content="Haiyan  Zhang" /></meta><meta name="dc.Creator" content="Fei  Mao" /></meta><meta name="dc.Description" content="Starting from a screening-hit compound, via structure modifications and optimizations, a series of nonfused and nonassembly pyrimidinylthiourea derivatives (2–5) was designed, synthesized, and eval..." /></meta><meta name="Description" content="Starting from a screening-hit compound, via structure modifications and optimizations, a series of nonfused and nonassembly pyrimidinylthiourea derivatives (2–5) was designed, synthesized, and eval..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 6, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00636" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00636" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00636" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00636" /></link>
        
    
    

<title>Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00636" /></meta><meta property="og:title" content="Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0020.jpeg" /></meta><meta property="og:description" content="Starting from a screening-hit compound, via structure modifications and optimizations, a series of nonfused and nonassembly pyrimidinylthiourea derivatives (2–5) was designed, synthesized, and evaluated as novel multifunctional agents against Alzheimer’s disease. Biological activity results demonstrated that compounds 5r and 5t exhibited potent inhibition and excellent selectivity toward acetylcholinesterase (AChE, 5r, IC50 = 0.204 μM, SI &gt; 196; 5t, IC50 = 0.067 μM, SI &gt; 597), specific metal-chelating ability, significant antioxidant effects, modulation of metal-induced Aβ aggregation, inhibition of ROS production by copper redox cycle, low cytotoxicity, and moderate neuroprotection to human neuroblastoma SH-SY5Y cells. Moreover, compound 5r displayed appropriate blood–brain barrier (BBB) permeability both in vitro and in vivo and could improve memory and cognitive function of scopolamine-induced amnesia mice. The multifunctional profiles of 5r and its effectivity in AD mice highlight these structurally distinct pyrimidinylthiourea derivatives as prospective prototypes in the research of innovative multifunctional drugs for Alzheimer’s disease." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00636"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00636">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00636&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00636&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00636&amp;href=/doi/10.1021/acs.jmedchem.6b00636" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8326-8344</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00515" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00697" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaokang++Li">Xiaokang Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huan++Wang">Huan Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhengyu++Lu">Zhengyu Lu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinyu++Zheng">Xinyu Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Ni">Wei Ni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Zhu">Jin Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Fu">Yan Fu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fulin++Lian">Fulin Lian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naixia++Zhang">Naixia Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Li">Jian Li</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haiyan++Zhang">Haiyan Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Mao">Fei Mao</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>For J.L.: phone, +86-21-64252584; fax, +86-21-64252584; e-mail, <a href="/cdn-cgi/l/email-protection#abc1c2cac5c7c2ebcec8ded8df85cecfde85c8c5"><span class="__cf_email__" data-cfemail="513b38303f3d381134322422257f3435247f323f">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For H.Z.: phone, +86-21-50806710; e-mail, <a href="/cdn-cgi/l/email-protection#cda5b7a5aca3aa8dbea4a0a0e3acaee3aea3"><span class="__cf_email__" data-cfemail="1b7361737a757c5b68727676357a78357875">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For F.M.: phone, +86-21-64252584; fax, +86-21-64252584; e-mail, <a href="/cdn-cgi/l/email-protection#6c010d030a09052c090f191f1842090819420f02"><span class="__cf_email__" data-cfemail="a4c9c5cbc2c1cde4c1c7d1d7d08ac1c0d18ac7ca">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00636&amp;href=/doi/10.1021%2Facs.jmedchem.6b00636" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8326–8344</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 23, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 April 2016</li><li><span class="item_label"><b>Published</b> online</span>6 September 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 September 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00636" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00636</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8326%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaokang%2BLi%252C%2BHuan%2BWang%252C%2BZhengyu%2BLu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D18%26contentID%3Dacs.jmedchem.6b00636%26title%3DDevelopment%2Bof%2BMultifunctional%2BPyrimidinylthiourea%2BDerivatives%2Bas%2BPotential%2BAnti-Alzheimer%2BAgents%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8344%26publicationDate%3DSeptember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00636"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2812</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00636" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaokang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Huan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhengyu&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Xinyu&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Ni&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Fulin&quot;,&quot;last_name&quot;:&quot;Lian&quot;},{&quot;first_name&quot;:&quot;Naixia&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Haiyan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Mao&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;8326-8344&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00636&quot;},&quot;abstract&quot;:&quot;Starting from a screening-hit compound, via structure modifications and optimizations, a series of nonfused and nonassembly pyrimidinylthiourea derivatives (2–5) was designed, synthesized, and evaluated as novel multifunctional agents against Alzheimer’s disease. Biological activity results demonstrated that compounds 5r and 5t exhibited potent inhibition and excellent selectivity toward acetylcholinesterase (AChE, 5r, IC50 = 0.204 μM, SI &gt; 196; 5t, IC50 = 0.067 μM, SI &gt; 597), specific metal-chelating ability, significant antioxidant effects, modulation of metal-induced Aβ aggregation, inhibition of ROS production by copper redox cycle, low cytotoxicity, and moderate neuroprotection to human neuroblastoma SH-SY5Y cells. Moreover, compound 5r displayed appropriate blood–brain barrier (BBB) permeability both in vitro and in vivo and could improve memory and cognitive function of scopolamine-induced amnesia mice. The multifunctional profiles of 5r and its effectivity in AD mice highlight these structurally disti&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00636&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00636" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00636&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00636" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00636&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00636" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00636&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00636&amp;href=/doi/10.1021/acs.jmedchem.6b00636" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00636" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00636" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00636%26sid%3Dliteratum%253Aachs%26pmid%3D27552582%26genre%3Darticle%26aulast%3DLi%26date%3D2016%26atitle%3DDevelopment%2Bof%2BMultifunctional%2BPyrimidinylthiourea%2BDerivatives%2Bas%2BPotential%2BAnti-Alzheimer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D18%26spage%3D8326%26epage%3D8344%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/jmcmar.2016.59.issue-18/20160922/jmcmar.2016.59.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Starting from a screening-hit compound, via structure modifications and optimizations, a series of nonfused and nonassembly pyrimidinylthiourea derivatives (<b>2</b>–<b>5</b>) was designed, synthesized, and evaluated as novel multifunctional agents against Alzheimer’s disease. Biological activity results demonstrated that compounds <b>5r</b> and <b>5t</b> exhibited potent inhibition and excellent selectivity toward acetylcholinesterase (AChE, <b>5r</b>, IC<sub>50</sub> = 0.204 μM, SI > 196; <b>5t</b>, IC<sub>50</sub> = 0.067 μM, SI > 597), specific metal-chelating ability, significant antioxidant effects, modulation of metal-induced Aβ aggregation, inhibition of ROS production by copper redox cycle, low cytotoxicity, and moderate neuroprotection to human neuroblastoma SH-SY5Y cells. Moreover, compound <b>5r</b> displayed appropriate blood–brain barrier (BBB) permeability both in vitro and in vivo and could improve memory and cognitive function of scopolamine-induced amnesia mice. The multifunctional profiles of <b>5r</b> and its effectivity in AD mice highlight these structurally distinct pyrimidinylthiourea derivatives as prospective prototypes in the research of innovative multifunctional drugs for Alzheimer’s disease.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a chronic, fatal, and neurodegenerative disease in the brain; its mechanism has not been fully elucidated due to complex etiology. As the most common form of dementia and the leading cause of death among the elderly, approximately 44 million patients suffer from AD, and the number is increasing annually.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Commercial drugs for AD treatment are unable to meet the market demand. The failure of several candidates based on new targets in clinical trials actuated new strategies for drug development.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus, multitarget-directed ligands (MTDLs), aiming to simultaneously target multiple pathological processes involved in the neurodegenerative cascade, were developed as a therapeutic approach.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13">(4-13)</a></div><div class="NLM_p">Acetylcholine (ACh), a major neurotransmitter widely existing in the brain, plays an important role in learning, memory, cognition, and maintaining consciousness.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Studies indicated that 90% of cholinergic neurons were damaged in the brain of AD patients, and the associated cholinergic neurotransmitter in the cerebral cortex and hippocampus decreased dramatically.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Thus, remedying the physiological ACh levels has been considered a feasible therapy for AD.<a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14, 19)</a> The major pathway of ACh activity termination is hydrolysis by AChE. Therefore, inhibitors of AChE appear to be a beneficial approach to repair the cholinergic transmission pathway.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Currently, the therapeutic options for AD treatment are limited to four AChE inhibitors (AChEIs),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> namely, donepezil, rivastigmine, galantamine, and huperzine A (Hup A, approved by CFDA) and one <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid (NMDA) receptor antagonist, memantine.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">An increasing body of evidence suggests that the pathogenesis of AD is an extremely complex interconnected network.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> In addition to the low level of the neurotransmitter ACh, this complex multisystem disease features multiple pathological hallmarks, including abnormal accumulation and deposition of β amyloid protein (Aβ), dysregulation of biometals, oxidative stress, and neuroinflammation of the CNS (central nervous system).<a onclick="showRef(event, 'ref23 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref25 ref26">(23, 25, 26)</a> The high levels and dysregulation of biometal ions, such as Cu<sup>2+</sup>, Zn<sup>2+</sup>, and Fe<sup>2+</sup>, are closely implicated in the pathogenesis of AD. These metal ions (especially Cu<sup>2+</sup> and Zn<sup>2+</sup>) bind to Aβ peptides and influence the Aβ aggregation pathway, leading to the generation of toxic Aβ oligomers.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> Moreover, redox-active metal ions, Cu(I/II) and Fe(II/III), which are associated with Aβ, were demonstrated to produce reactive oxygen species (ROS) under physiological conditions through Fenton-like reactions. The overproduction of ROS leads to oxidative stress and eventually neuronal death in AD patients.<a onclick="showRef(event, 'ref23 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref23 ref27 ref28 ref29 ref30">(23, 27-30)</a> Therefore, biometal chelators endowed with the ability to modulate metal–Aβ interactions, as well as the metal distribution in the brain, have been considered as a potential therapeutic approach for AD. In addition, neurotoxic ROS and oxidative damage of neuronal cells are generally associated with AD, so compounds with antioxidant activities may be beneficial for the treatment of AD.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div><div class="NLM_p">Many researchers have devoted their efforts to the development of MTDLs as a hopeful approach to combat the multifactorial nature of AD. Typically, two or three bioactive scaffolds with beneficial anti-AD properties were assembled or fused to obtain new chemical entities, which possessed multiple abilities due to the functional superposition of each constituent fragment and additional synergetic activities (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Table S1, Supporting Information</a>). For example, tacrine–8-hydroxyquinoline hybrid,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> 6-chlorotacrine–metal–Aβ modulator hybrid,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> donepezil–8-hydroxyquinoline–propargylamine hybrid,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> tacrine–flavonoid hybrid,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> HLA20A and M30D<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> were all obtained by assembling AChEIs and metal chelator fragments (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The hybrid strategies have had success in the field of MTLDs but possess an apparent design flaw: excessive dependence on the structure of limited known bioactive compounds, such as tacrine, donepezil, clioquinol, rhein, melatonin, resveratrol, and coumarin (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Table S1</a>). Therefore, to broaden the research extent of multifunctional anti-AD drugs, the discovery of nonfused and nonassembly lead compounds with multiple anti-AD properties is extremely urgent.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative MTDLs bearing AChE and metal-chelating properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Toward this end, we have identified a series of nonfused and nonassembly multifunctional pyrimidinylthiourea derivatives as prospective anti-AD agents. Among them, the aminomethylimidazole-containing pyrimidinylthiourea derivatives <b>5l</b>–<b>x</b> showed potent inhibition and excellent selectivity toward AChE, as well as mild antioxidant properties. Integrally considering the abilities of metal-chelating, modulating metal-induced Aβ aggregation, free radical scavenging, low cytotoxicity, and moderate neuroprotective effect, compounds <b>5r</b> and <b>5t</b> were identified as the prototype of potential multifunctional anti-Alzheimer agents. Compound <b>5r</b> also showed positive results in an AD mice cognitive ability test, demonstrating that our pyrimidinylthiourea derivatives possess development potential as prospective anti-AD agents.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Discovery of Hit Compound <b>1</b></h3><div class="NLM_p last">Because several AChEIs have successfully been approved to be marketed as drugs and have made prominent contributions to the symptomatic improvement of AD patients,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> AChE inhibitory ability should be first considered in the process of searching for new multifunctional anti-AD scaffolds. An in-house library with 630 small molecular compounds (MW < 300) was screened using the AChE inhibition assay. A “cocktail” of tactics was imitated to simplify this process. The detailed steps are as follows. First, 630 compounds were screened through the AChE inhibition assay in 96-well plates with 10 compounds per well. Then, each constituent in positive wells was screened again using the same method but with one compound per well. Finally, the positive wells contained compounds with potential AChE inhibitory activity. Pyrimidine derivative <b>1</b> was one of the discovered compounds and exhibited some AChE inhibitory activity (inhibition rate: 32.15% at 40 μM). Compound <b>1</b> was designated as a hit compound because a similar disubstituted pyrimidine scaffold has appeared in potential anti-AD agents, such as AChEI, Aβ-aggregation inhibitors, and receptor for advanced glycation end products (RAGE) inhibitors,<a onclick="showRef(event, 'ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41">(38-41)</a> and also has good synthetic accessibility.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis</h3><div class="NLM_p">First, the ethylamino group of hit <b>1</b> was replaced by ethyoxyl, <i>n</i>-propyl, benzylamino, amino, acetylamino, and different substituted thiourea moieties to produce target compounds <b>2a</b>–<b>o</b>. As depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, reaction of pyrazole and commercially available 4,6-dichloropyrimidine or 4-amino-6-chloropyrimidine gave the key intermediate <b>6</b> and compound <b>2d</b>, respectively. Nucleophilic substitution of the C-2 chlorine of intermediate <b>6</b> provided target compounds <b>2a</b>–<b>c</b>. Target compound <b>2e</b> was obtained by acetylation of <b>2d</b> with acetyl chloride in the presence of Et<sub>3</sub>N. The reaction of <b>2d</b> with ethyl isocyanate and different substituted isothiocyanates in the presence of NaH provided the target compounds <b>2f</b> and <b>2g</b>–<b>o</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b> and <b>2a</b>–<b>o</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4,6-dichloropyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (b) 4-amino-6-chloropyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 12 h. (c) (i) For <b>1</b>, <b>2c</b>: RNH<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40–50 °C, overnight. (ii) For <b>2a</b>: CH<sub>3</sub>CH<sub>2</sub>OH, NaH, DMF, 4 h. (iii) For <b>2b</b>: <i>n</i>-propylmagnesium bromide, ferrous acetylacetonate, anhydrous THF, N<sub>2</sub>, −30 °C, 1 h. (d) (i) For <b>2e</b>: AcCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, overnight. (ii) For <b>2f</b>–<b>o</b>: RNCO or RNCS, NaH, DMF, rt, 0.5 h.</p></p></figure><div class="NLM_p">Ethylthiourea analogue <b>2g</b> was treated as lead compound for its significantly increased activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The ethylthiourea moiety was demonstrated as indispensable pharmacophore for AChE inhibitory activity and played important role in generating metal chelation<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and antioxidant properties.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a> The pyrazolyl group of compound <b>2g</b> was regarded as a modification site and was replaced by various aza-aromatics, such as pyrrolyl (<b>3a</b>), imidazolyl (<b>3b</b>), 1,2,3-triazolyl (<b>3c</b>), 1,2,4-triazolyl (<b>3d</b>), benzo[<i>d</i>]imidazolyl (<b>3e</b>), and different alicyclic amino groups, such as pyrrolidinyl (<b>3f)</b>, morpholino (<b>3g</b>), 4-methylpiperazinyl (<b>3h</b>), benzylamino (<b>3i</b>) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Commercially available 4-amino-6-chloropyrimidine was reacted with aza-aromatic compounds or alicyclic amines to provide intermediates <b>7a</b>–<b>i</b>, followed by treatment with ethyl isothiocyanate to afford target compounds <b>3a</b>–<b>i</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>3a</b>–<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) (i) For <b>7a</b>: pyrrole, NaH, DMF, rt, 2 h. (ii) For <b>7b</b>–<b>i</b>: aza-aromatic compounds or alicyclic amines, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100–120 °C, 12–24 h. (c) CH<sub>3</sub>CH<sub>2</sub>NCS, NaH, DMF, rt, 0.5 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and rAChE Inhibitory Activities of Compounds <b>1</b> and <b>2a</b>–<b>o</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">inhibition of rAChE, [I] = 40 μM</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ± SD (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="char" char=".">32.15</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>O</td><td class="colsep0 rowsep0" align="char" char=".">11.76</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">9.88</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="char" char=".">10.75</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">18.91</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CONH</td><td class="colsep0 rowsep0" align="char" char=".">5.09</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>NHCONH</td><td class="colsep0 rowsep0" align="char" char=".">22.14</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>NHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">77.26</td><td class="colsep0 rowsep0" align="left">8.14 ± 0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2h</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>NHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">46.00</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2i</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>NHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">64.01</td><td class="colsep0 rowsep0" align="left">22.00 ± 1.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2j</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>3</sub>)<sub>2</sub>CHNHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">36.22</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2k</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">66.58</td><td class="colsep0 rowsep0" align="left">23.40 ± 0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2l</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>3</sub>)<sub>3</sub>CNHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">11.30</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2m</b></td><td class="colsep0 rowsep0" align="left">cyclohexyl-NHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">11.21</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2n</b></td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>NHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">17.29</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2o</b></td><td class="colsep0 rowsep0" align="left">3-Cl-C<sub>6</sub>H<sub>4</sub>NHCSNH</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="left">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Results are expressed as the mean of at least three experiments. “–” indicates no test.</p></div></div></div><div class="NLM_p">Imidazolyl analogue <b>3b</b> showed improved potency (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) and had sufficient modifiable sites. The imidazolyl moiety (<b>3b</b>) remained in the following structure modification. The 4,6-disubstituted pyrimidine core was treated as the next replacement part. Then, target compounds <b>4a</b>–<b>e</b> were designed and obtained by the reaction of intermediates <b>8a</b>–<b>e</b> (synthetic details, see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Supporting Information</a>) with ethyl isothiocyanate in the presence of NaH (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>4a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CH<sub>2</sub>NCS, NaH, DMF, rt, 0.5 h.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and rAChE Inhibitory Activities of Compounds <b>3a</b>–<b>i</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0014.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Results are expressed as the mean of at least three experiments.</p></div></div><div></div></div><div class="NLM_p">Having maintained the integrity of compound <b>3b</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), a series of target compounds <b>5a</b>–<b>k</b> with diverse substituents at C-2 or C-4 of the imidazole ring were designed and synthesized to improve the biological activities and to expand the SAR studies (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Nucleophilic substitution of 4-amino-6-chloropyrimidine with substituted imidazole derivatives afforded intermediates <b>9a</b>–<b>j</b>, which were further reacted with ethyl isothiocyanate in the presence of NaH to obtain compounds <b>5a</b>–<b>j</b>. Reduction of <b>5i</b> with NaBH<sub>4</sub> gave compound <b>5k</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>5a</b>–<b>x</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100–120 °C, rt, 12–24 h; (b) CH<sub>3</sub>CH<sub>2</sub>NCS, DMF, rt, 0.5 h; (c) NaBH<sub>4</sub>, MeOH/DCM = 1:1, rt, 5 h; (d) NaBH<sub>3</sub>(CN), MeOH/DCE = 1:1, AcOH, rt, 12 h.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structures and rAChE Inhibitory Activities of Compounds <b>4a</b>–<b>e</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0016.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Results are expressed as the mean of at least three experiments.</p></div></div><div></div></div><div class="NLM_p">Finally, for the potent inhibitory activity of compound <b>5i</b> against AChE, a series of compounds <b>5l</b>–<b>x</b>, possessing diverse aminomethyl groups on the C-4 position of the imidazole ring, were designed and synthesized (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Compounds <b>5l</b>–<b>x</b> were prepared by reductive amination of compound <b>5i</b> with diverse aliphatic amines in the presence of NaBH<sub>3</sub>(CN).</div><div class="NLM_p">In total, 53 derivatives (i.e., <b>2a</b>–<b>o</b>, <b>3a</b>–<b>i</b>, <b>4a</b>–<b>4e</b>, and <b>5a</b>–<b>x</b>) were designed and synthesized, their chemical structures are shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, and details of the synthetic procedures and structural characterization are described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structures, rAChE, and rBuChE Inhibitory Activities, Selectivity Index for rAChE, and Oxygen Radical Absorbance Capacity (ORAC, Trolox Equivalents) of Compounds <b>5a</b>–<b>x</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0018.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0019.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Results are expressed as the mean of at least three experiments. “–“ indicates no test.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Selectivity index for AChE is defined as IC<sub>50</sub>(rBuChE)/IC<sub>50</sub>(rAChE).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">The mean ± SD of three independent experiments. Data are expressed as μmol of Trolox equivalent/μmol of tested compounds.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cholinesterase (ChE) Inhibitory Activity</h3><div class="NLM_p">To determine the therapeutic potential of these pyrimidine derivatives for the treatment of AD, compounds <b>2a</b>–<b>o</b>, <b>3a</b>–<b>i</b>, <b>4a</b>–<b>4e</b>, and <b>5a</b>–<b>x</b> were assayed against rat AChE (rAChE) by the modified method of Ellman et al.,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> using huperzine A (Hup A) as reference. The experimental results were presented as IC<sub>50</sub> (μM) or, for poorly active compounds, as the percentage of inhibition at 40 μM. The tested compounds displayed poor to excellent rAChE inhibitory activity (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compounds <b>5i</b>, <b>5l</b>–<b>m</b>, <b>5o</b>–<b>x</b> with good rAChE inhibition were further tested for their inhibitory activities against rat butyrylcholinesterase (rBuChE) using the same method, and the activity results and selectivity indexes (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">SI</a>) are summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div class="NLM_p">Examples of variation in the initial ethylamino group of hit <b>1</b> gave encouraging results (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Compound <b>2g</b>, with the ethylamino group replaced by an ethylthiourea group, exhibited good inhibitory activity, with an IC<sub>50</sub> of 8.14 μM. However, replacement of the ethylthiourea group with a similar ethylurea group was not tolerated (<b>2g</b> vs <b>2f</b>). Introduction of either larger (<b>2i</b>–<b>o</b>) or smaller (<b>2h</b>) substituents on the N-3 atom decreased the potency. This observation indicates that steric hindrance of the N-3 substituent of thiourea may play an important role in the binding modes of compounds to AChE.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, changing pyrazolyl into various types of aza-aromatics or alicyclic amino groups remarkably affected the AChE inhibitory activities. Generally, alicyclic amino substituents (<b>3f</b>–<b>i</b>) were not beneficial, while the introduction of aza-aromatic substituents (<b>3b</b>–<b>e</b>), except pyrrolyl (<b>3a</b>), was favorable. Among them, compounds <b>3b</b> and <b>3d</b> were relatively potent, with IC<sub>50</sub> values of 1.59 μM and 1.05 μM, respectively. In the studied set of central cores (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), changing the position of the N atom in the ring (<b>4c</b>,<b>d</b>) and introducing substituents on the ring (<b>4a</b>,<b>b</b> and <b>4e</b>) were not tolerated, leading to an obvious decline in potency.</div><div class="NLM_p">The data in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> show that introduction alkyl groups on the C-2 position of the imidazole ring (<b>5a</b>,<b>b</b>) was not beneficial. Compared with C-2 methyl derivative <b>5a</b>, C-4 methyl derivative <b>5c</b> showed relatively increased potency, so the C-4 position was considered the preferable modification site. Fortunately, the following C-4-substituted derivatives <b>5d</b>–<b>k</b> exhibited more increased activities than prototype <b>3b</b>. The two most effective inhibitors, <b>5h</b> (IC<sub>50</sub> = 0.170 μM) and <b>5i</b> (IC<sub>50</sub> = 0.166 μM), were nearly 10-fold more potent than <b>3b</b>. Compounds <b>5l</b>–<b>x</b> possessed aminomethyl moieties on the C-4 position of the imidazole ring and exhibited good potency. Among them, compound <b>5t</b> was the most potent, with an IC<sub>50</sub> value of 0.067 μM, more potent than the approved drug Hup A (0.082 μM).</div><div class="NLM_p last">As presented in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, compounds <b>5i</b>, <b>5l</b>–<b>m</b>, <b>5o</b>–<b>x</b> displayed poor to micromolar potency against rBuChE and excellent selectivity toward rAChE. Compound <b>5v</b> was the strongest rBuChE inhibitor and displayed the lowest SI value of 59. The most potent compound, <b>5t</b>, exhibited weak BuChE inhibitory activity, indicating <b>5t</b> was an outstanding selective AChE inhibitor over BuChE.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> SAR Studies</h3><div class="NLM_p">On the basis of hit <b>1</b>, the key transitionary compounds of structural optimization are illustrated in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. The SAR studies of the 53 derivatives provided important insight into the essential structural requirements for effective AChE inhibition. An analysis of the data shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> reveals noteworthy observations of the SARs for compounds <b>2a</b>–<b>o</b>, <b>3a</b>–<b>i</b>, <b>4a</b>–<b>e</b>, and <b>5a</b>–<b>x</b>: (1) the thiourea moiety is indispensable pharmacophore for AChE inhibitory activity; replacement of thiourea moiety with urea or other groups decreases the activity dramatically (<b>2g</b> vs <b>1</b>, <b>2f</b>, <b>2a</b>–<b>e</b>). There is an extremely rigid requirement for the steric hindrance of the N-3 substituents of thiourea; an ethyl group (<b>2g</b>) is optimal, and smaller (<b>2h</b>) or bigger (<b>2i</b>–<b>o</b>) substituents result in obvious loss of potency. (2) Considering the improved potency and sufficient modifiable sites, the imidazole ring is the most suitable substituent at the C-6 position of the pyrimidine ring (<b>3b</b> vs <b>2g</b>, <b>3a</b>, <b>3c</b>, <b>3e</b>–<b>i</b>; <b>3b</b> vs <b>3d</b>). (3) The 4,6-disubstituted pyrimidine core is critical for AChE inhibition; changing the N atom position or introduction other substituents led to remarkable decline of inhibitory activity (<b>3b</b> vs <b>4a</b>–<b>e</b>), and (4) the C-4 position on imidazole ring was a promising substituted site (<b>5c</b> vs <b>5a</b>; <b>5d</b>–<b>k</b> vs <b>3b</b>); compounds <b>5l</b>–<b>x</b> with protonatable aminomethyl moieties are potent AChE inhibitors. The N-monosubstituted aminomethyl derivatives <b>5l</b>–<b>o</b> display relatively weak inhibitory potency. For N-disubstituted aminomethyl derivatives, the potencies increase in the order of diethylaminomethyl > dimethylaminomethyl > benzyl(methyl)aminomethyl > dipropylaminomethyl (<b>5q</b> > <b>5p</b> > <b>5s</b> > <b>5r</b>); for the cyclic aminomethyl derivatives, the potencies decrease following the augmentation of the cycle size: pyrrolidinylmethyl > piperidinylmethyl > azepanylmethyl (<b>5t</b> > <b>5u</b> > <b>5v</b>). In brief, the SARs are highly explicit. Analogue <b>5t</b> represented the most robust combination, leading to 121-fold potency improvement compared to the lead compound <b>2g</b>.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Key transition compounds of the structural optimization and a brief summary of SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Free Oxygen Radical Scavenging Ability</h3><div class="NLM_p last">To evaluate the antioxidant activities of compounds <b>5i</b>, <b>5l</b>–<b>m</b>, <b>5o</b>–<b>x</b>, the oxygen radical absorbance capacity assay (ORAC-FL) was performed using fluorescein as the fluorescent probe and AAPH (2,2′-azobis-(amidinopropane)dihydrochloride) as the peroxyl radical inducer.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Trolox, a vitamin E analogue, was used as a standard. CQ was tested as reference, and compound <b>5y</b> (without thiourea fragment, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Supporting Information</a>) was measured as a negative control. The results (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) indicated that all the tested compounds exhibited mild antioxidant ability with ORAC values of 1.17–1.48, except compound <b>5i</b>, which featured an aldehyde group on the imidazole ring (0.31). Compound <b>5w</b> displayed the highest activity, with an ORAC-FL value of 1.48. Moreover, the thiourea fragment played a crucial role in scavenging ROS (<b>5t</b> vs <b>5y</b>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Metal Binding Properties of <b>5r</b> and <b>5t</b></h3><div class="NLM_p">A UV–vis spectroscopy assay was performed to evaluate the ability of compounds <b>5r</b> and <b>5t</b> to chelate biometals, such as Cu<sup>2+</sup>, Fe<sup>2+</sup>, and Zn<sup>2+</sup>. The results showed that when CuCl<sub>2</sub> was added to the solutions of <b>5r</b> and <b>5t</b>, the maximum absorption both decreased dramatically at 290 nm, demonstrating the formation of <b>5r</b>–Cu<sup>2+</sup> and <b>5t</b>–Cu<sup>2+</sup> complexes (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). There were only vague optical shift and maximum absorption fluctuation when FeSO<sub>4</sub>, FeCl<sub>3</sub>, and ZnCl<sub>2</sub> were added, indicating <b>5r</b> and <b>5t</b> had poor chelation abilities to Fe<sup>2+</sup>, Fe<sup>3+</sup>, and Zn<sup>2+</sup>. Compound <b>5t</b> was selected to test its binding property to other biological relevant metals, such as Mg<sup>2+</sup>, Ca<sup>2+</sup>, Mn<sup>2+</sup>, Ni<sup>2+</sup>, Co<sup>2+</sup> and exhibited very weak chelation ability (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Figure S2, Supporting Information</a>). A competition experiment was performed to verify the metal ion selectivity of <b>5t</b>, the results demonstrated that Cu<sup>2+</sup> could competitively bind to <b>5t</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Figure S3, Supporting Information</a>). Compound <b>5y</b>, without thiourea fragment, was tested as negative control to determine the role of thiourea moiety played in the chelating experiment. As expected, the absorption curve exhibited a slight shift when CuCl<sub>2</sub>, FeSO<sub>4</sub>, FeCl<sub>3</sub>, and ZnCl<sub>2</sub> were added (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). The above results proved that target compound <b>5t</b> could selectively chelate Cu<sup>2+</sup>, and this property was determined by the thiourea fragment. Clioquinol (CQ) was selected as control (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. UV spectra of compounds (40 μM) alone and in the presence of CuCl<sub>2</sub> (20 μM), FeSO<sub>4</sub> (20 μM), FeCl<sub>3</sub> (20 μM), or ZnCl<sub>2</sub> (20 μM) in buffer (20 mM HEPES, 150 mM NaCl, pH 7.4): (A) <b>5r</b>; (B) <b>5t</b>; (C) <b>5y</b>. (D) UV spectrum of compound CQ (40 μM) alone and in the presence of CuCl<sub>2</sub> (20 μM), FeSO<sub>4</sub> (20 μM), FeCl<sub>3</sub> (20 μM), or ZnCl<sub>2</sub> (20 μM) in ethanol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Dot Blot Assay and TEM Assay</h3><div class="NLM_p">The modulation of metal-induced Aβ aggregation by compounds <b>5r</b> and <b>5t</b> was studied through a dot blot assay,<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> and a transmission electron microscopy (TEM)<a onclick="showRef(event, 'ref4 ref13'); return false;" href="javascript:void(0);" class="ref ref4 ref13">(4, 13)</a> assay was then performed to examine the morphological changes of Aβ species. In the dot blot assay, samples were probed by A11 antibody to determine oligomeric Aβ, and total Aβ was detected by 6E10 as the loading control. A representative scan graph and a statistical histogram are presented in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A; the gray density of the spots is proportional to the Aβ oligomerization level. After a 24 h incubation, Aβ aggregated extremely and compounds <b>5r</b> and <b>5t</b> showed no effect on Aβ self-aggregation. Epigallocatechin gallate (EGCG) was tested as positive control. To verify this result, we performed a thioflavine T (ThT) fluorescence assay and achieved similar estimates (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Figure S4, Supporting Information</a>). Most importantly, the dot blot assay clearly showed that Cu<sup>2+</sup> could accelerate Aβ aggregation, and this process was significantly regulated by compounds <b>5r</b> and <b>5t</b>.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of compounds on Cu<sup>2+</sup>-induced Aβ<sub>1–42</sub> aggregation. (A) Scan and bar graph of the dot blot assay. Aggregated Aβ was detected by A11 antibody, and total Aβ was probed by 6E10 antibody. Data are shown as the mean ± SEM, ($) <i>p</i> < 0.05, ($$) <i>p</i> < 0.01 vs Aβ alone group; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs Aβ + Cu<sup>2+</sup> group; <i>N</i> = 3. (B) TEM image analysis of the inhibition of compounds on Cu<sup>2+</sup>-induced Aβ<sub>1–42</sub> aggregation. Serial numbers indicate the following: (1) fresh Aβ<sub>1–42</sub>, (2) Aβ<sub>1–42</sub> alone, (3) Aβ<sub>1–42</sub> + Cu<sup>2+</sup>, (4) Aβ<sub>1–42</sub> + Cu<sup>2+</sup> + <b>5r</b>, (4) Aβ<sub>1–42</sub> + Cu<sup>2+</sup> + <b>5t</b>, (6) Aβ<sub>1–42</sub> + Cu<sup>2+</sup> + CQ. Experimental conditions were the follwoing: Aβ<sub>1–42</sub> (25 μM); compound/Aβ<sub>1–42</sub>/Cu<sup>2+</sup> = 2:1:1; HEPES (20 μM) and NaCl (150 μM); pH 6.6; 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Further visual morphological changes of the Aβ samples were observed by TEM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). The TEM images demonstrated that the Cu<sup>2+</sup>-treated sample of fresh Aβ produced more fibrils than the untreated sample (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B, sequences 2 and 3). Aβ aggregates obviously decreased, and fewer Aβ fibrils were detected when compounds <b>5r</b> and <b>5t</b> and CQ were incubated with the sample (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B, sequences 4, 5, and 6). These TEM results were consistent with the results of the dot blot assay and jointly demonstrated that compounds <b>5r</b> and <b>5t</b> can indeed modulate Cu<sup>2+</sup>-induced Aβ aggregation.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Inhibition of ROS Produced by Copper Redox Cycling</h3><div class="NLM_p">Increased generation of ROS is a significant pathological feature of AD patients, and clinical evidence indicated that redox-active metal ions were closely involved in the high oxidative stress caused by ROS.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Moreover, Aβ could spontaneously produce ROS in the presence of trace amounts of metals, especially copper.<a onclick="showRef(event, 'ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54">(51-54)</a> Considering their biological activities as metal chelators, the abilities of compounds <b>5r</b> and <b>5t</b> to halt Cu(II)-related redox under aerobic conditions were evaluated, utilizing the model of the Cu-ascorbate redox system described by Faller and co-workers<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). Hydroxyl radicals (OH·), produced by copper redox cycling in the presence of ascorbate, were measured by coincubation with coumarin-3-carboxylic acid (CCA), which generated fluorescent 7-hydroxy-CCA with the oxidation of OH·. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B, the OH· in the copper-ascorbate system increased steadily with time and reached a plateau at approximately 800 s. However, this process was entirely inhibited when compounds <b>5r</b> and <b>5t</b> were coincubated with the Cu-ascorbate system, indicating that the ligands were capable of halting copper redox cycling by generating a redox-inactive complex.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The documented metal chelator ethylenediaminetetraacetic acid (EDTA) was measured as a control.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Oxygen reduction by copper redox cycling in the presence of ascorbate. (B) Fluorescence intensity of the copper–ascorbate–<b>5r</b>, copper–ascorbate–<b>5t</b>, copper–ascorbate–EDTA, copper–ascorbate, and ascorbate alone systems. CCA (50 μM) and ascorbate (150 μM) were incubated in each system. Cu(II) = 5 μM, <b>5r</b> = 10 μM, <b>5t</b> = 10 μM, EDTA = 10 μM. PBS buffer (20 mM KH<sub>2</sub>PO<sub>4</sub>, 150 mM NaCl); <i>N</i> = 3; pH = 7.4; 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> MTT Assay</h3><div class="NLM_p">To investigate the safety of the pyrimidinylthiourea derivatives, the cytotoxicity of compounds <b>5r</b> and <b>5t</b> on the human neuroblastoma cell line SH-SY5Y was studied using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to determine cell death. Marketed anti-AD drugs Hup A and donepezil (Don) were tested as references. As depicted in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A, compounds <b>5r</b> and <b>5t</b>, like Hup A and Don, exhibited no cytotoxicity at concentrations of 10 μM and 30 μM after incubation for 24 h. After increasing the concentration to a relatively high level of 100 μM, <b>5r</b>, <b>5t</b>, and Don decreased the cell viability (<i>p</i> < 0.01, <i>p</i> < 0.01, and <i>p</i> < 0.001, respectively), while Hup A had no obvious influence on cell viability. Therefore, compounds <b>5r</b> and <b>5t</b> were proved to have low cytotoxicity.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Cell viability of SH-SY5Y cells exposed to compounds <b>5r</b>, <b>5t</b>, Hup A, and Don at different concentrations (range 10–100 μM) for 24 h. Vehicle-treated cells were used as control. The results are expressed as the percentage of viable cells observed after treatment with compounds vs vehicle-treated cells (100%) and are shown as the mean ± SEM; <i>N</i> = 4. (B) Protection of compounds <b>5r</b> and <b>5t</b> from Cu<sup>2+</sup>-induced Aβ<sub>1–42</sub> neurotoxicity. Data are shown as the mean ± SEM; <i>N</i> = 4. Experimental conditions: Aβ<sub>1–42</sub> (1 μM); compounds/Aβ<sub>1–42</sub>/Cu<sup>2+</sup> = 2:1:1, (##) <i>p</i> < 0.01, (###) <i>p</i> < 0.001 vs vehicle group; ($$$) <i>p</i> < 0.001 vs Aβ alone group; (∗∗∗)<i>p</i> < 0.001 vs Aβ + Cu<sup>2+</sup> group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Next, to determine whether compounds <b>5r</b> and <b>5t</b> can protect neuronal cells from toxic Aβ species, cell viability experiments were conducted using the same cell line. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B, incubation of SH-SY5Y cells with Aβ in the presence of Cu<sup>2+</sup> caused significant toxicity; its cell viability was approximately 39% lower than the vehicle group (<i>P</i> < 0.001) and 11% lower than the Aβ alone group (<i>P</i> < 0.001). Compounds <b>5r</b> and <b>5t</b> could protect the human neuronal SH-SY5Y cells from Cu<sup>2+</sup>-induced Aβ aggregate toxicity, leading to significant increase in cell viability compared with the Aβ + Cu<sup>2+</sup> group (<i>P</i> < 0.001 and <i>P</i> < 0.001). CQ was tested as positive control. Moreover, compounds <b>5r</b> and <b>5t</b> could not interact with Aβ directly to restrain the cytotoxicity of Aβ aggregates. These results are highly consistent with the results from the dot blot assay. Compounds <b>5r</b> and <b>5t</b> in the presence of Cu<sup>2+</sup> or Cu<sup>2+</sup> alone did not influence the SH-SY5Y cell viability in the tested concentrations.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vitro Blood–Brain Barrier Permeation Assay and Druglikeness Evaluation</h3><div class="NLM_p">Blood–brain barrier (BBB) permeability is the first requirement for developing anti-AD drugs. The parallel artificial membrane permeation assay (PAMPA)<a onclick="showRef(event, 'ref13 ref57'); return false;" href="javascript:void(0);" class="ref ref13 ref57">(13, 57)</a> was used to predict passive BBB permeation of optimized compounds <b>5p</b>–<b>x</b>. From the results presented in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, it can be observed that the most potent AChE inhibitor, compound <b>5t</b>, exhibited poor BBB permeation (CNS−). Compounds <b>5r</b>,<b>s</b> and <b>5u</b>,<b>v</b>, which possess compensatory hydrophobic substituents on the nitrogen atom of the C-4 aminomethyl of the imidazole ring, have <i>P</i><sub>e</sub> values above the threshold for good BBB permeation (CNS+), indicating they could cross the BBB. Among them, compounds <b>5r</b>,<b>s</b> exhibited comparatively better BBB permeability than <b>5u</b>,<b>v</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Permeability Results (<i>P</i><sub>e</sub>, 10<sup>–6</sup> cm s<sup>–1</sup>) from the PAMPA-BBB Assay for Compounds <b>5p</b>–<b>x</b> and Their Prediction of BBB Penetration</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">prediction<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5p</b></td><td class="colsep0 rowsep0" align="left">3.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">CNS±</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5q</b></td><td class="colsep0 rowsep0" align="left">1.0 ± 0.35</td><td class="colsep0 rowsep0" align="left">CNS–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5r</b></td><td class="colsep0 rowsep0" align="left">7.5 ± 0.5</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5s</b></td><td class="colsep0 rowsep0" align="left">8.8 ± 0.05</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5t</b></td><td class="colsep0 rowsep0" align="left">1.15 ± 0.44</td><td class="colsep0 rowsep0" align="left">CNS–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5u</b></td><td class="colsep0 rowsep0" align="left">5.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5v</b></td><td class="colsep0 rowsep0" align="left">5.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5w</b></td><td class="colsep0 rowsep0" align="left">0.35 ± 0.03</td><td class="colsep0 rowsep0" align="left">CNS–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5x</b></td><td class="colsep0 rowsep0" align="left">1.95 ± 0.08</td><td class="colsep0 rowsep0" align="left">CNS±</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">desipramine</td><td class="colsep0 rowsep0" align="left">16.6 ± 1.20</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values are expressed as the mean ± SD of at least three independent experiments.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Compounds with permeabilities <i>P</i><sub>e</sub> > 4.7 × 10<sup>–6</sup> cm s<sup>–1</sup> could cross the BBB by passive diffusion (CNS+). Compounds with <i>P</i><sub>e</sub> < 1.8 × 10<sup>–6</sup> cm s<sup>–1</sup> could not cross the BBB (CNS−), and compounds with 1.8 × 10<sup>–6</sup> cm s<sup>–1</sup> < <i>P</i><sub>e</sub> < 4.7 × 10<sup>–6</sup> cm s<sup>–1</sup> show uncertain BBB permeation (CNS±).</p></div></div></div><div class="NLM_p">To determine the potential druggability of compounds <b>5r</b>–<b>s</b>, their druglike physicochemical properties were evaluated.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> As shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>, compounds <b>5r</b>,<b>s</b> both obey the Lipinski’s rule of five<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> and fulfill the restrictions of topological polar surface area (tPSA)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and melting point (MP)<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> for CNS drugs. Compound <b>5r</b> shows a relatively high value of clogP (calculated logarithm of the octanol–water partition coefficient),<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and the corresponding hydrochloride <b>5r·HCl</b> displays better water solubility than <b>5s·HCl</b>. Therefore, compound <b>5r·HCl</b> was selected to conduct further animal cognitive ability experiments.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Druglike Physicochemical Properties of Compounds <b>5r</b>–<b>t</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">HBA</th><th class="colsep0 rowsep0" align="center">HBD</th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">tPSA<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">mp (°C)</th><th class="colsep0 rowsep0" align="center">water solubility (mg/mL)</th><th class="colsep0 rowsep0" align="center">water solubility of hydrochloride (mg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5t</b></td><td class="colsep0 rowsep0" align="left">331.44</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" align="left">70.90</td><td class="colsep0 rowsep0" align="left">179–180</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">19.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5r</b></td><td class="colsep0 rowsep0" align="left">361.51</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2.26</td><td class="colsep0 rowsep0" align="left">70.90</td><td class="colsep0 rowsep0" align="left">158–161</td><td class="colsep0 rowsep0" align="left">0.058</td><td class="colsep0 rowsep0" align="left">3.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5s</b></td><td class="colsep0 rowsep0" align="left">381.50</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1.91</td><td class="colsep0 rowsep0" align="left">70.90</td><td class="colsep0 rowsep0" align="left">153–155</td><td class="colsep0 rowsep0" align="left">0.058</td><td class="colsep0 rowsep0" align="left">2.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rules</td><td class="colsep0 rowsep0" align="left"><450<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><5<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><5<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><90<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">60–220<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">MW: molecular weight. HBA: hydrogen-bond acceptor atoms. HBD: hydrogen-bond donor atoms. clogP: calculated logarithm of the octanol–water partition coefficient. tPSA: topological polar surface area. MP: melting point.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last"><a href="http://www.molinspiration.com/cgi-bin/properties" class="extLink">http://www.molinspiration.com/cgi-bin/properties</a>.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">See ref <a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">64</a>.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Lipinski’s rules.</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">See ref <a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">62</a>.</p></div><div class="footnote" id="t6fn6"><sup>f</sup><p class="last">See ref <a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">63</a>.</p></div></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Cognitive Improvement in Mice Model of AD</h3><div class="NLM_p">The effects of compounds <b>5r·HCl</b> and <b>5t·HCl</b> on cognitive improvement were assessed in a scopolamine (Scop)-induced amnesia animal model using a passageway water maze; Hup A at 0.1 mg/kg was used as a positive control. Scop can block the cholinergic pathway by antagonizing the muscarinic receptor,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> which provides a typical AD model to explore the role of the cholinergic system in cognition and to evaluate anticholinergic drug candidates preclinically.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> In the experiment, all mice received 2 training sessions daily for 4 days before a cognitive ability test; then, the trained mice were randomly allocated into 5 groups: control (Con), Scop, Scop + <b>5t·HCl</b>, Scop + <b>5r·HCl</b>, and Scop + Hup A. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, the Scop group exhibited longer escape latency and more frequent error than the Con group (saline-injected group). Compound <b>5r·HCl</b>, administered to mice by oral gavage at a dose of 200 mg/kg, rescued the escape latency and reduced the number of errors induced by scopolamine. The effectivity of <b>5r·HCl</b> for symptom improvement in AD mice model identifies it as a potential lead anti-AD agent, especially for the treatment of cholinergic deficiency in the early stages of the disease.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compounds <b>5t·HCl</b> and <b>5r·HCl</b> (200 mg/kg) on scopolamine-induced cognitive deficits mice, with Hup A (0.1 mg/kg) as reference: (A) escape latency of mice in passageway water maze; (B) number of errors of mice in passageway water maze. Data are shown as the mean ± SEM: (###) <i>p</i> < 0.001 vs control group, (∗∗∗) <i>p</i> < 0.001 vs scopolamine group; <i>N</i> = 17.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Measuring <b>5r</b> in Plasma and Brain Samples</h3><div class="NLM_p">Liquid chromatography tandem mass spectroscopy (LC–MS/MS) was used to identify and quantify the plasma and brain (cortex, hippocampus) levels of compound <b>5r</b> after oral administration<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(66, 67)</a> (<b>5r·HCl</b> at 200 mg/kg). As shown in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>, compound <b>5r</b> was detected in the brain tissues (cortex, 296.3 ng/g; hippocampus, 579.1 ng/g) and plasma (1738.9 ng/g). The log BB values were used to evaluate BBB permeability; two vital brain areas showed the log BB values of −0.85 (cortex) and −0.49 (hippocampus), which were within the established threshold that defines a compound as crossing the BBB (log BB ≥ −1).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(68)</a> Therefore, compound <b>5r</b> crosses the blood–brain barrier.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. <b>5r</b> Concentrations in Plasma, Cortex, and Hippocampus and log BB Values 1 h after Oral Administration to Mice<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">sample</th><th class="colsep0 rowsep0" align="center">plasma (ng/mL)</th><th class="colsep0 rowsep0" align="center">Ctx (ng/g)</th><th class="colsep0 rowsep0" align="center">Hipp (ng/g)</th><th class="colsep0 rowsep0" align="center">log BB (Ctx)</th><th class="colsep0 rowsep0" align="center">log BB (Hipp)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>N</i> = 3</td><td class="colsep0 rowsep0" align="left">1738.9 ± 249.7</td><td class="colsep0 rowsep0" align="left">296.3 ± 232.7</td><td class="colsep0 rowsep0" align="left">579.1 ± 183.0</td><td class="colsep0 rowsep0" align="left">–0.85 ± 0.38</td><td class="colsep0 rowsep0" align="left">–0.49 ± 0.19</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Ctx, cortex; Hipp, hippocampus; Br, brain. Values are expressed as the mean ± SD of three independent experiments. BB is the ratio of the brain tissue to plasma concentration.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By understanding the heterogeneity and the multifactorial nature of the disease, a single chemical entity against multiple disease-relevant targets might offer a potential approach to the treatment of AD. Given that most of the drugs marketed for AD are cholinergic agents, AChE inhibitory activity was recognized as a prospective focus point to guide MTDL design strategy. The deficiency of novel bioactive scaffolds largely hindered the development of multifunctional anti-AD agents, especially because many researchers continue to concentrate on the strategy of fusing or assembling pharmacophores of limited known bioactive entities. Therefore, it is urgent to search for a new scaffold as the hit compound for multifunctional anti-AD agent design.</div><div class="NLM_p">Through an in vitro HTS campaign, hit <b>1</b>, with some AChE inhibitory activity, was screened out. Then, a series of pyrimidinylthiourea derivatives was rationally designed, synthesized, and assayed. The SAR studies revealed that the thiourea fragment acted as an indispensable pharmacophore for AChE inhibitory activity and played a crucial role in generating metal-chelating and antioxidant properties. Compounds <b>5r</b> and <b>5t</b> exhibited multiple anti-AD properties and showed low cytotoxicity and moderate neuroprotection to human neuroblastoma SH-SY5Y cells. By changing the R<sup>3</sup>, R<sup>4</sup> substituents (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) on the nitrogen atom of the C-4 aminomethyl on the imidazole ring, the water solubility, lipophilicity, and BBB permeability could be modified. Compound <b>5r</b> exerted appropriate BBB permeation and fulfilled druglike rules. Its hydrochloride was used to conduct the animal cognitive ability experiment and showed a remarkable improvement of memory and cognitive function in a Scop-induced amnesia animal model.</div><div class="NLM_p last">In conclusion, this work clearly validates the nonfused and nonassembly multifunctional ligands design strategy and discovers a series of novel pyrimidinylthiourea derivatives with multiple anti-AD profiles. These compounds can be considered as potential prototypes to guide the future research of innovative multifunctional drugs for Alzheimer’s disease.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Chemistry. General Method</h3><div class="NLM_p last">Reagents and solvents were purchased from Adamas-beta, J&K, Energy Chemical, Target Molecule, TCI, Alfa Aesar, and Acros and were used without further purification. Analytical thin-layer chromatography (TLC) was performed using HSGF 254 (150–200 μm thickness; Yantai Huiyou Co., China), and spots were visualized with UV light. Yields were not optimized. Melting points were measured in capillary tubes on a SGW X-4 melting point apparatus without correction. Nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker AMX-400 NMR (IS as TMS). Chemical shifts were reported in parts per million (ppm, δ) downfield from tetramethylsilane. Proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). High-resolution mass spectra (HRMS) were obtained by electric ionization (EI) and electrospray ionization (ESI) using a Waters GCT Premie and Waters LCT. HPLC data analysis of compounds <b>2</b>–<b>5</b> was performed on an Agilent 1100 with a quaternary pump and diode array detector (DAD). The peak purity was verified by UV spectra. All analogs were confirmed to be ≥95% pure (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Table S2, Supporting Information</a>).</div></div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-Ethyl-6-(1<i>H</i>-pyrazol-1-yl)pyrimidin-4-amine (<b>1</b>)</h3><div class="NLM_p last">A mixture of <b>6</b> (390 mg, 2 mmol), ethylamine (4 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.30 g, 4 mmol) was stirred in DMF (10 mL) at 40–50 °C overnight. Water (60 mL) was added. The mixture was extracted with EtOAc (3 × 60 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of EtOAc/petroleum ether (1:3, v/v), to afford compound <b>1</b> as yellow solid. 58% yield. Mp 119–121 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (d, <i>J</i> = 2.6 Hz, 1H), 8.40 (s, 1H), 7.75 (d, <i>J</i> = 0.9 Hz, 1H), 7.26 (s, 1H), 6.91 (s, 1H), 6.46 (dd, <i>J</i> = 2.6, 1.7 Hz, 1H), 5.38 (s, 1H), 3.52–3.31 (m, 2H), 1.34–1.22 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>9</sub>H<sub>11</sub>N<sub>5</sub> (M<sup>+</sup>) 189.1014, found 189.1015.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-Ethoxy-6-(1<i>H</i>-pyrazol-1-yl)pyrimidine (<b>2a</b>)</h3><div class="NLM_p last">To a solution of NaH (60% dispersion in mineral oil, 240 mg, 6 mmol) in stirred anhydrous DMF (10 mL) were added anhydrous EtOH (263 μL, 4.5 mmol) and intermediate <b>6</b> (542 mg, 3 mmol). The reaction mixture was stirred at room temperature for 4 h. Water (50 mL) was added and the mixture was extracted with EtOAc (3 × 60 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of EtOAc/petroleum ether (1:50, v/v), to afford <b>2a</b> (280 mg, 49%) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.60 (d, <i>J</i> = 0.5 Hz, 1H), 8.57–8.50 (m, 1H), 7.76 (d, <i>J</i> = 1.0 Hz, 1H), 7.25 (d, <i>J</i> = 0.9 Hz, 1H), 6.48 (dd, <i>J</i> = 2.6, 1.7 Hz, 1H), 4.47 (q, <i>J</i> = 7.1 Hz, 2H), 1.43 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>9</sub>H<sub>10</sub>N<sub>4</sub>O (M<sup>+</sup>) 190.0855, found 190.0854.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-Propyl-6-(1<i>H</i>-pyrazol-1-yl)pyrimidine (<b>2b</b>)</h3><div class="NLM_p last">A mixture of <b>6</b> (90 mg, 0.5 mmol) and ferrous acetylacetonate (25.4 mg, 0.1 mmol) in anhydrous THF were stirred at −30 °C for 10 min, with protection of N<sub>2</sub>. Then <i>n</i>-propylmagnesium bromide (2 M in THF, 0.5 mL, 1 mmol) was added by syringe. Saturated NH<sub>4</sub>Cl aqueous solution was added 1 h later. The mixture was extracted with EtOAc. The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of EtOAc/petroleum ether (1:15, v/v), to afford <b>2b</b> as a brown oil. 15% yield. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>) δ 8.90 (s, 1H), 8.65 (d, <i>J</i> = 2.6 Hz, 1H), 7.85 (s, 1H), 7.82 (s, 1H), 6.60 (s, 1H), 2.82 (t, <i>J</i> = 14.1, 5.9 Hz, 2H), 1.90–1.73 (m, 2H), 0.99 (t, <i>J</i> = 7.4 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>12</sub>N<sub>4</sub> (M<sup>+</sup>) 188.1062, found 188.1063.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-Benzyl-6-(1<i>H</i>-pyrazol-1-yl)pyrimidin-4-amine (<b>2c</b>)</h3><div class="NLM_p last">A mixture of <b>6</b> (390 mg, 2 mmol), benzylamine (4 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.30 g, 4 mmol) was stirred in DMF (10 mL) at 40–50 °C overnight. Water (60 mL) was added. The mixture was extracted with EtOAc (3 × 60 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of EtOAc/petroleum ether (1:3, v/v), to afford <b>2c</b> as yellow solid. 60% yield. Mp 167–170 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (d, <i>J</i> = 2.5 Hz, 1H), 8.39 (s, 1H), 8.25 (s, 1H), 7.84 (s, 1H), 7.38–7.31 (m, 4H), 7.30–7.19 (m, 1H), 7.02 (s, 1H), 6.56 (s, 1H), 4.62 (s, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>13</sub>N<sub>5</sub> (M<sup>+</sup>) 251.1171, found 251.1170.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-amine (<b>2d</b>)</h3><div class="NLM_p last">A mixture of pyrazole (0.75 g, 10 mmol), 4-amino-6-chloropyrimidine (1.30 g, 10 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (3.91 g, 12 mmol) was stirred in DMF (20 mL) for 12 h at 120 °C. Water (100 mL) was added. The mixture was extracted with EtOAc (3 × 60 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of EtOAc/petroleum ether (1:1, v/v), to afford <b>2d</b> (835 mg, 52%) as a yellow solid. Mp 235–237 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.48–8.43 (m, 1H), 8.33 (d, <i>J</i> = 0.8 Hz, 1H), 7.82 (t, <i>J</i> = 1.4 Hz, 1H), 7.20 (s, 2H), 7.15–7.08 (m, 1H), 6.57 (d, <i>J</i> = 1.0 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>7</sub>H<sub>7</sub>N<sub>5</sub> (M<sup>+</sup>) 161.0701, found 161.0702.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)acetamide (<b>2e</b>)</h3><div class="NLM_p last">To a solution of <b>2d</b> (161 mg, 1 mmol) and Et<sub>3</sub>N (278 μL, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) stirred in ice bath was added AcCl (142 μL, 2 mmol) dropwise. The reaction mixture was stirred at room temperature overnight. Remove the precipitate by filtration, and evaporate the solvent to dryness under reduced pressure. The residue was purified on a silica gel column using mixtures of EtOAc/petroleum ether (1:3, v/v) as eluent, obtaining target compound <b>2e</b>. White solid. 58% yield. Mp 232–235 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.65 (d, <i>J</i> = 0.9 Hz, 1H), 8.62 (br, 1H), 8.55 (d, <i>J</i> = 2.2 Hz, 1H), 7.82 (d, <i>J</i> = 0.9 Hz, 1H), 6.51 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 2.29 (s, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>9</sub>H<sub>9</sub>N<sub>5</sub>O (M<sup>+</sup>) 203.0807, found 203.0808.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure for the Synthesis of 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-substituted Thioureas (<b>2f</b>–<b>m</b>)</h3><div class="NLM_p last">To a solution of <b>2d</b> (1 mmol) in DMF (10 mL) was added NaH (60% dispersion in mineral oil, 48 mg, 1.2 mmol). The mixture was stirred for 5 min, and then corresponding isocyanate and isothiocyanates were added. The reaction mixture was stirred at room temperature for 0.5 h. Water was added, and the mixture was extracted with EtOAc (3 × 50 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to afford corresponding target compounds in good yield.</div></div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-ethylurea (<b>2f</b>)</h3><div class="NLM_p last">White solid. 45% yield. Mp 195–197 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 1H), 8.64 (s, 1H), 8.62 (d, <i>J</i> = 2.7 Hz, 1H), 8.09 (s, 1H), 7.93 (d, <i>J</i> = 19.3 Hz, 1H), 7.49 (s, 1H), 6.62 (dd, <i>J</i> = 2.6, 1.6 Hz, 1H), 3.20 (m, <i>J</i> = 14.1, 7.1 Hz, 2H), 1.10 (t, <i>J</i> = 7.2 Hz, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>12</sub>N<sub>6</sub>O (M<sup>+</sup>) 232.1073, found 232.1074.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>2g</b>)</h3><div class="NLM_p last">White solid. 40% yield. Mp 201–203 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.30 (t, <i>J</i> = 5.1 Hz, 1H), 11.09 (s, 1H), 8.73 (t, <i>J</i> = 7.5 Hz, 1H), 8.63 (dd, <i>J</i> = 2.7, 0.5 Hz, 1H), 7.94 (d, <i>J</i> = 1.0 Hz, 1H), 7.64 (d, <i>J</i> = 0.9 Hz, 1H), 6.64 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 3.79–3.53 (m, 2H), 1.28–1.06 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>12</sub>N<sub>6</sub>S (M<sup>+</sup>) 248.0844, found 248.0845.</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-methylthiourea (<b>2h</b>)</h3><div class="NLM_p last">White solid. 63% yield. Mp 255–257 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.22 (d, <i>J</i> = 4.4 Hz, 1H), 11.16 (s, 1H), 8.72 (d, <i>J</i> = 0.9 Hz, 1H), 8.63 (d, <i>J</i> = 2.6 Hz, 1H), 7.94 (d, <i>J</i> = 1.1 Hz, 1H), 7.62 (d, <i>J</i> = 0.9 Hz, 1H), 6.64 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 3.12 (d, <i>J</i> = 4.6 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>9</sub>H<sub>10</sub>N<sub>6</sub>S (M<sup>+</sup>) 234.0688, found 234.0687.</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-propylthiourea (<b>2i</b>)</h3><div class="NLM_p last">White solid. 74% yield. Mp 166–168 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.38 (s, 1H), 11.14 (s, 1H), 8.75 (s, 1H), 8.63 (s, 1H), 7.95 (s, 1H), 7.64 (s, 1H), 6.64 (s, 1H), 3.59 (dd, <i>J</i> = 12.7, 6.5 Hz, 2H), 1.77–1.55 (m, 2H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 262.1001, found 262.1002.</div></div><div id="sec4_1_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-isopropylthiourea (<b>2j</b>)</h3><div class="NLM_p last">White solid. 76% yield. Mp 180–182 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.30 (d, <i>J</i> = 7.5 Hz, 1H), 11.07 (s, 1H), 8.75 (d, <i>J</i> = 0.8 Hz, 1H), 8.66–8.50 (m, 1H), 7.94 (d, <i>J</i> = 1.0 Hz, 1H), 7.64 (d, <i>J</i> = 0.9 Hz, 1H), 6.64 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 4.42 (m, <i>J</i> = 13.2, 6.6 Hz, 1H), 1.28 (d, <i>J</i> = 6.6 Hz, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 262.1001, found 262.1002.</div></div><div id="sec4_1_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-butylthiourea (<b>2k</b>)</h3><div class="NLM_p last">White solid. 68% yield. Mp 142–144 °C; <sup>1</sup>H NMR (400 MHz, DMSO) δ 11.36 (t, <i>J</i> = 4.8 Hz, 1H), 11.13 (s, 1H), 8.75 (s, 1H), 8.63 (s, 1H), 7.95 (s, 1H), 7.63 (s, 1H), 6.64 (s, 1H), 3.62 (dd, <i>J</i> = 12.8, 6.5 Hz, 2H), 1.70–1.56 (m, 2H), 1.44–1.30 (m, 2H), 0.94 (t, <i>J</i> = 7.3 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>16</sub>N<sub>6</sub>S (M<sup>+</sup>) 276.1157, found 276.1158.</div></div><div id="sec4_1_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-(<i>tert</i>-butyl)thiourea (<b>2l</b>)</h3><div class="NLM_p last">White solid. 69% yield. Mp 148–151 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (s, 1H), 10.86 (s, 1H), 8.74 (s, 1H), 8.66–8.48 (m, 1H), 7.93 (t, <i>J</i> = 7.6 Hz, 1H), 7.62 (d, <i>J</i> = 0.9 Hz, 1H), 6.64 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 1.56 (s, 8H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>16</sub>N<sub>6</sub>S (M<sup>+</sup>) 276.1157, found 276.1158.</div></div><div id="sec4_1_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-cyclohexylthiourea (<b>2m</b>)</h3><div class="NLM_p last">White solid. 80% yield. Mp 195–197 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.44 (d, <i>J</i> = 7.7 Hz, 1H), 11.08 (s, 1H), 8.76 (s, 1H), 8.63 (d, <i>J</i> = 2.7 Hz, 1H), 7.94 (d, <i>J</i> = 1.0 Hz, 1H), 7.64 (d, <i>J</i> = 0.8 Hz, 1H), 6.64 (dd, <i>J</i> = 2.6, 1.6 Hz, 1H), 4.21 (s, 1H), 1.98 (m, <i>J</i> = 8.6 Hz, 2H), 1.69 (m, 2H), 1.56 (m, <i>J</i> = 6.0 Hz, 1H), 1.49–1.22 (m, 5H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>18</sub>N<sub>6</sub>S (M<sup>+</sup>) 302.1314, found 302.1313.</div></div><div id="sec4_1_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-benzylthiourea (<b>2n</b>)</h3><div class="NLM_p last">White solid. 72% yield. Mp 217–219 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (t, <i>J</i> = 5.5 Hz, 1H), 11.28 (s, 1H), 8.71 (d, <i>J</i> = 0.9 Hz, 1H), 8.65–8.48 (m, 1H), 7.94 (t, <i>J</i> = 8.4 Hz, 1H), 7.67 (d, <i>J</i> = 0.9 Hz, 1H), 7.51–7.18 (m, 5H), 6.65–6.53 (m, 1H), 4.93 (d, <i>J</i> = 5.6 Hz, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>15</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 310.1001, found 310.1002.</div></div><div id="sec4_1_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(6-(1<i>H</i>-Pyrazol-1-yl)pyrimidin-4-yl)-3-(3-chlorophenyl)thiourea (<b>2o</b>)</h3><div class="NLM_p last">White solid. 75% yield. Mp 191–194 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.50 (s, 1H), 11.52 (s, 1H), 8.83 (d, <i>J</i> = 24.3 Hz, 1H), 8.64 (t, <i>J</i> = 15.7 Hz, 1H), 8.04–7.89 (m, 2H), 7.74 (s, 1H), 7.65 (d, <i>J</i> = 8.2 Hz, 1H), 7.46 (t, <i>J</i> = 8.1 Hz, 1H), 7.29 (dd, <i>J</i> = 35.4, 19.6 Hz, 1H), 6.67 (dd, <i>J</i> = 2.6, 1.6 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>11</sub>ClN<sub>6</sub>S (M<sup>+</sup>) 330.0454, found 330.0452.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> General Procedure for the Synthesis of Different 1-Pyrimidin-3-ethylthioureas <b>3a</b>–<b>l</b></h3><div class="NLM_p last">To a solution of corresponding intermediates <b>7a</b>–<b>l</b> (1 mmol) in DMF (8 mL) was added NaH (60% dispersion in mineral oil, 48 mg, 1.2 mmol). The solution was stirred for 5 min, and then ethyl isothiocyanate (87 mg, 1 mmol) was added. The reaction mixture was stirred at room temperature for 0.5 h. Water was added, and the mixture was extracted with EtOAc (3 × 50 mL). Organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to afford corresponding target compounds in good yield.</div></div><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(6-(1<i>H</i>-Pyrrol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>3a</b>)</h3><div class="NLM_p last">White solid. 60% yield. Mp 226–229 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.25 (t, <i>J</i> = 5.0 Hz, 1H), 10.81 (s, 1H), 8.69 (s, 1H), 7.58–7.44 (m, 2H), 7.24 (d, <i>J</i> = 0.7 Hz, 1H), 6.54–6.26 (m, 2H), 3.77–3.54 (m, 2H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>13</sub>N<sub>5</sub>S (M<sup>+</sup>) 247.0892, found 247.0892.</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(6-(1<i>H</i>-Imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>3b</b>)</h3><div class="NLM_p last">White solid. 54% yield. Mp 221–223 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.12 (d, <i>J</i> = 54.2 Hz, 1H), 10.98 (s, 1H), 8.77 (d, <i>J</i> = 0.8 Hz, 1H), 8.47 (d, <i>J</i> = 15.4 Hz, 1H), 7.75 (t, <i>J</i> = 1.4 Hz, 1H), 7.29 (t, <i>J</i> = 16.7 Hz, 1H), 7.23–6.97 (m, 1H), 3.76–3.56 (m, 1H), 1.31–1.08 (m, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>12</sub>N<sub>6</sub>S (M<sup>+</sup>) 248.0844, found 248.0845.</div></div><div id="sec4_1_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-(6-(1<i>H</i>-1,2,3-Triazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>3c</b>)</h3><div class="NLM_p last">White solid. 48% yield. Mp 252–254 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.26 (s, 1H), 11.22 (s, 1H), 9.17–8.77 (m, 2H), 8.06 (d, <i>J</i> = 1.0 Hz, 1H), 7.88 (s, 1H), 3.90–3.48 (m, 2H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>9</sub>H<sub>11</sub>N<sub>7</sub>S (M<sup>+</sup>) 249.0797, found 249.0796.</div></div><div id="sec4_1_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(6-(1<i>H</i>-1,2,4-Triazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>3d</b>)</h3><div class="NLM_p last">White solid. 50% yield. Mp 246–247 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.22 (d, <i>J</i> = 10.9 Hz, 1H), 9.45 (s, 1H), 8.81 (d, <i>J</i> = 0.9 Hz, 1H), 8.40 (s, 1H), 7.61 (d, <i>J</i> = 0.9 Hz, 1H), 3.76–3.56 (m, 1H), 1.23 (t, <i>J</i> = 7.2 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>9</sub>H<sub>11</sub>N<sub>7</sub>S (M<sup>+</sup>) 249.0797, found 249.0796.</div></div><div id="sec4_1_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-(6-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>3e</b>)</h3><div class="NLM_p last">White solid. 46% yield. Mp 227–230 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.21 (s, 1H), 11.02 (s, 1H), 8.92 (s, 1H), 8.86 (s, 1H), 8.17 (d, <i>J</i> = 8.2 Hz, 1H), 7.83 (d, <i>J</i> = 7.8 Hz, 1H), 7.64 (s, 1H), 7.56–7.09 (m, 3H), 3.81–3.55 (m, 2H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 298.1001, found 298.1002.</div></div><div id="sec4_1_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-Ethyl-3-(6-(pyrrolidin-1-yl)pyrimidin-4-yl)thiourea (<b>3f</b>)</h3><div class="NLM_p last">Yellow solid. 44% yield. Mp 194–196 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.57 (t, <i>J</i> = 5.0 Hz, 1H), 10.27 (s, 1H), 8.29 (d, <i>J</i> = 38.6 Hz, 1H), 6.06 (s, 1H), 3.73–3.53 (m, 2H), 3.53–2.99 (m, 4H), 1.96 (d, <i>J</i> = 24.4 Hz, 3H), 1.24–1.06 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>17</sub>N<sub>5</sub>S (M<sup>+</sup>) 251.1205, found 251.1204.</div></div><div id="sec4_1_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-Ethyl-3-(6-morpholinopyrimidin-4-yl)thiourea (<b>3g</b>)</h3><div class="NLM_p last">Yellow solid. 54% yield. Mp 168–170 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.46 (s, 1H), 10.32 (s, 1H), 8.31 (s, 1H), 6.35 (s, 1H), 3.71–3.64 (m, 3H), 3.64–3.53 (m, 2H), 3.52–3.42 (m, 3H), 1.19 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>17</sub>N<sub>5</sub>OS (M<sup>+</sup>) 267.1154, found 267.1155.</div></div><div id="sec4_1_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-Ethyl-3-(6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)thiourea (<b>3h</b>)</h3><div class="NLM_p last">Yellow solid. 41% yield. Mp 169–172 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.52 (s, 1H), 8.33 (s, 1H), 8.27 (s, 1H), 5.79 (s, 1H), 3.82–3.71 (m, 2H), 3.71 (s, 4H), 2.55 (s, 3H), 2.40 (s, 3H), 1.32 (t, <i>J</i> = 7.3 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>20</sub>N<sub>6</sub>S (M<sup>+</sup>) 280.1470, found 280.1473.</div></div><div id="sec4_1_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-(6-(Benzylamino)pyrimidin-4-yl)-3-ethylthiourea (<b>3i</b>)</h3><div class="NLM_p last">Yellow solid. 51% yield. Mp 207–211 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.51 (t, <i>J</i> = 5.0 Hz, 1H), 10.33 (s, 1H), 8.19 (s, 1H), 8.00 (s, 1H), 7.59–6.98 (m, 5H), 6.11 (s, 1H), 4.46 (s, 2H), 3.70–3.40 (m, 2H), 1.16 (t, <i>J</i> = 7.1, 2.8 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>17</sub>N<sub>5</sub>S (M<sup>+</sup>) 287.1205, found 287.1206.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedure for the Synthesis of Target Compounds <b>4a</b>–<b>e</b></h3><div class="NLM_p last">To a solution of corresponding intermediates <b>8a</b>–<b>e</b> (1 mmol) in DMF (8 mL) was added NaH (60% dispersion in mineral oil, 48 mg, 1.2 mmol). The solution was stirred for 5 min, and then ethyl isothiocyanate (87 mg, 1 mmol) was added. The reaction mixture was stirred at room temperature for 0.5 h. Water was added, and the mixture was extracted with EtOAc (3 × 50 mL). Organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to afford corresponding target compounds <b>4a</b>–<b>e</b> in good yield.</div></div><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-(6-(1<i>H</i>-Imidazol-1-yl)-2-methylpyrimidin-4-yl)-3-ethylthiourea (<b>4a</b>)</h3><div class="NLM_p last">White solid. 60% yield. Mp 237–239 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.33 (s, 1H), 10.90 (s, 1H), 8.41 (s, 1H), 7.73 (s, 1H), 7.18 (s, 1H), 7.13 (s, 1H), 3.75–3.51 (m, 2H), 2.59 (s, 2H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 262.1001, found 262.1002.</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-(6-(1<i>H</i>-Imidazol-1-yl)-5-methylpyrimidin-4-yl)-3-ethylthiourea (<b>4b</b>)</h3><div class="NLM_p last">White solid. 58% yield. Mp 198–200 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.37 (s, 1H), 9.50 (s, 1H), 8.71 (s, 1H), 8.14 (s, 1H), 7.63 (s, 1H), 7.14 (s, 1H), 3.79–3.48 (m, 2H), 2.26 (s, 3H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 262.1001, found 262.1002.</div></div><div id="sec4_1_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-(2-(1<i>H</i>-Imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>4c</b>)</h3><div class="NLM_p last">White solid. 65% yield. Mp 242–245 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.10 (s, 1H), 10.45 (s, 1H), 8.55 (d, <i>J</i> = 5.8 Hz, 1H), 8.49 (s, 1H), 7.84 (s, 1H), 7.17 (s, 1H), 7.09 (d, <i>J</i> = 5.8 Hz, 1H), 3.77–3.50 (m, 2H), 1.28 (t, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>12</sub>N<sub>6</sub>S (M<sup>+</sup>) 248.0844, found 248.0845.</div></div><div id="sec4_1_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-(4-(1<i>H</i>-Imidazol-1-yl)pyrimidin-2-yl)-3-ethylthiourea (<b>4d</b>)</h3><div class="NLM_p last">White solid. 68% yield. Mp 244–246 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.90 (d, <i>J</i> = 71.8 Hz, 1H), 10.72 (s, 1H), 8.72 (d, <i>J</i> = 5.6 Hz, 1H), 8.66 (s, 1H), 8.01 (s, 1H), 7.55 (d, <i>J</i> = 5.7 Hz, 1H), 7.20 (s, 1H), 3.81–3.54 (m, 2H), 1.22 (t, <i>J</i> = 19.2, 12.1 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>12</sub>N<sub>6</sub>S (M<sup>+</sup>) 248.0844, found 248.0845.</div></div><div id="sec4_1_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-(4-(1<i>H</i>-Imidazol-1-yl)-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-2-yl)-3-ethylthiourea (<b>4e</b>)</h3><div class="NLM_p last">White solid. 63% yield. Mp 285–286 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.91 (s, 1H), 10.60 (s, 1H), 8.45 (s, 1H), 7.89 (s, 1H), 7.21 (s, 1H), 3.73–3.54 (m, 2H), 3.22–3.09 (m, 2H), 3.05–2.88 (m, 2H), 2.22–2.06 (m, 2H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>13</sub>H<sub>16</sub>N<sub>6</sub>S (M<sup>+</sup>) 288.1157, found 288.1158.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> General Procedure for the Synthesis of 1-(6-(1<i>H</i>-Imidazol-1-yl)pyrimidin-4-yl)-3-ethylthioureas <b>5a</b>–<b>j</b></h3><div class="NLM_p last">To a solution of corresponding intermediates <b>9a</b>–<b>j</b> (1 mmol) in DMF (8 mL) was added NaH (60% dispersion in mineral oil, 48 mg, 1.2 mmol). The solution was stirred for 5 min, and then ethyl isothiocyanate (87 mg, 1 mmol) was added. The reaction mixture was stirred at room temperature for 0.5 h. Water was added, and the mixture was extracted with EtOAc (3 × 50 mL). Organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to afford corresponding target compounds <b>5a</b>–<b>j</b> in good yields.</div></div><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-Ethyl-3-(6-(2-methyl-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5a</b>)</h3><div class="NLM_p last">White solid. 60% yield. Mp 201–204 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.29–11.04 (m, 1H), 10.99 (s, 1H), 8.80 (s, 1H), 7.60 (d, <i>J</i> = 1.5 Hz, 1H), 7.33 (s, 1H), 6.94 (t, <i>J</i> = 17.7 Hz, 1H), 3.77–3.55 (m, 2H), 2.58 (s, 3H), 1.26–1.17 (m, 4H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 262.1001, found 262.1002.</div></div><div id="sec4_1_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-Ethyl-3-(6-(2-ethyl-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5b</b>)</h3><div class="NLM_p last">White solid. 68% yield. Mp 166–168 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.18 (t, <i>J</i> = 5.1 Hz, 1H), 11.01 (s, 1H), 8.80 (s, 1H), 7.56 (d, <i>J</i> = 1.3 Hz, 1H), 7.28 (s, 1H), 7.00 (d, <i>J</i> = 1.3 Hz, 1H), 3.73–3.50 (m, 2H), 2.96 (q, <i>J</i> = 7.4 Hz, 2H), 1.39–1.10 (m, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>16</sub>N<sub>6</sub>S (M<sup>+</sup>) 276.1157, found 276.1158.</div></div><div id="sec4_1_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-Ethyl-3-(6-(4-methyl-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5c</b>)</h3><div class="NLM_p last">White solid. 69% yield. Mp 252–255 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (s, 1H), 10.95 (s, 1H), 8.76 (d, <i>J</i> = 24.7 Hz, 1H), 8.34 (d, <i>J</i> = 0.7 Hz, 1H), 7.38 (d, <i>J</i> = 35.7 Hz, 1H), 7.23 (s, 1H), 3.79–3.54 (m, 2H), 2.19 (s, 3H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>14</sub>N<sub>6</sub>S (M<sup>+</sup>) 262.1001, found 262.1001.</div></div><div id="sec4_1_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-(6-(4-Chloro-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5d</b>)</h3><div class="NLM_p last">White solid. 60% yield. Mp 241–250 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.15 (s, 1H), 11.06 (s, 1H), 8.75 (t, <i>J</i> = 17.8 Hz, 1H), 8.45 (d, <i>J</i> = 1.5 Hz, 1H), 7.89 (d, <i>J</i> = 1.5 Hz, 1H), 7.29 (d, <i>J</i> = 0.7 Hz, 1H), 3.81–3.50 (m, 2H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>11</sub>ClN<sub>6</sub>S (M<sup>+</sup>) 282.0454, found 282.0459.</div></div><div id="sec4_1_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1-(6-(4-Bromo-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5e</b>)</h3><div class="NLM_p last">White solid. 63% yield. Mp 262–265 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.15 (s, 1H), 11.05 (s, 1H), 8.78 (s, 1H), 8.45 (s, 1H), 7.93 (d, <i>J</i> = 1.0 Hz, 1H), 7.29 (s, 1H), 3.79–3.46 (m, 2H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>11</sub>BrN<sub>6</sub>S (M<sup>+</sup>) 325.9949, found 325.9947.</div></div><div id="sec4_1_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1-Ethyl-3-(6-(4-iodo-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5f</b>)</h3><div class="NLM_p last">White solid. 68% yield. Mp 268–270 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.15 (t, <i>J</i> = 5.0 Hz, 1H), 11.02 (s, 1H), 8.77 (s, 1H), 8.39 (s, 1H), 7.94 (s, 1H), 7.27 (s, 1H), 3.72–3.56 (m, 2H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>11</sub>IN<sub>6</sub>S (M<sup>+</sup>) 373.9811, found 373.9812.</div></div><div id="sec4_1_5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1-Ethyl-3-(6-(4-(trifluoromethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5g</b>)</h3><div class="NLM_p last">White solid. 64% yield. Mp 262–264 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.14 (t, <i>J</i> = 5.1 Hz, 1H), 11.08 (s, 1H), 8.83 (s, 1H), 8.63 (s, 1H), 8.42 (s, 1H), 7.41 (s, 1H), 3.75–3.51 (m, 2H), 1.37–1.13 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>11</sub>F<sub>3</sub>N<sub>6</sub>S (M<sup>+</sup>) 316.0718, found 306.0721.</div></div><div id="sec4_1_5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 1-Ethyl-3-(6-(4-nitro-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5h</b>)</h3><div class="NLM_p last">White solid. 50% yield. Mp 243–244 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.16 (s, 1H), 11.12 (s, 1H), 8.86 (s, 2H), 8.62 (s, 1H), 7.47 (s, 1H), 3.78–3.50 (m, 2H), 1.23 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>10</sub>H<sub>11</sub>N<sub>7</sub>O<sub>2</sub>S (M<sup>+</sup>) 293.0695, found 293.0696.</div></div><div id="sec4_1_5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 1-Ethyl-3-(6-(4-formyl-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5i</b>)</h3><div class="NLM_p last">Yellow solid. 48% yield. Mp 212–213 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.14 (t, <i>J</i> = 5.1 Hz, 1H), 11.10 (s, 1H), 9.88 (s, 1H), 8.83 (s, 1H), 8.62 (s, 2H), 7.43 (s, 1H), 3.72–3.57 (m, 2H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>12</sub>N<sub>6</sub>OS (M<sup>+</sup>) 276.0793, found 276.0795.</div></div><div id="sec4_1_5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Methyl 1-(6-(3-Ethylthioureido)pyrimidin-4-yl)-1<i>H</i>-imidazole-4-carboxylate (<b>5j</b>)</h3><div class="NLM_p last">White solid. 53% yield. Mp 240–243 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.15 (d, <i>J</i> = 5.4 Hz, 1H), 11.04 (s, 1H), 8.82 (s, 1H), 8.54 (d, <i>J</i> = 1.2 Hz, 1H), 8.36 (d, <i>J</i> = 1.2 Hz, 1H), 7.40 (s, 1H), 3.82 (s, 3H), 3.72–3.55 (m, 2H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>14</sub>N<sub>6</sub>O<sub>2</sub>S (M<sup>+</sup>) 306.0899, found 306.0900.</div></div><div id="sec4_1_5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-Ethyl-3-(6-(4-(hydroxymethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5k</b>)</h3><div class="NLM_p last">To a solution of compound <b>5i</b> (276 mg, 1 mmol) in MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:1 (5:5 mL) was added NaBH<sub>4</sub> (45.4 mg, 1.2 mmol), and the mixture was stirred at room temperature for 5 h, and the solvent was evaporated to dryness under reduced pressure. The residue was purified on a silica gel column using mixtures of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:20, v/v) as eluent, obtaining the target compound <b>5k</b>. White solid, 50% yield. Mp 238–240 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (t, <i>J</i> = 5.0 Hz, 1H), 10.93 (s, 1H), 8.75 (s, 1H), 8.39 (s, 1H), 7.52 (s, 1H), 7.27 (s, 1H), 5.13 (t, <i>J</i> = 5.7 Hz, 1H), 4.43 (d, <i>J</i> = 5.6 Hz, 2H), 3.75–3.50 (m, 2H), 1.31–1.14 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>14</sub>N<sub>6</sub>OS (M<sup>+</sup>) 278.0950, found 287.0952.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> General Procedure for the Synthesis of 1-(6-(4-(Aminomethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthioureas <b>5l</b>–<b>x</b></h3><div class="NLM_p last">To a solution of compound <b>5i</b> (138 mg, 0.5 mmol) in MeOH/DCE = 1:1 was added corresponding alicyclic amines (1 mmol), AcOH (1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol) in sequence. The mixture was stirred at room temperature for 12 h, and solvent was evaporated to dryness under reduced pressure. The residue was purified on a silica gel column using mixtures of MeOH/CH<sub>2</sub>Cl<sub>2</sub> as eluent, obtaining the target compounds <b>5l</b>–<b>x</b>.</div></div><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 1-Ethyl-3-(6-(4-((methylamino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5l</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), methylamine (1 mmol, 2 M in THF), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:5, v/v) as eluent. Compound <b>5l</b>: yellow solid. 40% yield. Mp 114–117 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (s, 1H), 8.85–8.69 (m, 1H), 8.59–8.36 (m, 1H), 7.66 (s, 1H), 7.33–7.22 (m, 1H), 3.77 (s, 2H), 3.70–3.57 (m, 3H), 2.40 (s, 3H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>17</sub>N<sub>7</sub>S (M<sup>+</sup>) 291.1266, found 291.1267.</div></div><div id="sec4_1_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1-Ethyl-3-(6-(4-((ethylamino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5m</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), ethylamine (1 mmol, 2 M in THF), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10, v/v) as eluent. Compound <b>5m</b>: yellow solid. 55% yield. Mp 105–108 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.20 (t, <i>J</i> = 5.0 Hz, 1H), 8.77 (d, <i>J</i> = 15.5 Hz, 1H), 8.53–8.32 (m, 1H), 7.59 (s, 1H), 7.39–7.23 (m, 1H), 3.71 (s, 2H), 3.68–3.59 (m, 3H), 2.70–2.58 (m, 2H), 1.23 (t, <i>J</i> = 7.1 Hz, 3H), 1.13–1.02 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>13</sub>H<sub>19</sub>N<sub>7</sub>S (M<sup>+</sup>) 305.1423, found 305.1424.</div></div><div id="sec4_1_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1-(6-(4-((Cyclohexylamino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5n</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), cyclohexylamine (114 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:20, v/v) as eluent. Compound <b>5n</b>: white solid. 50% yield. Mp 171–174 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (t, <i>J</i> = 5.0 Hz, 1H), 8.75 (s, 1H), 8.38 (d, <i>J</i> = 13.9 Hz, 1H), 7.44 (d, <i>J</i> = 108.6 Hz, 1H), 7.28 (s, 1H), 3.70 (d, <i>J</i> = 20.8 Hz, 2H), 3.69–3.58 (m, 2H), 1.87 (d, <i>J</i> = 11.5 Hz, 2H), 1.75–1.63 (m, 2H), 1.56 (d, <i>J</i> = 10.4 Hz, 1H), 1.30–0.98 (m, 9H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>17</sub>H<sub>26</sub>N<sub>7</sub>S [M + H]<sup>+</sup> 360.1970, found 360.1973.</div></div><div id="sec4_1_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1-(6-(4-((Benzylamino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5o</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), benzylamine (109 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:20, v/v) as eluent. Compound <b>5o</b>: yellow solid. 56% yield. Mp 182–185 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.28 (s, 1H), 9.72 (s, 1H), 8.63 (s, 1H), 8.42 (d, <i>J</i> = 20.8 Hz, 1H), 7.48 (s, 1H), 7.42–7.30 (m, 4H), 7.25 (d, <i>J</i> = 10.7 Hz, 2H), 6.82 (s, 1H), 3.89 (s, 2H), 3.84 (s, 2H), 3.81–3.73 (m, 2H), 1.36 (t, <i>J</i> = 7.3 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>21</sub>N<sub>7</sub>S [M + H]<sup>+</sup> 368.1657, found 368.1659.</div></div><div id="sec4_1_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 1-(6-(4-((Dimethylamino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5p</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), dimethylamine (1 mmol, 2 M in THF), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10, v/v) as eluent. Compound <b>5p</b>: white solid. 42% yield. Mp 181–183 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.17 (t, <i>J</i> = 5.2 Hz, 1H), 11.02 (s, 1H), 8.79 (s, 1H), 8.52 (s, 1H), 7.82 (s, 1H), 7.33 (s, 1H), 3.99 (s, 1H), 3.72–3.58 (m, 1H), 2.57 (s, 6H), 1.30–1.16 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>13</sub>H<sub>19</sub>N<sub>7</sub>S (M<sup>+</sup>) 305.1423, found 305.1425.</div></div><div id="sec4_1_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 1-(6-(4-((Diethylamino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5q</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), diethylamine (103 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10, v/v) as eluent. Compound <b>5q</b>: white solid. 48% yield. Mp 152–155 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.17 (t, <i>J</i> = 5.3 Hz, 1H), 10.92 (s, 1H), 8.76 (s, 1H), 8.41 (s, 1H), 7.63 (s, 1H), 7.31 (s, 1H), 3.72 (s, 2H), 3.68–3.54 (m, 2H), 2.63 (s, 4H), 1.24 (t, <i>J</i> = 7.1 Hz, 3H), 1.07 (t, <i>J</i> = 6.7 Hz, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>15</sub>H<sub>23</sub>N<sub>7</sub>S (M<sup>+</sup>) 333.1736, found 333.1738.</div></div><div id="sec4_1_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 1-(6-(4-((Dipropylamino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5r</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), dipropylamine (137 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:15, v/v) as eluent. Compound <b>5r</b>: white solid. 58% yield. Mp 158–161 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.32 (s, 1H), 9.93 (s, 1H), 8.65 (s, 1H), 8.40 (s, 1H), 7.51 (s, 1H), 6.96 (s, 1H), 3.91–3.73 (m, 2H), 3.69 (s, 2H), 2.57–2.44 (m, 4H), 1.63–1.48 (m, 4H), 1.38 (t, <i>J</i> = 7.3 Hz, 3H), 0.90 (t, <i>J</i> = 7.3 Hz, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>17</sub>H<sub>27</sub>N<sub>7</sub>S (M<sup>+</sup>) 361.2049, found 361.2050.</div></div><div id="sec4_1_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1-(6-(4-((Benzyl(methyl)amino)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5s</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), <i>N</i>-methylbenzylamine (129 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:15, v/v) as eluent. Compound <b>5s</b>: white solid. 50% yield. Mp 153–155 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (s, 1H), 10.92 (s, 1H), 8.76 (s, 1H), 8.40 (s, 1H), 7.58 (s, 1H), 7.45–7.29 (m, 3H), 7.26 (d, <i>J</i> = 6.4 Hz, 1H), 3.64 (m, <i>J</i> = 13.8, 7.0 Hz, 2H), 3.56 (s, 1H), 3.53 (s, 1H), 2.16 (s, 3H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>19</sub>H<sub>23</sub>N<sub>7</sub>S [M + H]<sup>+</sup> 382.1814, found 382.1813.</div></div><div id="sec4_1_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 1-Ethyl-3-(6-(4-(pyrrolidin-1-ylmethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5t</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), tetrahydropyrrole (82 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:8, v/v) as eluent. Compound <b>5t</b>: white solid. 66% yield. Mp 179–180 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.18 (t, <i>J</i> = 5.2 Hz, 1H), 10.92 (s, 1H), 8.75 (s, 1H), 8.39 (s, 1H), 7.58 (s, 1H), 7.29 (s, 1H), 3.72–3.58 (m, 4H), 2.60 (s, 4H), 1.71 (s, 4H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>15</sub>H<sub>21</sub>N<sub>7</sub>S (M<sup>+</sup>) 331.1579, found 331.1581.</div></div><div id="sec4_1_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 1-Ethyl-3-(6-(4-(piperidin-1-ylmethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5u</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), piperidine (92 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10, v/v) as eluent. Compound <b>5u</b>: white solid. 48% yield. Mp 156–159 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (t, <i>J</i> = 5.0 Hz, 1H), 10.97 (s, 1H), 8.76 (s, 1H), 8.41 (s, 1H), 7.62 (s, 1H), 7.30 (s, 1H), 3.73–3.60 (m, 2H), 3.52 (d, <i>J</i> = 41.2 Hz, 2H), 2.61 (d, <i>J</i> = 52.6 Hz, 4H), 1.54 (s, 4H), 1.40 (s, 2H), 1.23 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>23</sub>N<sub>7</sub>S (M<sup>+</sup>) 345.1736, found 345.1738.</div></div><div id="sec4_1_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 1-(6-(4-(Azepan-1-ylmethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)-3-ethylthiourea (<b>5v</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), hexamethylenimine (113 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:15, v/v) as eluent. Compound <b>5v</b>: yellow solid. 64% yield. Mp 141–144 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.27 (s, 1H), 9.74 (s, 1H), 8.64 (s, 1H), 8.43 (s, 1H), 7.78 (s, 1H), 7.12 (s, 1H), 3.90 (s, 2H), 3.86–3.72 (m, 2H), 3.00–2.89 (m, 4H), 1.78 (s, 4H), 1.66 (s, 4H), 1.40–1.31 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>17</sub>H<sub>25</sub>N<sub>7</sub>S (M<sup>+</sup>) 359.1892, found 359.1893.</div></div><div id="sec4_1_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 1-Ethyl-3-(6-(4-(morpholinomethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5w</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), morpholine (87 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10, v/v) as eluent. Compound <b>5w</b>: white solid. 60% yield. Mp 188–190 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.24 (s, 1H), 9.46 (s, 1H), 8.65 (s, 1H), 8.42 (s, 1H), 7.69 (s, 1H), 6.97 (s, 1H), 3.91–3.62 (m, 8H), 2.75 (s, 4H), 1.37 (t, <i>J</i> = 7.3 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>15</sub>H<sub>21</sub>N<sub>7</sub>OS (M<sup>+</sup>) 347.1528, found 347.1515.</div></div><div id="sec4_1_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 1-Ethyl-3-(6-(4-((4-methylpiperazin-1-yl)methyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-yl)thiourea (<b>5x</b>)</h3><div class="NLM_p last">Reagents used were compound <b>5i</b> (138 mg, 0.5 mmol), 1-methylpiperazine (111 μL, 1 mmol), AcOH (60 mg, 1 mmol), and NaBH<sub>3</sub>(CN) (62.8 mg, 1 mmol). Purification involved the use of MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:8, v/v) as eluent. Compound <b>5l</b>: white solid. 48% yield. Mp 178–179 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (t, <i>J</i> = 5.3 Hz, 1H), 10.94 (s, 1H), 8.75 (s, 1H), 8.38 (s, 1H), 7.55 (s, 1H), 7.29 (s, 1H), 3.75–3.56 (m, 2H), 3.46 (s, 2H), 3.41–3.21 (m, 4H), 2.48–2.30 (m, 4H), 2.21 (s, 3H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>24</sub>N<sub>8</sub>S (M<sup>+</sup>) 360.1845, found 360.1847.</div></div><div id="sec4_1_6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 4-Chloro-6-(1<i>H</i>-pyrazol-1-yl)pyrimidine (<b>6</b>)</h3><div class="NLM_p last">A mixture of pyrazole (272 mg, 4 mmol), 4,6-dichloropyrimidine (596 mg, 4 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1434 mg, 4.4 mmol) was stirred in DMF (10 mL) for 12 h at room temperature. Water (60 mL) was added. The mixture was extracted with EtOAc (3 × 60 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of EtOAc/petroleum ether (1:50, v/v), to afford <b>6</b> (427 mg, 60%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97 (d, <i>J</i> = 0.9 Hz, 1H), 8.76–8.68 (m, 1H), 8.01 (d, <i>J</i> = 1.1 Hz, 1H), 7.98 (d, <i>J</i> = 0.9 Hz, 1H), 6.71 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H).</div></div><div id="sec4_1_6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 6-(1<i>H</i>-Pyrrol-1-yl)pyrimidin-4-amine (<b>7a</b>)</h3><div class="NLM_p last">To a solution of pyrrole (70 μL, 1 mmol) in DMF was added NaH (60% dispersion in mineral oil, 60 mg, 1.5 mmol). The mixture was stirred for 5 min, and then 4-amino-6-chloropyrimidine (130 mg, 1 mmol) was added. The reaction mixture was stirred at room temperature for 2 h, then water was added. The mixture was extracted with EtOAc (3 × 50 mL), the organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub>, obtaining target compound <b>7a</b>. Yellow solid, 15% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (s, 1H), 7.54 (s, 2H), 7.00 (s, 2H), 6.48 (s, 1H), 6.30 (s, 2H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> General Procedure for the Synthesis of 6-Substituted Pyrimidin-4-amines (<b>7b</b>–<b>i</b>)</h3><div class="NLM_p last">A mixture of 4-amino-6-chloropyrimidine (1.30 g, 10 mmol), corresponding nitrogen heterocyclic compounds or alicyclic amine (11 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (3.91 g, 12 mmol) was stirred in DMF (20 mL) for 12–24 h at 100–120 °C. Water (100 mL) was added. The mixture was extracted with EtOAc (3 × 100 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to afford the intermediates <b>7b</b>–<b>i</b>.</div></div><div id="sec4_1_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 6-(1<i>H</i>-Imidazol-1-yl)pyrimidin-4-amine (<b>7b</b>)</h3><div class="NLM_p last">White solid. 45% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.48–8.43 (m, 1H), 8.33 (d, <i>J</i> = 0.8 Hz, 1H), 7.82 (t, <i>J</i> = 1.4 Hz, 1H), 7.20 (s, 2H), 7.15–7.08 (m, 1H), 6.57 (d, <i>J</i> = 1.0 Hz, 1H).</div></div><div id="sec4_1_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 6-(1<i>H</i>-1,2,3-Triazol-1-yl)pyrimidin-4-amine (<b>7c</b>)</h3><div class="NLM_p last">White solid. 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (d, <i>J</i> = 1.1 Hz, 1H), 8.42 (s, 1H), 7.99 (d, <i>J</i> = 1.1 Hz, 1H), 7.45 (s, 2H), 7.09 (d, <i>J</i> = 0.7 Hz, 1H).</div></div><div id="sec4_1_7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 6-(1<i>H</i>-1,2,4-Triazol-1-yl)pyrimidin-4-amine (<b>7d</b>)</h3><div class="NLM_p last">White solid. 42% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.32 (s, 1H), 8.37 (t, <i>J</i> = 5.1 Hz, 4H), 8.32 (s, 4H), 7.39 (s, 8H), 6.84 (d, <i>J</i> = 0.9 Hz, 5H).</div></div><div id="sec4_1_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 6-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)pyrimidin-4-amine (<b>7e</b>)</h3><div class="NLM_p last">White solid. 35% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.89 (s, 1H), 8.45 (d, <i>J</i> = 0.7 Hz, 1H), 8.20 (t, <i>J</i> = 7.7 Hz, 1H), 7.87–7.69 (m, 1H), 7.47–7.30 (m, 2H), 7.24 (s, 2H), 6.82 (d, <i>J</i> = 0.9 Hz, 1H).</div></div><div id="sec4_1_7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 6-(Pyrrolidin-1-yl)pyrimidin-4-amine (<b>7f</b>)</h3><div class="NLM_p last">White solid. 25% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 7.27 (s, 1H), 5.33 (d, <i>J</i> = 18.2 Hz, 1H), 4.63 (s, 2H), 3.42 (s, 4H), 1.99 (s, 4H).</div></div><div id="sec4_1_7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 6-Morpholinopyrimidin-4-amine (<b>7g</b>)</h3><div class="NLM_p last">White solid. 50% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (d, <i>J</i> = 16.6 Hz, 1H), 7.27 (s, 1H), 5.53 (d, <i>J</i> = 35.7 Hz, 1H), 4.78 (s, 2H), 3.89–3.69 (m, 4H), 3.65–3.40 (m, 4H).</div></div><div id="sec4_1_7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 6-(4-Methylpiperazin-1-yl)pyrimidin-4-amine (<b>7h</b>)</h3><div class="NLM_p last">White solid. 55% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.19 (s, 1H), 7.27 (s, 1H), 5.58 (s, 1H), 4.62 (s, 2H), 3.61 (dd, <i>J</i> = 16.5, 11.5 Hz, 4H), 2.59–2.44 (m, 4H), 2.35 (s, 3H).</div></div><div id="sec4_1_7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> <i>N</i>4-Benzylpyrimidine-4,6-diamine (<b>7i</b>)</h3><div class="NLM_p last">White solid. 15% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12 (s, 1H), 7.33 (m, <i>J</i> = 14.5, 7.3 Hz, 5H), 5.37 (s, 1H), 5.23 (br, 1H), 4.56 (br, 2H), 4.43 (d, <i>J</i> = 5.8 Hz, 2H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> General Procedure for the Synthesis of Intermediates <b>9a</b>–<b>j</b></h3><div class="NLM_p last">A mixture of 4-amino-6-chloropyrimidine (1.30 g, 10 mmol), corresponding substituted imidazoles (11 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (3.91 g, 12 mmol) was stirred in DMF (20 mL) for 12–24 h at 100–120 °C. Water (100 mL) was added. The mixture was extracted with EtOAc (3 × 100 mL). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of the solvents produced a residue which was purified using column chromatography, eluted with a mixture of MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to afford the intermediates <b>9a</b>–<b>j</b>.</div></div><div id="sec4_1_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 6-(2-Methyl-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9a</b>)</h3><div class="NLM_p last">Yellow solid. 55% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36 (d, <i>J</i> = 0.7 Hz, 1H), 7.51 (d, <i>J</i> = 1.5 Hz, 1H), 7.20 (s, 2H), 6.90 (d, <i>J</i> = 1.5 Hz, 1H), 6.48 (d, <i>J</i> = 0.9 Hz, 1H), 2.52 (d, <i>J</i> = 2.6 Hz, 3H).</div></div><div id="sec4_1_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 6-(2-Ethyl-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9b</b>)</h3><div class="NLM_p last">Yellow solid. 50% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (t, <i>J</i> = 6.6 Hz, 1H), 7.48 (d, <i>J</i> = 1.5 Hz, 1H), 7.21 (s, 2H), 6.92 (d, <i>J</i> = 1.5 Hz, 1H), 6.46 (t, <i>J</i> = 3.3 Hz, 1H), 2.92 (q, <i>J</i> = 7.5 Hz, 2H), 1.35–1.06 (m, 3H).</div></div><div id="sec4_1_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 6-(4-Methyl-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9c</b>)</h3><div class="NLM_p last">Yellow solid. 50% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (d, <i>J</i> = 1.1 Hz, 1H), 8.29 (s, 1H), 7.50 (s, 1H), 7.14 (s, 2H), 6.48 (d, <i>J</i> = 0.8 Hz, 1H), 2.16 (s, 3H).</div></div><div id="sec4_1_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 6-(4-Chloro-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9d</b>)</h3><div class="NLM_p last">Yellow solid. 48% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (dd, <i>J</i> = 19.5, 1.5 Hz, 1H), 8.33 (d, <i>J</i> = 0.6 Hz, 1H), 7.98 (d, <i>J</i> = 1.6 Hz, 1H), 7.29 (s, 2H), 6.57 (d, <i>J</i> = 0.9 Hz, 1H).</div></div><div id="sec4_1_8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 6-(4-Bromo-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9e</b>)</h3><div class="NLM_p last">Yellow solid. 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45 (d, <i>J</i> = 1.4 Hz, 1H), 8.33 (s, 1H), 8.03 (d, <i>J</i> = 1.4 Hz, 1H), 7.28 (s, 2H), 6.58 (s, 1H).</div></div><div id="sec4_1_8_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> 6-(4-Iodo-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9f</b>)</h3><div class="NLM_p last">Yellow solid. 41% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 1.1 Hz, 1H), 8.32 (s, 1H), 8.05 (d, <i>J</i> = 1.1 Hz, 1H), 7.25 (s, 2H), 6.56 (s, 1H).</div></div><div id="sec4_1_8_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> 6-(4-(Trifluoromethyl)-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9g</b>)</h3><div class="NLM_p last">Yellow solid. 30% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (d, <i>J</i> = 19.8 Hz, 1H), 8.52 (s, 1H), 8.38 (d, <i>J</i> = 11.9 Hz, 1H), 7.34 (s, 2H), 6.71 (s, 1H).</div></div><div id="sec4_1_8_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 6-(4-Nitro-1<i>H</i>-imidazol-1-yl)pyrimidin-4-amine (<b>9h</b>)</h3><div class="NLM_p last">Yellow solid. 10% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (d, <i>J</i> = 1.4 Hz, 1H), 8.63 (d, <i>J</i> = 1.4 Hz, 1H), 8.40 (s, 1H), 8.32 (d, <i>J</i> = 1.0 Hz, 1H), 7.85 (s, 1H), 7.43 (s, 2H), 6.80 (s, 1H).</div></div><div id="sec4_1_8_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 1-(6-Aminopyrimidin-4-yl)-1<i>H</i>-imidazole-4-carbaldehyde (<b>9i</b>)</h3><div class="NLM_p last">Yellow solid. 30% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.86 (d, <i>J</i> = 19.8 Hz, 1H), 8.71 (s, 1H), 8.64 (s, 1H), 8.38 (s, 1H), 7.35 (s, 2H), 6.72 (s, 1H).</div></div><div id="sec4_1_8_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Methyl 1-(6-Aminopyrimidin-4-yl)-1<i>H</i>-imidazole-4-carboxylate (<b>9j</b>)</h3><div class="NLM_p last">Yellow solid. 8% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (d, <i>J</i> = 28.8 Hz, 1H), 8.49 (d, <i>J</i> = 1.0 Hz, 1H), 8.38 (d, <i>J</i> = 16.0 Hz, 1H), 7.33 (d, <i>J</i> = 28.6 Hz, 2H), 6.73 (s, 1H), 3.81 (d, <i>J</i> = 11.8 Hz, 2H).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Inhibition of ChE</h3><div class="NLM_p last">The ChE assay was performed using the method of Ellman et al. with slight modification.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The rat cortex was homogenized in cold 75 mM sodium phosphate buffer (pH 7.4) as the AChE source, and the rat serum was collected as the BuChE source. The assay solution consisted of 50 μL of 0.1 M phosphate buffer, 50 μL of 0.2% 5,5′-dithiobis (2-nitrobenzoic acid) (DTNB, Sigma), 109 or 99 μL of deionized water, 10 μL of rat cortex homogenate or 20 μL of rat serum, and 30 μL of 2 mM acetylthiocholine iodide (Sigma) or 40 μL of 2 mM butyrylthiocholine (Sigma) as the substrate of the AChE or BuChE enzymatic reaction, respectively. An appropriate concentration of compound (1 nM to 10 mM; 1 μL) and the assay solution were mixed and then incubated for 20 min at room temperature. The production of the yellow anion of 5-thio-2-nitrobenzoic acid was measured with a microplate reader (DTX 880, Beckman Coulter) at 450 nm. The inhibition percentage caused by the presence of test compound was calculated, and the IC<sub>50</sub> was defined as the concentration of the compound that reduced 50% of the enzymatic activity without inhibitor.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> Oxygen Radical Absorbance Capacity (ORAC-FL) Assay</h3><div class="NLM_p last">The tested compound and fluorescein (FL) stock solution were diluted with 75 mM phosphate buffer (pH 7.4) to 20 μM and 0.117 μM, respectively. A solution of (±)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) was diluted with the same buffer to 100, 80, 60, 50, 40, 20, and 10 μM. A solution of 2,2′-azobis(amidinopropane) dihydrochloride (AAPH) was prepared before the experiment by dissolving 108.4 mg of AAPH in 10 mL of 75 mM phosphate buffer (pH 7.4) to a concentration of 40 mM. The mixture of the tested compounds (20 μL) and FL (120 μL; 70 nM, final concentration) was preincubated for 10 min at 37 °C, and then 60 μL of the AAPH solution was added. The fluorescence was recorded by Molecular Devices every minute for 180 min (SpectraMax i3; excitation, 485 nm; emission, 520 nm). A blank using phosphate buffer instead of the tested compounds was also analyzed. All reaction mixtures were prepared in triplicate, and at least three independent runs were performed for each sample. The antioxidant curves (fluorescence versus time) were normalized to the curve of the blank. The area under the fluorescence decay curve (AUC) was calculated using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/jm-2016-00636p_m001.gif" alt="" /></img></span>where <i>f</i><sub>0</sub> is the initial fluorescence reading at 0 min and <i>f</i><sub><i>i</i></sub> is the fluorescence reading at time <i>i</i>. The net AUC was calculated by the expression AUC<sub>sample</sub> – AUC<sub>blank</sub>. Regression equations between the net AUC and Trolox concentrations were calculated. The ORAC-FL values for each sample were calculated using the standard curve, which gives the ORAC-FL value of the tested compounds expressed as Trolox equivalents.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Metal-Chelating Study</h3><div class="NLM_p last">The chelating studies were performed with a UV–vis spectrophotometer at wavelengths ranging from 200 to 500 nm. The absorption spectra of each compound (<b>5r</b>, <b>5t</b>, <b>5y</b>, 40 μM, final concentration) alone or in the presence of CuCl<sub>2</sub>, FeSO<sub>4</sub>, FeCl<sub>3</sub>, or ZnCl<sub>2</sub> (20 μM, final concentration) for 1 h in buffer (20 mM HEPES, 150 mM NaCl, pH 7.4) were recorded at room temperature. Due to poor water solubility, the reference CQ (40 μM, final concentration) was tested alone or in the presence of CuCl<sub>2</sub>, FeSO<sub>4</sub>, FeCl<sub>3</sub>, or ZnCl<sub>2</sub> (20 μM, final concentration) in ethanol.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Dot Blot Assay</h3><div class="NLM_p">Aβ<sub>1–42</sub> (Sigma, CA, U.S.) was dissolved in ammonium hydroxide (1% v/v) to give a stock solution (2000 μM), which was aliquoted into small samples and stored at −80 °C. For the experiments, the Aβ<sub>1–42</sub> stock solution was diluted in 20 μM HEPES (pH 6.6) with 150 μM NaCl. The mixture of the peptide (25 μM, final concentration) with or without Cu(II) (25 μM, final concentration) and the test compound (50 μM, final concentration) was incubated at 37 °C for 24 h.</div><div class="NLM_p last">For the dot immunoblot assay, each Aβ sample was spotted (5 μL) on nitrocellulose membranes (GE Healthcare). Afterward, the membranes were blocked by 5% nonfat milk for 1 h and probed with A11 (Millipore) or 6E10 (Convance) antibodies at 4 °C overnight. The blots were washed with TBST and incubated with suitable horseradish peroxidase-conjugated secondary antibodies at room temperature for 1 h. Images were acquired by an image system (Tanon) and were analyzed using ImageJ software.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> TEM Assay<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(69, 70)</a></h3><div class="NLM_p last">For the inhibition of the Cu(II)-induced Aβ<sub>1–42</sub> aggregation experiment, the preparation of the sample was the same as the dot blot assay. Aliquots (10 μL) of the samples were placed on a carbon-coated copper grid for 20 min. Each grid was stained with phosphotungstic acid (2%, 10 μL) for 1 min. After draining the excess staining solution, the specimen was transferred for imaging by transmission electron microscopy (JEM-1400). All compounds were solubilized in the buffer used for the experiment.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Ascorbate</h3><div class="NLM_p last">All of the solutions, except CuSO<sub>4</sub> (dissolved in water and diluted in PBS) and <b>5r</b> and <b>5t</b> (dissolved in methanol and diluted in PBS), were mixed and diluted in a PBS buffer (20 mM, containing NaCl 100 mM, pH 7.4) with a final sample volume of 200 μL. Each experiment was performed in triplicate. Hydroxyl radical production was measured as the conversion of CCA into 7-hydroxy-CCA by Molecular Devices at 37 °C (SpectraMax i3; excitation, 395 nm; emission, 450 nm). The general order of addition was as follows: ligand [15 μM] or PBS, Cu(II) [5 μM], deferoxamine [1 μM], CCA [50 μM], and then ascorbate [150 μM]. All of the test solutions contained 0.1% methanol.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Cell Viability Assay</h3><div class="NLM_p">SH-SY5Y human neuroblastoma cells were cultured in Dulbecco’s modified Eagle medium (DMEM)/F12 medium (GIBCO), containing 10% fetal bovine serum (FBS, GIBCO). Cells were seeded into 96-well plates (Corning) at a density of 3 × 10<sup>4</sup> cells per well for the following experiments. For neurotoxicity test, cells were treated with compounds at 10 μM, 30 μM, 100 μM for 24 h. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sangon Biotech, China) analysis. Briefly, 10 μL of MTT (5 mg/mL) was added into each well and incubated at 37 °C for 4 h. The production of MTT formazan was determined by measuring the absorbance at 490 nm. The cell viability was calculated and presented by the percentage of vehicle-treated group.</div><div class="NLM_p last">For neuroprotection of compounds <b>5r</b> and <b>5t</b> on Cu<sup>2+</sup>-induced Aβ<sub>1–42</sub> neurotoxic model, Aβ samples, which has the same preparation condition as dot blot assay, were added into the cell cultures at a concentration of 1 μM for 24 h. Then the cell viability was measured by MTT assay and normalized by vehicle group.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> In Vitro Blood–Brain Barrier Permeation Assay</h3><div class="NLM_p">Brain penetration of compounds was evaluated using a parallel artificial membrane permeation assay (PAMPA), in a similar manner as described by Di et al. Commercial drugs were purchased from Sigma and Alfa Aesar. The porcine brain lipid (PBL) was obtained from Avanti Polar Lipids. The donor microplate (PVDF membrane, pore size 0.45 mm) and the acceptor microplate were both from Millipore. The 96-well UV plate was from Corning Incorporated. The acceptor 96-well microplate was filled with 300 μL of PBS/EtOH (7:3), and the filter membrane was impregnated with 4 μL of PBL in dodecane (20 mg mL<sup>–1</sup>). Compounds were dissolved in DMSO at 5 mg mL<sup>–1</sup> and diluted 50-fold in PBS/EtOH (7:3) to get the concentration of 100 μg mL<sup>–1</sup>, then 200 μL was added to the donor wells. The acceptor filter plate was carefully placed on the donor plate to form a sandwich, which was left undisturbed for 10 h at 25 °C. After incubation, the donor plate was carefully removed and the concentration of compounds in the acceptor wells was determined using a UV plate reader (Flexstation 3). Each sample was analyzed at five wavelengths, in four wells, in at least three independent runs, and the results are given as the mean ± standard deviation. <i>P</i><sub>e</sub> was calculated using the following equation.<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/jm-2016-00636p_m002.gif" alt="" /></img></span>where <i>V</i><sub>d</sub> is the volume in the donor well, <i>V</i><sub>a</sub> is the volume in the acceptor well, <i>A</i> is the filter area, <i>t</i> is the permeation time, [drug]<sub>acceptor</sub> is the absorbance of the compound in the acceptor well, and [drug]<sub>equilibrium</sub> is the theoretical equilibrium absorbance.</div><div class="NLM_p last">In the experiment, 13 quality control standards of known BBB permeability were included to validate the analysis set (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Table S3, Supporting Information</a>). A plot of the experimental data versus reference values gave a strong linear correlation, <i>P</i><sub>e</sub> (exp) = 1.4574<i>P</i><sub>e</sub> (lit.) – 1.0773 (<i>R</i><sup>2</sup> = 0.9427) (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Figure S5, Supporting Information</a>). From this equation and the limit established by Di et al. for blood–brain barrier permeation, we concluded that compounds with permeability greater than 4.7 × 10<sup>–6</sup> cm/s could cross the blood–brain barrier (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">Table S4, Supporting Information</a>).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Water Solubility Assay</h3><div class="NLM_p last">The water solubility of compounds <b>5t</b>, <b>5r</b>, <b>5s</b>, <b>5t·HCl</b>, <b>5r·HCl</b>, and <b>5ts·HCl</b> was determined by HPLC (Agilent 1100 with quaternary pump, diode array detector). Stock solutions (1 mg/mL) of sample were prepared in methanol. Then, samples of 10 μL of dilute solutions with concentrations of 1, 0.5, 0.2, 0.1, 0.05, 0.002, 0.001, and 0.0005 mg/mL were injected into the HPLC system to assess linearity. Calibration curves were plotted as the peak area versus concentration of sample. To prepare the saturated water solution, 10 mg of compound was added to a 5 mL centrifuge tube, and 1 mL of pure water was pipetted into the tube. If the solution was unsaturated and remained clear and transparent, additional test compound was added. After stirring for 24 h, the solution was filtered with a syringe filter, and 10 μL was injected into the HPLC system. Water solubility was calculated by comparing the peak area of the tested compound to the calibration curves.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> Cognitive Ability Test</h3><div class="NLM_p">Imprinting control region (ICR) mice (18–20 g) were obtained from the Shanghai Laboratory Animal Center, Chinese Academy of Sciences. The animal handling and experiment protocols were approved by the Institutional Animal Care and Use Committee of the Shanghai Institute of Materia Medica.</div><div class="NLM_p last">A passageway water maze (80 cm × 50 cm × 20 cm) was used to evaluate the cognition and memory of mice. The mice were placed into the water maze, with their nose toward the wall of the starting point, and were trained to find the final point. Each mouse received 2 training sessions daily for 4 days. Trained mice were randomly assigned to subgroups (<i>N</i> = 17). Compounds (200 mg/kg) were administered (ig) 1 h before and scopolamine was injected (ip) 20 min before the behavior test. The escape latency and number of errors were recorded. Hup A was administered as a positive control.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Measuring <b>5r</b> in Plasma and Brain Samples</h3><div class="NLM_p last">LC–MS/MS was applied to determine the ability of <b>5r</b> to penetrate the blood–brain barrier (BBB) in vivo. Compound <b>5r·HCl</b> was administered to mice by oral gavage at 200 mg/kg, and the plasma, cortex, hippocampus were collected from three animals after 1 h. For the preparation of plasma samples, 25 μL of plasma was mixed with 25 μL of methanol, 25 μL of internal standard solution, and 75 μL of acetonitrile and centrifuged at 14 400 rpm for 5 min. The resulting supernatant was injected into the LC–MS/MS. For brain samples, the tissue was sonicated in 4× mass of saline to obtain the brain homogenate. A 50 μL volume of methanol, 50 μL of internal standard solutionn and 50 μL of acetonitrile were added to 50 μL of brain homogenate to precipitate the proteins, and the solution was subjected to the above-described extraction procedure. The calibration standards were prepared in blank samples on the day of analysis by adding the appropriate volume of diluted compound <b>5r·HCl</b> solution.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Statistical Analysis</h3><div class="NLM_p last">Data were analyzed by one-way ANOVA followed by Dunnett’s test for multiple comparisons or by Student’s <i>t</i> test for single comparison. A <i>P</i> value <0.05 was considered significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00636">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00636" class="ext-link">10.1021/acs.jmedchem.6b00636</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC reports for the purity check of the target compounds and the synthesis of compounds <b>5r·HCl</b>, <b>5s·HCl</b>, <b>5t·HCl</b>, <b>5y</b> and intermediates <b>8a</b>–<b>e</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf">jm6b00636_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_002.csv">jm6b00636_si_002.csv (2.95 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00636" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6e04070f0002072e0b0d1b1d1a400b0a1b400d00"><span class="__cf_email__" data-cfemail="72181b131c1e1b3217110701065c1716075c111c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiyan Zhang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f69e8c9e979891b6859f9b9bd89795d89598"><span class="__cf_email__" data-cfemail="e78f9d8f868980a7948e8a8ac98684c98489">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Mao</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0e636f61686b674e6b6d7b7d7a206b6a7b206d60"><span class="__cf_email__" data-cfemail="315c505e5754587154524442451f5455441f525f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaokang Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huan Wang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhengyu Lu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinyu Zheng</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Ni</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Zhu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Fu</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fulin Lian</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naixia Zhang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>X.L. and H.W. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d20e7323-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i124">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support of this research provided by the Fundamental Research Funds for the Central Universities (Grant 22A201514054), the Chinese Postdoctoral Science Foundation (Grant 2015M580300), and the National Natural Science Foundation of China (Grant 8152200403) is gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i125" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i125"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i126" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i126"> Abbreviations Used</h2><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multitarget-directed ligand</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChEI</td><td class="NLM_def"><p class="first last">AChE inhibitor</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid protein</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">BuChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">Hup A</td><td class="NLM_def"><p class="first last">huperzine A</p></td></tr><tr><td class="NLM_term">ORAC</td><td class="NLM_def"><p class="first last">free oxygen radical absorbance capacity</p></td></tr><tr><td class="NLM_term">CQ</td><td class="NLM_def"><p class="first last">clioquinol</p></td></tr><tr><td class="NLM_term">TEM</td><td class="NLM_def"><p class="first last">transmission electron microscopy</p></td></tr><tr><td class="NLM_term">ThT</td><td class="NLM_def"><p class="first last">thioflavine T</p></td></tr><tr><td class="NLM_term">EGCG</td><td class="NLM_def"><p class="first last">epigallocatechin gallate</p></td></tr><tr><td class="NLM_term">CCA</td><td class="NLM_def"><p class="first last">coumarin-3-carboxylic acid</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">Don</td><td class="NLM_def"><p class="first last">donepezil</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">mp</td><td class="NLM_def"><p class="first last">melting point</p></td></tr><tr><td class="NLM_term">clogP</td><td class="NLM_def"><p class="first last">calculated logarithm of the octanol–water partition coefficient</p></td></tr><tr><td class="NLM_term">Scop</td><td class="NLM_def"><p class="first last">scopolamine</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">AAPH</td><td class="NLM_def"><p class="first last">2,2′-azobis-(amidinopropane)dihydrochloride</p></td></tr><tr><td class="NLM_term">LC–MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography tandem mass spectrometry</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffer salt</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i127">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Prince, M.; Albanese, E.; Guerchet, M.</span><span> </span><span class="NLM_article-title">World Alzheimer Report 2014. Dementia and Risk Reduction: An Analaysis of Protective and Modifiable Factors</span>. <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prince%2C+M.%3B+Albanese%2C+E.%3B+Guerchet%2C+M.+World+Alzheimer+Report+2014.+Dementia+and+Risk+Reduction%3A+An+Analaysis+of+Protective+and+Modifiable+Factors.+Alzheimer%E2%80%99s+Disease+International%3A+London%2C+2014%3B+pp+1%E2%80%9399."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26atitle%3DWorld%2520Alzheimer%2520Report%25202014.%2520Dementia%2520and%2520Risk%2520Reduction%253A%2520An%2520Analaysis%2520of%2520Protective%2520and%2520Modifiable%2520Factors%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2014%26spage%3D1%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Emmerzaal, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiliaan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, D. R.</span><span> </span><span class="NLM_article-title">2003–2013: a decade of body mass index, Alzheimer’s disease, and dementia</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.3233/JAD-141086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.3233%2FJAD-141086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=25147111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FktlWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=739-755&author=T.+L.+Emmerzaalauthor=A.+J.+Kiliaanauthor=D.+R.+Gustafson&title=2003%E2%80%932013%3A+a+decade+of+body+mass+index%2C+Alzheimer%E2%80%99s+disease%2C+and+dementia&doi=10.3233%2FJAD-141086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">2003-2013: a decade of body mass index, Alzheimer's disease, and dementia</span></div><div class="casAuthors">Emmerzaal Tim L; Kiliaan Amanda J; Gustafson Deborah R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">739-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The occurrence of obesity, commonly estimated using body mass index (BMI), and the most common late-onset dementia, Alzheimer's disease (AD), are increasing globally.  The year 2013 marked a decade of epidemiologic observational reports on the association between BMI and late-onset dementias.  In this review, we highlight epidemiological studies that measured both mid- and late-life BMI in association with dementia.  Studies investigating the association between midlife BMI and risk for dementia demonstrated generally an increased risk among overweight and obese adults.  When measured in late-life, elevated BMI has been associated with lower risk.  In addition, being underweight and/or having a decrease in BMI in late-life are associated with higher dementia risk compared to BMI in the normal range or stable BMI.  In this review, a decade (2003-2013) of epidemiologic observational studies on associations between BMI and AD is highlighted.  These observations provide a strong base for addressing biological mechanisms underlying this complex association.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbhEAsl7zZDP69nzq6467DfW6udTcc2ea9TOsctT839rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FktlWlsA%253D%253D&md5=85551c5cbdf88ecce4179bacd5ea4f3d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3233%2FJAD-141086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141086%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerzaal%26aufirst%3DT.%2BL.%26aulast%3DKiliaan%26aufirst%3DA.%2BJ.%26aulast%3DGustafson%26aufirst%3DD.%2BR.%26atitle%3D2003%25E2%2580%25932013%253A%2520a%2520decade%2520of%2520body%2520mass%2520index%252C%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520and%2520dementia%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2015%26volume%3D43%26spage%3D739%26epage%3D755%26doi%3D10.3233%2FJAD-141086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=K.+Zhongauthor=T.+Morstorf&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+Few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2ebMhMvGLaFHgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DMorstorf%26aufirst%3DT.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520Few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savelieff, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brender, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer’s disease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span><span class="refDoi"> DOI: 10.1021/ja409801p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja409801p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=299-310&author=S.+Leeauthor=X.+Zhengauthor=J.+Krishnamoorthyauthor=M.+G.+Savelieffauthor=H.+M.+Parkauthor=J.+R.+Brenderauthor=J.+H.+Kimauthor=J.+S.+Derrickauthor=A.+Kochiauthor=H.+J.+Leeauthor=C.+Kimauthor=A.+Ramamoorthyauthor=M.+T.+Bowersauthor=M.+H.+Lim&title=Rational+design+of+a+structural+framework+with+potential+use+to+develop+chemical+reagents+that+target+and+modulate+multiple+facets+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fja409801p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer's Disease</span></div><div class="casAuthors">Lee, Sanghyun; Zheng, Xueyun; Krishnamoorthy, Janarthanan; Savelieff, Masha G.; Park, Hyun Min; Brender, Jeffrey R.; Kim, Jin Hoon; Derrick, Jeffrey S.; Kochi, Akiko; Lee, Hyuck Jin; Kim, Cheal; Ramamoorthy, Ayyalusamy; Bowers, Michael T.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by multiple, intertwined pathol. features, including amyloid-β (Aβ) aggregation, metal ion dyshomeostasis, and oxidative stress.  The authors report a novel compd. (ML) prototype of a rationally designed mol. obtained by integrating structural elements for Aβ aggregation control, metal chelation, reactive oxygen species (ROS) regulation, and antioxidant activity within a single mol.  Chem., biochem., ion mobility mass spectrometric, and NMR studies indicate that the compd. ML targets metal-free and metal-bound Aβ (metal-Aβ) species, suppresses Aβ aggregation in vitro, and diminishes toxicity induced by Aβ and metal-treated Aβ in living cells.  Comparison of ML to its structural moieties (i.e., 4-(dimethylamino)-phenol (DAP) and (8-aminoquinolin-2-yl)-methanol ) for reactivity with Aβ and metal-Aβ suggests the synergy of incorporating structural components for both metal chelation and Aβ interaction.  Moreover, ML is water-sol. and potentially brain permeable, as well as regulates the formation and presence of free radicals.  Overall, the authors demonstrate that a rational structure-based design strategy can generate a small mol. that can target and modulate multiple factors, providing a new tool to uncover and address AD complexity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcx8TkzbV9U7Vg90H21EOLACvtfcHk0liIYcoH5A9GHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I&md5=808d231c5dca419453c176265d16bfe3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fja409801p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja409801p%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DKrishnamoorthy%26aufirst%3DJ.%26aulast%3DSavelieff%26aufirst%3DM.%2BG.%26aulast%3DPark%26aufirst%3DH.%2BM.%26aulast%3DBrender%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DBowers%26aufirst%3DM.%2BT.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DRational%2520design%2520of%2520a%2520structural%2520framework%2520with%2520potential%2520use%2520to%2520develop%2520chemical%2520reagents%2520that%2520target%2520and%2520modulate%2520multiple%2520facets%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D299%26epage%3D310%26doi%3D10.1021%2Fja409801p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earnest, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozbil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korshavn, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruotolo, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: In vitro and in vivo efficacy and molecular mechanisms</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">14785</span><span class="NLM_x">–</span> <span class="NLM_lpage">14797</span><span class="refDoi"> DOI: 10.1021/jacs.5b10043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b10043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=14785-14797&author=J.+S.+Derrickauthor=R.+A.+Kerrauthor=Y.+Namauthor=S.+B.+Ohauthor=H.+J.+Leeauthor=K.+G.+Earnestauthor=N.+Suhauthor=K.+L.+Peckauthor=M.+Ozbilauthor=K.+J.+Korshavnauthor=A.+Ramamoorthyauthor=R.+Prabhakarauthor=E.+J.+Merinoauthor=J.+Shearerauthor=J.-Y.+Leeauthor=B.+T.+Ruotoloauthor=M.+H.+Lim&title=A+redox-active%2C+compact+molecule+for+cross-linking+amyloidogenic+peptides+into+nontoxic%2C+off-pathway+aggregates%3A+In+vitro+and+in+vivo+efficacy+and+molecular+mechanisms&doi=10.1021%2Fjacs.5b10043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms</span></div><div class="casAuthors">Derrick, Jeffrey S.; Kerr, Richard A.; Nam, Younwoo; Oh, Shin Bi; Lee, Hyuck Jin; Earnest, Kaylin G.; Suh, Nayoung; Peck, Kristy L.; Ozbil, Mehmet; Korshavn, Kyle J.; Ramamoorthy, Ayyalusamy; Prabhakar, Rajeev; Merino, Edward J.; Shearer, Jason; Lee, Joo-Yong; Ruotolo, Brandon T.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">14785-14797</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. reagents targeting and controlling amyloidogenic peptides have received much attention for helping identify their roles in the pathogenesis of protein-misfolding disorders.  Herein, the authors report a novel strategy for redirecting amyloidogenic peptides into nontoxic, off-pathway aggregates, which utilizes redox properties of a small mol. (DMPD, N,N-dimethyl-p-phenylenediamine) to trigger covalent adduct formation with the peptide.  In addn., for the first time, biochem., biophys., and mol. dynamics simulation studies have been performed to demonstrate a mechanistic understanding for such an interaction between a small mol. (DMPD) and amyloid-β (Aβ) and its subsequent anti-amyloidogenic activity, which, upon its transformation, generates ligand-peptide adducts via primary amine-dependent intramol. crosslinking correlated with structural compaction.  Furthermore, in vivo efficacy of DMPD toward amyloid pathol. and cognitive impairment was evaluated employing 5xFAD mice of Alzheimer's disease (AD).  Such a small mol. (DMPD) is indicated to noticeably reduce the overall cerebral amyloid load of sol. Aβ forms and amyloid deposits as well as significantly improve cognitive defects in the AD mouse model.  Overall, the authors' in vitro and in vivo studies of DMPD toward Aβ with the first mol.-level mechanistic investigations present the feasibility of developing new, innovative approaches that employ redox-active compds. without the structural complexity as next-generation chem. tools for amyloid management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVgBBoRUmXObVg90H21EOLACvtfcHk0lgTz3ib5Ex_Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmt7fL&md5=f95a3cad02c9a2752ea0389e69820943</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b10043%26sid%3Dliteratum%253Aachs%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DKerr%26aufirst%3DR.%2BA.%26aulast%3DNam%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DS.%2BB.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DEarnest%26aufirst%3DK.%2BG.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DPeck%26aufirst%3DK.%2BL.%26aulast%3DOzbil%26aufirst%3DM.%26aulast%3DKorshavn%26aufirst%3DK.%2BJ.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DR.%26aulast%3DMerino%26aufirst%3DE.%2BJ.%26aulast%3DShearer%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.-Y.%26aulast%3DRuotolo%26aufirst%3DB.%2BT.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DA%2520redox-active%252C%2520compact%2520molecule%2520for%2520cross-linking%2520amyloidogenic%2520peptides%2520into%2520nontoxic%252C%2520off-pathway%2520aggregates%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520efficacy%2520and%2520molecular%2520mechanisms%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D14785%26epage%3D14797%26doi%3D10.1021%2Fjacs.5b10043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Baptista, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Cruz e Silva, O. A. B.</span><span> </span><span class="NLM_article-title">Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer’s disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1021/cn400213r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400213r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaltLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=83-92&author=F.+I.+Baptistaauthor=A.+G.+Henriquesauthor=A.+M.+S.+Silvaauthor=J.+Wiltfangauthor=O.+A.+B.+da+Cruz+e+Silva&title=Flavonoids+as+therapeutic+compounds+targeting+key+proteins+involved+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn400213r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer's Disease</span></div><div class="casAuthors">Baptista, Filipa I.; Henriques, Ana G.; Silva, Artur M. S.; Wiltfang, Jens; da Cruz e Silva, Odete A. B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-92</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is characterized by pathol. aggregation of protein tau and amyloid-β peptides, both of which are considered to be toxic to neurons.  Naturally occurring dietary flavonoids have received considerable attention as alternative candidates for Alzheimer's therapy taking into account their antiamyloidogenic, antioxidative, and anti-inflammatory properties.  Exptl. evidence supports the hypothesis that certain flavonoids may protect against Alzheimer's disease in part by interfering with the generation and assembly of amyloid-β peptides into neurotoxic oligomeric aggregates and also by reducing tau aggregation.  Several mechanisms have been proposed for the ability of flavonoids to prevent the onset or to slow the progression of the disease.  Some mechanisms include their interaction with important signaling pathways in the brain like the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways that regulate prosurvival transcription factors and gene expression.  Other processes include the disruption of amyloid-β aggregation and alterations in amyloid precursor protein processing through the inhibition of β-secretase and/or activation of α-secretase, and inhibiting cyclin-dependent kinase-5 and glycogen synthase kinase-3β activation, preventing abnormal tau phosphorylation.  The interaction of flavonoids with different signaling pathways put forward their therapeutic potential to prevent the onset and progression of Alzheimer's disease and to promote cognitive performance.  Nevertheless, further studies are needed to give addnl. insight into the specific mechanisms by which flavonoids exert their potential neuroprotective actions in the brain of Alzheimer's disease patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp4YgHRFlNqrVg90H21EOLACvtfcHk0lgTz3ib5Ex_Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaltLjL&md5=de814b1d8ce4bc863df6c89c6761a222</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcn400213r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400213r%26sid%3Dliteratum%253Aachs%26aulast%3DBaptista%26aufirst%3DF.%2BI.%26aulast%3DHenriques%26aufirst%3DA.%2BG.%26aulast%3DSilva%26aufirst%3DA.%2BM.%2BS.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3Dda%2BCruz%2Be%2BSilva%26aufirst%3DO.%2BA.%2BB.%26atitle%3DFlavonoids%2520as%2520therapeutic%2520compounds%2520targeting%2520key%2520proteins%2520involved%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D83%26epage%3D92%26doi%3D10.1021%2Fcn400213r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Li, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.ejmech.2013.09.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=632-646&author=S.-Y.+Liauthor=X.-B.+Wangauthor=S.-S.+Xieauthor=N.+Jiangauthor=K.+D.+G.+Wangauthor=H.-Q.+Yaoauthor=H.-B.+Sunauthor=L.-Y.+Kong&title=Multifunctional+tacrine-flavonoid+hybrids+with+cholinergic%2C+%CE%B2-amyloid-reducing%2C+and+metal+chelating+properties+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.09.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.-Y.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DYao%26aufirst%3DH.-Q.%26aulast%3DSun%26aufirst%3DH.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMultifunctional%2520tacrine-flavonoid%2520hybrids%2520with%2520cholinergic%252C%2520%25CE%25B2-amyloid-reducing%252C%2520and%2520metal%2520chelating%2520properties%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D632%26epage%3D646%26doi%3D10.1016%2Fj.ejmech.2013.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juarez-Jimenez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabateauthor=J.+Juarez-Jimenezauthor=B.+Perezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Munoz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lg-WZ37d57LIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DJuarez-Jimenez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena-Altamira, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesaresi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-beta aggregation and to exert anticholinesterase and antioxidant Effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8576</span><span class="NLM_x">–</span> <span class="NLM_lpage">8589</span><span class="refDoi"> DOI: 10.1021/jm5010804</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010804" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eju7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8576-8589&author=E.+Nepovimovaauthor=E.+Uliassiauthor=J.+Korabecnyauthor=L.+E.+Pena-Altamiraauthor=S.+Samezauthor=A.+Pesaresiauthor=G.+E.+Garciaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=C.+Bergaminiauthor=R.+Fatoauthor=D.+Lambaauthor=M.+Robertiauthor=K.+Kucaauthor=B.+Montiauthor=M.+L.+Bolognesi&title=Multitarget+drug+design+strategy%3A+quinone-tacrine+hybrids+designed+to+block+amyloid-beta+aggregation+and+to+exert+anticholinesterase+and+antioxidant+Effects&doi=10.1021%2Fjm5010804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Drug Design Strategy: Quinone-Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects</span></div><div class="casAuthors">Nepovimova, Eugenie; Uliassi, Elisa; Korabecny, Jan; Pena-Altamira, Luis Emiliano; Samez, Sarah; Pesaresi, Alessandro; Garcia, Gregory E.; Bartolini, Manuela; Andrisano, Vincenza; Bergamini, Christian; Fato, Romana; Lamba, Doriano; Roberti, Marinella; Kuca, Kamil; Monti, Barbara; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8576-8589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the identification of multitarget anti-Alzheimer compds. designed by combining a naphthoquinone function and a tacrine fragment.  In vitro, 15 compds. displayed excellent acetylcholinesterase (AChE) inhibitory potencies and interesting capabilities to block amyloid-β (Aβ) aggregation.  The X-ray anal. of one of those compds. in complex with AChE allowed rationalizing the outstanding activity data (IC50 = 0.72 nM).  Two of the compds. showed negligible toxicity in immortalized mouse cortical neurons Neuro2A and primary rat cerebellar granule neurons.  However, only one of them was less hepatotoxic than tacrine in HepG2 cells.  In T67 cells, both compds. showed antioxidant activity, following NQO1 induction.  Furthermore, in Neuro2A, they were able to completely revert the decrease in viability induced by Aβ.  Importantly, they crossed the blood-brain barrier, as demonstrated in ex vivo expts. with rats.  When ex vivo results were combined with in vitro studies, these two compds. emerged to be promising multitarget lead candidates worthy of further pursuit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6HUhlnJkHLrVg90H21EOLACvtfcHk0lg-WZ37d57LIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eju7bK&md5=2f58fc44a8a7044df7efc833e29c0880</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm5010804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010804%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DPena-Altamira%26aufirst%3DL.%2BE.%26aulast%3DSamez%26aufirst%3DS.%26aulast%3DPesaresi%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DRoberti%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DMultitarget%2520drug%2520design%2520strategy%253A%2520quinone-tacrine%2520hybrids%2520designed%2520to%2520block%2520amyloid-beta%2520aggregation%2520and%2520to%2520exert%2520anticholinesterase%2520and%2520antioxidant%2520Effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8576%26epage%3D8589%26doi%3D10.1021%2Fjm5010804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert-Freon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer’s disease: The design of donecopride</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3172</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3172-3187&author=C.+Rochaisauthor=C.+Lecouteyauthor=F.+Gavenauthor=P.+Giannoniauthor=K.+Hamidoucheauthor=D.+Hedouauthor=E.+Dubostauthor=D.+Genestauthor=S.+Yahiaouiauthor=T.+Freretauthor=V.+Bouetauthor=F.+Dauphinauthor=J.+Sopkova+de+Oliveira+Santosauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert-Freonauthor=R.+Legayauthor=M.+Boulouardauthor=S.+Claeysenauthor=P.+Dallemagne&title=Novel+multitarget-directed+ligands+%28MTDLs%29+with+acetylcholinesterase+%28AChE%29+inhibitory+and+serotonergic+subtype+4+receptor+%285-HT4R%29+agonist+activities+as+potential+agents+against+Alzheimer%E2%80%99s+disease%3A+The+design+of+donecopride&doi=10.1021%2Facs.jmedchem.5b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride</span></div><div class="casAuthors">Rochais, Christophe; Lecoutey, Cedric; Gaven, Florence; Giannoni, Patrizia; Hamidouche, Katia; Hedou, Damien; Dubost, Emmanuelle; Genest, David; Yahiaoui, Samir; Freret, Thomas; Bouet, Valentine; Dauphin, Francois; Sopkova de Oliveira Santos, Jana; Ballandonne, Celine; Corvaisier, Sophie; Malzert-Freon, Aurelie; Legay, Remi; Boulouard, Michel; Claeysen, Sylvie; Dallemagne, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3172-3187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice.  The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfqjY4Tl4ObVg90H21EOLACvtfcHk0lg-WZ37d57LIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D&md5=435652a2503e322ad880bd9607838103</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DHamidouche%26aufirst%3DK.%26aulast%3DHedou%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DSopkova%2Bde%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert-Freon%26aufirst%3DA.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DNovel%2520multitarget-directed%2520ligands%2520%2528MTDLs%2529%2520with%2520acetylcholinesterase%2520%2528AChE%2529%2520inhibitory%2520and%2520serotonergic%2520subtype%25204%2520receptor%2520%25285-HT4R%2529%2520agonist%2520activities%2520as%2520potential%2520agents%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520design%2520of%2520donecopride%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3172%26epage%3D3187%26doi%3D10.1021%2Facs.jmedchem.5b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03163-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands&doi=10.1016%2FS1359-6446%2804%2903163-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0lhwD12ow778Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651%26doi%3D10.1016%2FS1359-6446%2804%2903163-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lhwD12ow778Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8616</span><span class="NLM_x">–</span> <span class="NLM_lpage">8637</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8616-8637&author=Z.+Wangauthor=Y.+Wangauthor=B.+Wangauthor=W.+Liauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+evaluation+of+orally+available+clioquinol-moracin+M+hybrids+as+multitarget-directed+ligands+for+cognitive+improvement+in+a+rat+model+of+neurodegeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b01222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease</span></div><div class="casAuthors">Wang, Zhiren; Wang, Yali; Wang, Bo; Li, Wenrui; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8616-8637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of clioquinol-moracin hybrids were designed and synthesized by fusing the pharmacophores of clioquinol and moracin M, and their activities as multitarget-directed ligands against Alzheimer's disease were evaluated.  Biol. activity results demonstrated that these hybrids possessed significant inhibitory activities against phosphodiesterase 4D (PDE4D) and Aβ aggregation as well as remarkable antioxidant effects and excellent blood-brain barrier permeability.  The optimal compd., I (WBQ5187), exhibited excellent PDE4D inhibitory potency (IC50 = 0.32 μM), significant antioxidant effects, appropriate biometal chelating functions, and interesting properties that modulated self- and metal-induced Aβ aggregation.  Two-dimensional NMR studies revealed that I had significant interactions with Aβ1-42 at the R5, H6, H14, Q15, and F20 residues.  Furthermore, this typical hybrid possessed preeminent neuroprotective effects against inflammation in microglial cells.  Most importantly, oral administration of I·HCl demonstrated marked improvements in cognitive and spatial memory in a rat model of Alzheimer's disease and protected hippocampal neurons from necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcLe7jrheic7Vg90H21EOLACvtfcHk0lhwD12ow778Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI&md5=1230163c53dc646777185602d9fa9643</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01222%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520available%2520clioquinol-moracin%2520M%2520hybrids%2520as%2520multitarget-directed%2520ligands%2520for%2520cognitive%2520improvement%2520in%2520a%2520rat%2520model%2520of%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8616%26epage%3D8637%26doi%3D10.1021%2Facs.jmedchem.5b01222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bartus, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. L.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">The cholinergic hypothesis of geriatric memory dysfunction</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span><span class="refDoi"> DOI: 10.1126/science.7046051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1126%2Fscience.7046051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=7046051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaL38XkslShur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1982&pages=408-414&author=R.+T.+Bartusauthor=R.+L.+Deanauthor=B.+Beerauthor=A.+S.+Lippa&title=The+cholinergic+hypothesis+of+geriatric+memory+dysfunction&doi=10.1126%2Fscience.7046051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of geriatric memory dysfunction</span></div><div class="casAuthors">Bartus, Raymond T.; Dean, Reginald L., III; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">4558</span>),
    <span class="NLM_cas:pages">408-17</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 93 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC5hLTTFFYoLVg90H21EOLACvtfcHk0liBUF57-DbPwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslShur4%253D&md5=ff0661ed096b9cb45406dd159c88e15e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.7046051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7046051%26sid%3Dliteratum%253Aachs%26aulast%3DBartus%26aufirst%3DR.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BL.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DThe%2520cholinergic%2520hypothesis%2520of%2520geriatric%2520memory%2520dysfunction%26jtitle%3DScience%26date%3D1982%26volume%3D217%26spage%3D408%26epage%3D414%26doi%3D10.1126%2Fscience.7046051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Perry, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R.</span><span> </span><span class="NLM_article-title">Acetylcholine in mind: a neurotransmitter correlate of consciousness?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1016/S0166-2236(98)01361-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0166-2236%2898%2901361-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=273-280&author=E.+Perryauthor=M.+Walkerauthor=J.+Graceauthor=R.+Perry&title=Acetylcholine+in+mind%3A+a+neurotransmitter+correlate+of+consciousness%3F&doi=10.1016%2FS0166-2236%2898%2901361-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2898%2901361-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252898%252901361-7%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DE.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DGrace%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DR.%26atitle%3DAcetylcholine%2520in%2520mind%253A%2520a%2520neurotransmitter%2520correlate%2520of%2520consciousness%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D273%26epage%3D280%26doi%3D10.1016%2FS0166-2236%2898%2901361-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, M. R.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: a disorder of cortical cholinergic innervation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span><span class="refDoi"> DOI: 10.1126/science.6338589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1126%2Fscience.6338589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=6338589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADyaL3s7ks1egsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1983&pages=1184-1190&author=J.+T.+Coyleauthor=D.+L.+Priceauthor=M.+R.+DeLong&title=Alzheimer%E2%80%99s+disease%3A+a+disorder+of+cortical+cholinergic+innervation&doi=10.1126%2Fscience.6338589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: a disorder of cortical cholinergic innervation</span></div><div class="casAuthors">Coyle J T; Price D L; DeLong M R</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">4589</span>),
    <span class="NLM_cas:pages">1184-90</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Great emphasis is being placed on identification of neurotransmitter systems involved in the symptomatic manifestations of neurological and psychiatric disorders.  In the case of Alzheimer's disease, which now seems to be one of the most common causes of mental deterioration in the elderly, compelling evidence has been developed that acetylcholine-releasing neurons, whose cell bodies lie in the basal forebrain, selectively degenerate.  These cholinergic neurons provide widespread innervation of the cerebral cortex and related structures and appear to play an important role in cognitive functions, especially memory.  These advances reflect a close interaction between experimental and clinical neuroscientists in which information derived from basic neurobiology is rapidly utilized to analyze disorders of the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqtu7Bwk96tP69nzq6467DfW6udTcc2ebnnefv6uhQ_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7ks1egsg%253D%253D&md5=40217992dc463498c596ce10976ea557</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.6338589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6338589%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DDeLong%26aufirst%3DM.%2BR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520disorder%2520of%2520cortical%2520cholinergic%2520innervation%26jtitle%3DScience%26date%3D1983%26volume%3D219%26spage%3D1184%26epage%3D1190%26doi%3D10.1126%2Fscience.6338589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Francis, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snape, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, G. K.</span><span> </span><span class="NLM_article-title">The cholinergic hypothesis of Alzheimer’s disease: a review of progress</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1136/jnnp.66.2.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1136%2Fjnnp.66.2.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10071091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADyaK1M7mvVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1999&pages=137-147&author=P.+T.+Francisauthor=A.+M.+Palmerauthor=M.+Snapeauthor=G.+K.+Wilcock&title=The+cholinergic+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+a+review+of+progress&doi=10.1136%2Fjnnp.66.2.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of Alzheimer's disease: a review of progress</span></div><div class="casAuthors">Francis P T; Palmer A M; Snape M; Wilcock G K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-47</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Alzheimer's disease is one of the most common causes of mental deterioration in elderly people, accounting for around 50%-60% of the overall cases of dementia among persons over 65 years of age.  The past two decades have witnessed a considerable research effort directed towards discovering the cause of Alzheimer's disease with the ultimate hope of developing safe and effective pharmacological treatments.  This article examines the existing scientific applicability of the original cholinergic hypothesis of Alzheimer's disease by describing the biochemical and histopathological changes of neurotransmitter markers that occur in the brains of patients with Alzheimer's disease both at postmortem and neurosurgical cerebral biopsy and the behavioural consequences of cholinomimetic drugs and cholinergic lesions.  Such studies have resulted in the discovery of an association between a decline in learning and memory, and a deficit in excitatory amino acid (EAA) neurotransmission, together with important roles for the cholinergic system in attentional processing and as a modulator of EAA neurotransmission.  Accordingly, although there is presently no "cure" for Alzheimer's disease, a large number of potential therapeutic interventions have emerged that are designed to correct loss of presynaptic cholinergic function.  A few of these compounds have confirmed efficacy in delaying the deterioration of symptoms of Alzheimer's disease, a valuable treatment target considering the progressive nature of the disease.  Indeed, three compounds have received European approval for the treatment of the cognitive symptoms of Alzheimer's disease, first tacrine and more recently, donepezil and rivastigmine, all of which are cholinesterase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnFJROHH3HoJagfuraLLzSfW6udTcc2eY1vzaipCxez7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7mvVKnuw%253D%253D&md5=3c06fbfd49488233c971bb735a2410fd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.66.2.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.66.2.137%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26aulast%3DSnape%26aufirst%3DM.%26aulast%3DWilcock%26aufirst%3DG.%2BK.%26atitle%3DThe%2520cholinergic%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520of%2520progress%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D1999%26volume%3D66%26spage%3D137%26epage%3D147%26doi%3D10.1136%2Fjnnp.66.2.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Green, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span> </span><span class="NLM_article-title">hChAT: A Tool for the chemoenzymatic generation of potential acetyl/butyrylcholinesterase inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2191</span><span class="NLM_x">–</span> <span class="NLM_lpage">2194</span><span class="refDoi"> DOI: 10.1002/cbic.200900309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fcbic.200900309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2191-2194&author=K.+D.+Greenauthor=M.+Fridmanauthor=S.+Garneau-Tsodikova&title=hChAT%3A+A+Tool+for+the+chemoenzymatic+generation+of+potential+acetyl%2Fbutyrylcholinesterase+inhibitors&doi=10.1002%2Fcbic.200900309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900309%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DK.%2BD.%26aulast%3DFridman%26aufirst%3DM.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DhChAT%253A%2520A%2520Tool%2520for%2520the%2520chemoenzymatic%2520generation%2520of%2520potential%2520acetyl%252Fbutyrylcholinesterase%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D2191%26epage%3D2194%26doi%3D10.1002%2Fcbic.200900309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ballard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarsland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)61349-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0140-6736%2810%2961349-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=21371747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=1019-1031&author=C.+Ballardauthor=S.+Gauthierauthor=A.+Corbettauthor=C.+Brayneauthor=D.+Aarslandauthor=E.+Jones&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2810%2961349-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Ballard Clive; Gauthier Serge; Corbett Anne; Brayne Carol; Aarsland Dag; Jones Emma</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">9770</span>),
    <span class="NLM_cas:pages">1019-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease.  Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority.  Although there are licensed treatments that can alleviate symptoms of Alzheimer's disease, there is a pressing need to improve our understanding of pathogenesis to enable development of disease-modifying treatments.  Methods for improving diagnosis are also moving forward, but a better consensus is needed for development of a panel of biological and neuroimaging biomarkers that support clinical diagnosis.  There is now strong evidence of potential risk and protective factors for Alzheimer's disease, dementia, and cognitive decline, but further work is needed to understand these better and to establish whether interventions can substantially lower these risks.  In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPHrxmEUcI2DdblLE_E9PWfW6udTcc2eY1vzaipCxez7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D&md5=e37ee3fb78a85dfc774b372d0a9af0c5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2961349-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252961349-9%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DC.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DCorbett%26aufirst%3DA.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DAarsland%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DE.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D1019%26epage%3D1031%26doi%3D10.1016%2FS0140-6736%2810%2961349-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Holzgrabe, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alptuezuen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmann, E.</span><span> </span><span class="NLM_article-title">Targeting acetylcholinesterase to treat neurodegeneration</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1517/14728222.11.2.161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1517%2F14728222.11.2.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=17227232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=161-179&author=U.+Holzgrabeauthor=P.+Kapkovaauthor=V.+Alptuezuenauthor=J.+Scheiberauthor=E.+Kugelmann&title=Targeting+acetylcholinesterase+to+treat+neurodegeneration&doi=10.1517%2F14728222.11.2.161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase to treat neurodegeneration</span></div><div class="casAuthors">Holzgrabe, Ulrike; Kapkova, Petra; Alptuezuen, Vildan; Scheiber, Josef; Kugelmann, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-179</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders, such as Alzheimer's disease, are often characterized by the degeneration of the cholinergic system.  Thus, the aim of many treatment regimens is to support this system either by means of muscarinic agonists or by inhibitors of acetylcholinesterase (AChE), the latter being able to increase the concn. of acetylcholine.  However, both pharmacol. groups of drugs can only help in the beginning of the progressive disease.  The finding that the occupation of the peripheral anionic site of AChE is able to stop the formation of the amyloid plaque led to the development of bivalent ligands that occupy both the active and the peripheral site.  This dual action might be more beneficial for treatment of Alzheimer's disease than simple inhibition of the acetylcholine hydrolysis.  Thus, the new bivalent ligands are the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfJ1Ef8XjB3LVg90H21EOLACvtfcHk0lg_4fERa0r57g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D&md5=e38fa01804094ae9ed273d68f0e74a50</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.2.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.2.161%26sid%3Dliteratum%253Aachs%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DKapkova%26aufirst%3DP.%26aulast%3DAlptuezuen%26aufirst%3DV.%26aulast%3DScheiber%26aufirst%3DJ.%26aulast%3DKugelmann%26aufirst%3DE.%26atitle%3DTargeting%2520acetylcholinesterase%2520to%2520treat%2520neurodegeneration%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D161%26epage%3D179%26doi%3D10.1517%2F14728222.11.2.161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span> </span><span class="NLM_article-title">A review on cholinesterase inhibitors for Alzheimer’s disease. Arch</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1007/s12272-013-0036-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1007%2Fs12272-013-0036-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=23435942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=375-399&author=P.+Anandauthor=B.+Singh&title=A+review+on+cholinesterase+inhibitors+for+Alzheimer%E2%80%99s+disease.+Arch&doi=10.1007%2Fs12272-013-0036-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A review on cholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Anand, Preet; Singh, Baldev</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-399</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is characterized by the deficits in the cholinergic system and deposition of beta amyloid (Aβ) in the form of neurofibrillary tangles and amyloid plaques.  Since the cholinergic system plays an important role in the regulation of learning and memory processes, it has been targetted for the design of anti-Alzheimer's drugs.  Cholinesterase inhibitors enhance cholinergic transmission directly by inhibiting the enzyme acetylcholinesterase (AChE) which hydrolyzes acetylcholine.  Furthermore, it has been also demonstrated that both acetylcholinesterase and butrylcholinesterase (BuChE) play an important role in Aβ-aggregation during the early stages of senile plaque formation.  Therefore, AChE and BuChE inhibition have been documented as crit. targets for the effective management of AD by an increase in the availability of acetylcholine in the brain regions and decrease in the Aβ deposition.  This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogs developed for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe8p6U3r94ubVg90H21EOLACvtfcHk0lgB_O2X8AFHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D&md5=a8b48dbf6a7e7b988759182ad8cd9b6a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs12272-013-0036-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-013-0036-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26atitle%3DA%2520review%2520on%2520cholinesterase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease.%2520Arch%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2013%26volume%3D36%26spage%3D375%26epage%3D399%26doi%3D10.1007%2Fs12272-013-0036-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossberg, G. T.</span><span> </span><span class="NLM_article-title">Use of memantine for the treatment of dementia</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.1586/ern.11.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1586%2Fern.11.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=21955192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1359-1370&author=D.+Loauthor=G.+T.+Grossberg&title=Use+of+memantine+for+the+treatment+of+dementia&doi=10.1586%2Fern.11.132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Use of memantine for the treatment of dementia</span></div><div class="casAuthors">Lo, Daphne; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1359-1370</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The term dementia'' encompasses a no. of neurodegenerative diseases of which Alzheimer''s disease (AD) is the most common.  Prior to 2003, cholinesterase inhibitors, such as donezepil, were the only class of drugs approved to treat mild-to-moderate AD.  In 2003, memantine became the first drug approved by the US FDA to treat moderate-to-severe AD.  Currently, both memantine and donepezil are FDA approved for the treatment of moderate-to-severe AD.  This article examines the pharmacol. profile of memantine, evidence for memantine''s efficacy in moderate-to-severe AD and other dementias, its novel use in other neuropsychiatric disorders and future implications and research directions for memantine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGdBuGdnw3bVg90H21EOLACvtfcHk0lgB_O2X8AFHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM&md5=1108b2e6b6328bbafa7394f43205e450</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1586%2Fern.11.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.11.132%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DD.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DUse%2520of%2520memantine%2520for%2520the%2520treatment%2520of%2520dementia%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2011%26volume%3D11%26spage%3D1359%26epage%3D1370%26doi%3D10.1586%2Fern.11.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Scarpini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelterns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease; current status and new perspectives</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1016/S1474-4422(03)00502-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1474-4422%2803%2900502-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12941576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=539-547&author=E.+Scarpiniauthor=P.+Schelternsauthor=H.+Feldman&title=Treatment+of+Alzheimer%E2%80%99s+disease%3B+current+status+and+new+perspectives&doi=10.1016%2FS1474-4422%2803%2900502-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's disease: current status and new perspectives</span></div><div class="casAuthors">Scarpini, Elio; Scheltens, Philip; Feldman, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">539-547</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing.  Pharmacol. treatment of AD is based on the use of acetylcholinesterase inhibitors, which have beneficial effects on cognitive, functional, and behavioral symptoms of the disease, but their role in AD pathogenesis is unknown.  Other pharmacol. therapies are becoming available-including the recently approved drug memantine, an NMDA channel blocker indicated for advanced AD.  Here, we review clin. features of the available cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) including their pharmacol. properties, the evidence for switching from one agent to another, "head to head" studies, and the emerging evidence for the use of memantine in AD.  New therapeutic approaches-including those more closely targeted to the pathogenesis of the disease-will also be reviewed.  These potentially disease modifying treatments include amyloid-β-peptide vaccination, secretase inhibitors, cholesterol-lowering drugs, metal chelators, and anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcyZp4rgEiurVg90H21EOLACvtfcHk0lgB_O2X8AFHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D&md5=f7d73fefb0cfce13bf8c93eebf60a4dd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2803%2900502-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252803%252900502-7%26sid%3Dliteratum%253Aachs%26aulast%3DScarpini%26aufirst%3DE.%26aulast%3DSchelterns%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DH.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253B%2520current%2520status%2520and%2520new%2520perspectives%26jtitle%3DLancet%2520Neurol.%26date%3D2003%26volume%3D2%26spage%3D539%26epage%3D547%26doi%3D10.1016%2FS1474-4422%2803%2900502-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span><span class="refDoi"> DOI: 10.1016/S0140-6736(06)69113-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0140-6736%2806%2969113-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=16876668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFymsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2806%2969113-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Blennow, Kaj; de Leon, Mony J.; Zetterberg, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">9533</span>),
    <span class="NLM_cas:pages">387-403</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most common cause of dementia.  Research advances have enabled detailed understanding of the mol. pathogenesis of the hallmarks of the disease-ie, plaques, composed of amyloid β (Aβ), and tangles, composed of hyperphosphorylated tau.  However, as our knowledge increases so does our appreciation for the pathogenic complexity of the disorder.  Alzheimer's disease is a very rare autosomal dominant disease with early onset, caused by mutations in the amyloid precursor protein and presenilin genes, both linked to Aβ metab.  By contrast with familial disease, sporadic Alzheimer's disease is very common with more than 15 million people affected worldwide.  The cause of the sporadic form of the disease is unknown, probably because the disease is heterogeneous, caused by aging in concert with a complex interaction of both genetic and environmental risk factors.  This seminar reviews the key aspects of the disease, including epidemiol., genetics, pathogenesis, diagnosis, and treatment, as well as recent developments and controversies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOIYvvzbyybVg90H21EOLACvtfcHk0lheJ5MPMeUlpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFymsbY%253D&md5=f70c374fbe01be1953bd0eea290745bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2806%2969113-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252806%252969113-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403%26doi%3D10.1016%2FS0140-6736%2806%2969113-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Yankner, B. A.</span><span> </span><span class="NLM_article-title">Mechanisms of neuronal degeneration in Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80115-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0896-6273%2800%2980115-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=8630250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK28XjsVKgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=921-932&author=B.+A.+Yankner&title=Mechanisms+of+neuronal+degeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0896-6273%2800%2980115-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of neuronal degeneration in Alzheimer's disease</span></div><div class="casAuthors">Yankner, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">921-932</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with ∼200 refs. on recent advances in the mol. genetics and cell biol. of Alzheimer's disease and the potential pathogenic mechanisms that emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnQiMvbx7gXrVg90H21EOLACvtfcHk0lheJ5MPMeUlpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsVKgs7o%253D&md5=2c5ec5c4a5b18550f6a0c2abff3fc0c0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980115-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980115-4%26sid%3Dliteratum%253Aachs%26aulast%3DYankner%26aufirst%3DB.%2BA.%26atitle%3DMechanisms%2520of%2520neuronal%2520degeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D921%26epage%3D932%26doi%3D10.1016%2FS0896-6273%2800%2980115-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kepp, K. P.</span><span> </span><span class="NLM_article-title">Bioinorganic chemistry of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5193</span><span class="NLM_x">–</span> <span class="NLM_lpage">5239</span><span class="refDoi"> DOI: 10.1021/cr300009x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300009x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVejtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=5193-5239&author=K.+P.+Kepp&title=Bioinorganic+chemistry+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcr300009x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioinorganic Chemistry of Alzheimer's Disease</span></div><div class="casAuthors">Kepp, Kasper P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5193-5239</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The role of genetic and environmental risk factors as exogenous metal exposure-mediated neuronal accumulation in brain of β-amyloid peptides in pathogenesis of Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrksapTjHoTvrVg90H21EOLACvtfcHk0lheJ5MPMeUlpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVejtbnK&md5=e9eaffc178654ba1c0ecc0393ca2bc8d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcr300009x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300009x%26sid%3Dliteratum%253Aachs%26aulast%3DKepp%26aufirst%3DK.%2BP.%26atitle%3DBioinorganic%2520chemistry%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D5193%26epage%3D5239%26doi%3D10.1021%2Fcr300009x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korshavn, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Cholesterol and metal ions in Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6682</span><span class="refDoi"> DOI: 10.1039/C4CS00005F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1039%2FC4CS00005F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=24710074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6672-6682&author=H.+J.+Leeauthor=K.+J.+Korshavnauthor=A.+Kochiauthor=J.+S.+Derrickauthor=M.+H.+Lim&title=Cholesterol+and+metal+ions+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CS00005F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol and metal ions in Alzheimer's disease</span></div><div class="casAuthors">Lee, Hyuck Jin; Korshavn, Kyle J.; Kochi, Akiko; Derrick, Jeffrey S.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cholesterol and metal ions have been suggested to be assocd. with the onset and progression of Alzheimer's disease (AD).  Moreover, recent findings have demonstrated a potential interconnection between these two factors.  For example, (a) cholesterol has been shown to be misregulated in AD-afflicted brains, and the aberrant activity of proteins (particularly, apolipoprotein E (ApoE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase (HMGR)) has been linked to cholesterol-related AD exacerbation; (b) dyshomeostasis of metal ions assocd. with misfolded proteins (i.e., amyloid-β (Aβ) aggregates) found in the brains of AD patients is shown to promote oxidative stress leading to the malfunction of multiple proteins, including cytochrome c oxidase (CcO), and Cu/Zn superoxide dismutase (SOD1); (c) metal ion misregulation has also been obsd. to disrupt the activity of proteins (e.g., HMGR, low-d. lipoproteins (LDL)), required for cholesterol prodn. and regulation.  Herein, we briefly discuss the potential involvement of cholesterol and metal ions in AD neuropathogenesis in both individual and interrelated manners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIRcNDCbM9ELVg90H21EOLACvtfcHk0lheJ5MPMeUlpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nL&md5=9ce6cc08f84ed8d07deb6fe5518b66c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC4CS00005F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00005F%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKorshavn%26aufirst%3DK.%2BJ.%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DCholesterol%2520and%2520metal%2520ions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6672%26epage%3D6682%26doi%3D10.1039%2FC4CS00005F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Savelieff, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeToma, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer’s disease</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2482</span><span class="refDoi"> DOI: 10.1021/ar500152x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar500152x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GlurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=2475-2482&author=M.+G.+Savelieffauthor=A.+S.+DeTomaauthor=J.+S.+Derrickauthor=M.+H.+Lim&title=The+ongoing+search+for+small+molecules+to+study+metal-associated+amyloid-%CE%B2+species+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Far500152x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer's Disease</span></div><div class="casAuthors">Savelieff, Masha G.; DeToma, Alaina S.; Derrick, Jeffrey S.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2475-2482</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of a cure for Alzheimer's disease (AD) has been impeded by an inability to pinpoint the root cause of this disorder.  Although numerous potential pathol. factors have been indicated, acting either individually or mutually, the mol. mechanisms leading to disease onset and progression have not been clear.  Amyloid-β (Aβ), generated from proteolytic processing of the amyloid precursor protein (APP), and its aggregated forms, particularly oligomers, are suggested as key pathol. features in AD-affected brains.  Historically, highly concd. metals are found colocalized within Aβ plaques.  Metal binding to Aβ (metal-Aβ) generates/stabilizes potentially toxic Aβ oligomers, and produces reactive oxygen species (ROS) in vitro (redox active metal ions; plausible contribution to oxidative stress).  Consequently, clarification of the relationship between Aβ, metal ions, and toxicity, including oxidative stress via metal-Aβ, can lead to a deeper understanding of AD development.  To probe the involvement of metal-Aβ in AD pathogenesis, rationally designed and naturally occurring mols. have been examd. as chem. tools to target metal-Aβ species, modulate the interaction between the metal and Aβ, and subsequently redirect their aggregation into nontoxic, off-pathway unstructured aggregates.  These ligands are also capable of attenuating the generation of redox active metal-Aβ-induced ROS to mitigate oxidative stress.  One rational design concept, the incorporation approach, installs a metal binding site into a framework known to interact with Aβ.  This approach affords compds. with the simultaneous ability to chelate metal ions and interact with Aβ.  Natural products capable of Aβ interaction have been investigated for their influence on metal-induced Aβ aggregation and have inspired the construction of synthetic analogs.  Systematic studies of these synthetic or natural mols. could uncover relationships between chem. structures, metal/Aβ/metal-Aβ interactions, and inhibition of Aβ/metal-Aβ reactivity (i.e., aggregation modes of Aβ/metal-Aβ; assocd. ROS prodn.), suggesting mechanisms to refine the design strategy.  Interdisciplinary investigations have demonstrated that the designed mols. and natural products control the aggregation pathways of metal-Aβ species transforming their size/conformation distribution.  The aptitude of these mols. to impact metal-Aβ aggregation pathways, either via inhibition of Aβ aggregate formation, most importantly of oligomers, or disaggregation of preformed fibrils, could originate from their formation of complexes with metal-Aβ.  Potentially, these mols. could direct metal-Aβ size/conformational states into alternative nontoxic unstructured oligomers, and control the geometry at the Aβ-ligated metal center for limited ROS formation to lessen the overall toxicity induced by metal-Aβ.  Complexation between small mols. and Aβ/metal-Aβ has been obsd. by NMR spectroscopy (NMR) and ion mobility-mass spectrometry (IM-MS) pointing to mol. level interactions, validating the design strategy.  In addn., these mols. exhibit other attractive properties, such as antioxidant capacity, prevention of ROS prodn., potential blood-brain barrier (BBB) permeability, and redn. of Aβ-/metal-Aβ-induced cytotoxicity, making them desirable tools for unraveling AD complexity.  In this Account, we summarize the recent development of small mols., via both rational design and the selection and modification of natural products, as tools for investigating metal-Aβ complexes, to advance our understanding of their relation to AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonOeVndqFambVg90H21EOLACvtfcHk0lhoSRduFnjhKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GlurvF&md5=26cb7b5ff0499e657046f99776f48010</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Far500152x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far500152x%26sid%3Dliteratum%253Aachs%26aulast%3DSavelieff%26aufirst%3DM.%2BG.%26aulast%3DDeToma%26aufirst%3DA.%2BS.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DThe%2520ongoing%2520search%2520for%2520small%2520molecules%2520to%2520study%2520metal-associated%2520amyloid-%25CE%25B2%2520species%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2014%26volume%3D47%26spage%3D2475%26epage%3D2482%26doi%3D10.1021%2Far500152x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Duce, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Biological metals and Alzheimer’s disease: Implications for therapeutics and diagnostics</span> <span class="citation_source-journal">Prog. Neurobiol. (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.pneurobio.2010.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=20444428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1-18&author=J.+A.+Duceauthor=A.+I.+Bush&title=Biological+metals+and+Alzheimer%E2%80%99s+disease%3A+Implications+for+therapeutics+and+diagnostics&doi=10.1016%2Fj.pneurobio.2010.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics</span></div><div class="casAuthors">Duce, James A.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The equil. of metal ions is crit. for many physiol. functions, particularly in the central nervous system, where metals are essential for development and maintenance of enzymic activities, mitochondrial function, myelination, neurotransmission as well as learning and memory.  Due to their importance, cells have evolved complex machinery for controlling metal-ion homeostasis.  However, disruption of these mechanisms, or absorption of detrimental metals with no known biol. function, alter the ionic balance and can result in a disease state, including several neurodegenerative disorders such as Alzheimer's disease.  Understanding the complex structural and functional interactions of metal ions with the various intracellular and extracellular components of the central nervous system, under normal conditions and during neurodegeneration, is essential for the development of effective therapies.  Accordingly, assisting the balance of metal ions back to homeostatic levels has been proposed as a disease-modifying therapeutic strategy for Alzheimer's disease as well as other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHRXNaNohExLVg90H21EOLACvtfcHk0lhoSRduFnjhKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D&md5=2aa9da17774b3da9f6118f0ce3f122ae</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DBiological%2520metals%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Implications%2520for%2520therapeutics%2520and%2520diagnostics%26jtitle%3DProg.%2520Neurobiol.%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2010%26volume%3D92%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.pneurobio.2010.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Metallostasis in Alzheimer’s disease</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2012.10.558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.freeradbiomed.2012.10.558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=23142767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslymtrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=76-89&author=S.+Aytonauthor=P.+Leiauthor=A.+I.+Bush&title=Metallostasis+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.freeradbiomed.2012.10.558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Metallostasis in Alzheimer's disease</span></div><div class="casAuthors">Ayton, Scott; Lei, Peng; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-89</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  2012 Has been another year in which multiple large-scale clin. trials for Alzheimer's disease (AD) have failed to meet their clin. endpoints.  With the social and financial burden of this disease increasing every year, the onus is now on the field of AD researchers to investigate alternative ideas to deliver outcomes for patients.  Although several major clin. trials targeting Aβ have failed, three smaller clin. trials targeting metal interactions with Aβ have all shown benefit for patients.  Here we review the genetic, pathol., biochem., and pharmacol. evidence that underlies the metal hypothesis of AD.  The AD-affected brain suffers from metallostasis, or fatigue of metal trafficking, resulting in redistribution of metals into inappropriate compartments.  The metal hypothesis is built upon a triad of transition elements: iron, copper, and zinc.  The hypothesis has matured from early investigations showing amyloidogenic and oxidative stress consequences of these metals; recently, disease-related proteins, APP, tau, and presenilin, have been shown to have major roles in metal regulation, which provides insight into the pathway of neurodegeneration in AD and illuminates potential new therapeutic avenues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokaWTzAem-GbVg90H21EOLACvtfcHk0lhoSRduFnjhKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslymtrnN&md5=4228fa48389e53a4b44c85786c0d2aa3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.10.558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.10.558%26sid%3Dliteratum%253Aachs%26aulast%3DAyton%26aufirst%3DS.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DMetallostasis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2013%26volume%3D62%26spage%3D76%26epage%3D89%26doi%3D10.1016%2Fj.freeradbiomed.2012.10.558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Praticò, D.</span><span> </span><span class="NLM_article-title">Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1016/j.tips.2008.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.tips.2008.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=609-615&author=D.+Pratic%C3%B2&title=Oxidative+stress+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+a+reappraisal&doi=10.1016%2Fj.tips.2008.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DPratic%25C3%25B2%26aufirst%3DD.%26atitle%3DOxidative%2520stress%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520reappraisal%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D609%26epage%3D615%26doi%3D10.1016%2Fj.tips.2008.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lee, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadesus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunomura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span> </span><span class="NLM_article-title">Antioxidant approaches for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span><span class="refDoi"> DOI: 10.1586/ern.10.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1586%2Fern.10.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=20586698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC3cnjsFKgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1201-1208&author=H.+P.+Leeauthor=X.+Zhuauthor=G.+Casadesusauthor=R.+J.+Castellaniauthor=A.+Nunomuraauthor=M.+A.+Smithauthor=H.+G.+Leeauthor=G.+Perry&title=Antioxidant+approaches+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1586%2Fern.10.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant approaches for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Lee Hyun Pil; Zhu Xiongwei; Casadesus Gemma; Castellani Rudy J; Nunomura Akihiko; Smith Mark A; Lee Hyoung-gon; Perry George</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of neurotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1201-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxidative stress is an important factor, and one that acts in the earliest stages, of Alzheimer's disease (AD) pathogenesis.  The reduction of oxidative stress has been tested as a therapy for AD.  While the trial of vitamin E supplementation in moderately severe AD is the most promising so far, it also reveals the limitations of general antioxidant therapies that simply lower oxidative stress and, therefore, the complexity of the redox system.  The multiple contributing factors that foster the clinical manifestations of AD should be considered when designing antioxidative stress therapy.  In this article, we discuss the multiple pathogenic mechanisms of oxidative stress in AD and the potential targeting approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs7JD-wMaBKZw7prLlxLOzfW6udTcc2eaQ42Pi22z7BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnjsFKgsw%253D%253D&md5=3b10b89e2f26322dc333aba247c66b4d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1586%2Fern.10.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.10.74%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCasadesus%26aufirst%3DG.%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DNunomura%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DH.%2BG.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DAntioxidant%2520approaches%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2010%26volume%3D10%26spage%3D1201%26epage%3D1208%26doi%3D10.1586%2Fern.10.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">Novel tacrine–8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span><span class="refDoi"> DOI: 10.1021/jm100329q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100329q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4927-4937&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=S.+Condeauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Novel+tacrine%E2%80%938-hydroxyquinoline+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+neuroprotective%2C+cholinergic%2C+antioxidant%2C+and+copper-complexing+properties&doi=10.1021%2Fjm100329q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100329q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100329q%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNovel%2520tacrine%25E2%2580%25938-hydroxyquinoline%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520neuroprotective%252C%2520cholinergic%252C%2520antioxidant%252C%2520and%2520copper-complexing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4927%26epage%3D4937%26doi%3D10.1021%2Fjm100329q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckroat, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhoub, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span> </span><span class="NLM_article-title">A novel hybrid of 6-chlorotacrine and metal-amyloid-β modulator for inhibition of acetylcholinesterase and metal-induced amyloid-β aggregation</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">4137</span><span class="NLM_x">–</span> <span class="NLM_lpage">4145</span><span class="refDoi"> DOI: 10.1039/c3sc51902c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1039%2Fc3sc51902c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFegsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=4137-4145&author=A.+Kochiauthor=T.+J.+Eckroatauthor=K.+D.+Greenauthor=A.+S.+Mayhoubauthor=M.+H.+Limauthor=S.+Garneau-Tsodikova&title=A+novel+hybrid+of+6-chlorotacrine+and+metal-amyloid-%CE%B2+modulator+for+inhibition+of+acetylcholinesterase+and+metal-induced+amyloid-%CE%B2+aggregation&doi=10.1039%2Fc3sc51902c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A novel hybrid of 6-chlorotacrine and metal-amyloid-β modulator for inhibition of acetylcholinesterase and metal-induced amyloid-β aggregation</span></div><div class="casAuthors">Kochi, Akiko; Eckroat, Todd J.; Green, Keith D.; Mayhoub, Abdelrahman S.; Lim, Mi Hee; Garneau-Tsodikova, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4137-4145</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The no. of people suffering from Alzheimer's disease (AD) is expected to increase dramatically in the coming decades.  Currently, acetylcholinesterase inhibitors (AChEis) provide some relief of cognitive symptoms, while newer approaches, such as amyloid-β (Aβ)-targeted metal chelation, offer potential hope for slowing and/or reversing disease progression.  This work details the synthesis and biochem. evaluation of a novel hybrid of 6-chlorotacrine and a metal-Aβ modulator that chem. combines an AChEi and an Aβ-targeted metal chelator into a single mol.  This hybrid shows potent inhibition of AChE under various conditions, interaction with Cu2+ and Zn2+, control of metal-free and metal-induced Aβ aggregate assembly, and disaggregation of preformed metal-free and metal-assocd. Aβ aggregates.  As such, the hybrid described herein represents a promising, new multifunctional compd. for AD studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5evGjzbS4a7Vg90H21EOLACvtfcHk0lgpRRhUeXIywA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFegsr3O&md5=679a47d182cc7fc9c4d24e95e7bc7e6b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fc3sc51902c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc51902c%26sid%3Dliteratum%253Aachs%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DEckroat%26aufirst%3DT.%2BJ.%26aulast%3DGreen%26aufirst%3DK.%2BD.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DA%2520novel%2520hybrid%2520of%25206-chlorotacrine%2520and%2520metal-amyloid-%25CE%25B2%2520modulator%2520for%2520inhibition%2520of%2520acetylcholinesterase%2520and%2520metal-induced%2520amyloid-%25CE%25B2%2520aggregation%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D4137%26epage%3D4145%26doi%3D10.1039%2Fc3sc51902c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wu, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shionoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inokuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.ejmech.2015.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=26471320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=864-879&author=M.-Y.+Wuauthor=G.+Estebanauthor=S.+Brogiauthor=M.+Shionoyaauthor=L.+Wangauthor=G.+Campianiauthor=M.+Unzetaauthor=T.+Inokuchiauthor=S.+Butiniauthor=J.+Marco-Contelles&title=Donepezil-like+multifunctional+agents%3A+Design%2C+synthesis%2C+molecular+modeling+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2015.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation</span></div><div class="casAuthors">Wu, Ming-Yu; Esteban, Gerard; Brogi, Simone; Shionoya, Masahi; Wang, Li; Campiani, Giuseppe; Unzeta, Mercedes; Inokuchi, Tsutomu; Butini, Stefania; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">864-879</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Currently available drugs against Alzheimer's disease (AD) are only able to ameliorate the disease symptoms resulting in a moderate improvement in memory and cognitive function without any efficacy in preventing and inhibiting the progression of the pathol.  In an effort to obtain disease-modifying anti-Alzheimer's drugs (DMAADs) following the multifactorial nature of AD, we have recently developed multifunctional compds.  We herein describe the design, synthesis, mol. modeling and biol. evaluation of a new series of donepezil-related compds. possessing metal chelating properties, and being capable of targeting different enzymic systems related to AD (cholinesterases, ChEs, and monoamine oxidase A, MAO-A).  Among this set of analogs compd. I showed excellent ChEs inhibition potency and a selective MAO-A inhibition (vs MAO-B) coupled to strong complexing properties for zinc and copper ions, both known to be involved in the progression of AD.  Moreover, I exhibited moderate antioxidant properties as found by in vitro assessment.  This compd. represents a novel donepezil-hydroxyquinoline hybrid with DMAAD profile paving the way to the development of a novel class of drugs potentially able to treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCOvmO6AroXrVg90H21EOLACvtfcHk0lj6e5gYYiO6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL%252FM&md5=7bf3ba2586578a39287a0aacbbe3f672</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.-Y.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DShionoya%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DInokuchi%26aufirst%3DT.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDonepezil-like%2520multifunctional%2520agents%253A%2520Design%252C%2520synthesis%252C%2520molecular%2520modeling%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D864%26epage%3D879%26doi%3D10.1016%2Fj.ejmech.2015.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Li, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.ejmech.2013.09.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=632-646&author=S.-Y.+Liauthor=X.-B.+Wangauthor=S.-S.+Xieauthor=N.+Jiangauthor=K.+D.+G.+Wangauthor=H.-Q.+Yaoauthor=H.-B.+Sunauthor=L.-Y.+Kong&title=Multifunctional+tacrine-flavonoid+hybrids+with+cholinergic%2C+%CE%B2-amyloid-reducing%2C+and+metal+chelating+properties+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.09.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.-Y.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DYao%26aufirst%3DH.-Q.%26aulast%3DSun%26aufirst%3DH.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMultifunctional%2520tacrine-flavonoid%2520hybrids%2520with%2520cholinergic%252C%2520%25CE%25B2-amyloid-reducing%252C%2520and%2520metal%2520chelating%2520properties%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D632%26epage%3D646%26doi%3D10.1016%2Fj.ejmech.2013.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1007/s00702-012-0948-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1007%2Fs00702-012-0948-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=23238976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosl2qurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2013&pages=893-902&author=I.+Boleaauthor=A.+Gellaauthor=M.+Unzeta&title=Propargylamine-derived+multitarget-directed+ligands%3A+fighting+Alzheimer%E2%80%99s+disease+with+monoamine+oxidase+inhibitors&doi=10.1007%2Fs00702-012-0948-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors</span></div><div class="casAuthors">Bolea, Irene; Gella, Alejandro; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">893-902</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a complex neurodegenerative disorder with a multifaceted pathogenesis.  There are at present three Food and Drug Administration-approved drugs based on the "one drug, one target" paradigm (donepezil, galantamine and rivastigmine) that improve symptoms by inhibiting acetylcholinesterase.  However, apart from the beneficial palliative properties, cholinergic drugs have shown little efficacy to prevent the progression of the disease evidencing the unsuitability of this strategy for the complex nature of AD.  By contrast, the multifactorial nature of this neurodegenerative disorder supports the most current innovative therapeutic approach based on the "one drug, multiple targets" paradigm, which suggests the use of compds. with multiple activities at different target sites.  Accordingly, the also called multitarget-directed ligand (MTDL) approach has been the subject of increasing attention by many research groups, which have developed a variety of hybrid compds. acting on very diverse targets.  The therapeutic potential of monoamine oxidase inhibitors (MAOI) in AD has been suggested due to their demonstrated neuroprotective properties besides their enhancing effect on monoaminergic transmission.  Esp., those contg. a propargylamine moiety are of particular interest due to their reported beneficial actions.  Therefore, targeting MAO enzymes should be considered in therapeutic interventions.  This review makes a special emphasis on MTDLs that commonly target MAO enzymes.  There is at present an urgent need for real disease-modifying therapies for AD and the MTDL approach makes a breakthrough for the development of new drugs capable of addressing the biol. complexity of this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8SaG-kY0_7Vg90H21EOLACvtfcHk0lj6e5gYYiO6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosl2qurY%253D&md5=bf146b3d399378b7defd06c8d1bb1058</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00702-012-0948-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-012-0948-y%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DPropargylamine-derived%2520multitarget-directed%2520ligands%253A%2520fighting%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2013%26volume%3D120%26spage%3D893%26epage%3D902%26doi%3D10.1007%2Fs00702-012-0948-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, J. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasefi, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beazely, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P. N.</span><span> </span><span class="NLM_article-title">Development and evaluation of multifunctional agents for potential treatment of Alzheimer’s disease: Application to a pyrimidine-2,4-diamine template</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4707</span><span class="NLM_x">–</span> <span class="NLM_lpage">4712</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmcl.2012.05.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=22704921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslSlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4707-4712&author=T.+Mohamedauthor=J.+C.+K.+Yeungauthor=M.+S.+Vasefiauthor=M.+A.+Beazelyauthor=P.+P.+N.+Rao&title=Development+and+evaluation+of+multifunctional+agents+for+potential+treatment+of+Alzheimer%E2%80%99s+disease%3A+Application+to+a+pyrimidine-2%2C4-diamine+template&doi=10.1016%2Fj.bmcl.2012.05.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: Application to a pyrimidine-2,4-diamine template</span></div><div class="casAuthors">Mohamed, Tarek; Yeung, Jacky C. K.; Vasefi, Maryam S.; Beazely, Michael A.; Rao, Praveen P. N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4707-4712</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated a group of 2-benzylpiperidin-N-benzylpyrimidin-4-amines with various electron-withdrawing or electron-donating groups (EWGs or EDGs, resp.) as multi-targeted Alzheimer's disease (AD) therapeutics.  The synthesized derivs. were screened for anti-cholinesterase (AChE and BuChE), anti-Aβ-aggregation (AChE- and self-induced) and anti-β-secretase (BACE-1) activities in an effort to identify lead, multifunctional candidates as part of our multi-targeted approach to treat AD.  Biol. assessment revealed that the nature of the substituent on the C-4 benzylamine group (e.g., halogen vs methoxy-based) greatly affected the biol. profile.  In vitro screening identified N2-(1-benzylpiperidin-4-yl)-N4-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamine (7h) as the lead candidate with a dual ChE (AChE IC50 = 9.9 μM; BuChE IC50 = 11.4 μM), Aβ-aggregation (AChE-induced = 59.3%; self-induced = 17.4% at 100 μM) and BACE-1 (34% inhibition at 10 μM) inhibitory profile along with good cell viability (% neuroblastoma cell viability at 40 μM = 81.0%).  Mol. modeling studies indicate that a central pyrimidine-2,4-diamine ring serves as a suitable template to develop novel small mol. candidates to target multiple pathol. routes in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFR2oGdjFsjbVg90H21EOLACvtfcHk0liJs-Cdi97OjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslSlurw%253D&md5=0aa3c060e101470c2951d260427b218c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.077%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DYeung%26aufirst%3DJ.%2BC.%2BK.%26aulast%3DVasefi%26aufirst%3DM.%2BS.%26aulast%3DBeazely%26aufirst%3DM.%2BA.%26aulast%3DRao%26aufirst%3DP.%2BP.%2BN.%26atitle%3DDevelopment%2520and%2520evaluation%2520of%2520multifunctional%2520agents%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Application%2520to%2520a%2520pyrimidine-2%252C4-diamine%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4707%26epage%3D4712%26doi%3D10.1016%2Fj.bmcl.2012.05.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P. N.</span><span> </span><span class="NLM_article-title">Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: Dual activity as cholinesterase and Aβ-aggregation inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2281</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmc.2011.02.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2269-2281&author=T.+Mohamedauthor=X.+Zhaoauthor=L.+K.+Habibauthor=J.+Yangauthor=P.+P.+N.+Rao&title=Design%2C+synthesis+and+structure-activity+relationship+%28SAR%29+studies+of+2%2C4-disubstituted+pyrimidine+derivatives%3A+Dual+activity+as+cholinesterase+and+A%CE%B2-aggregation+inhibitors&doi=10.1016%2Fj.bmc.2011.02.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHabib%26aufirst%3DL.%2BK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DP.%2BP.%2BN.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%25202%252C4-disubstituted%2520pyrimidine%2520derivatives%253A%2520Dual%2520activity%2520as%2520cholinesterase%2520and%2520A%25CE%25B2-aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2269%26epage%3D2281%26doi%3D10.1016%2Fj.bmc.2011.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, J. C.K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P.N.</span><span> </span><span class="NLM_article-title">Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5881</span><span class="NLM_x">–</span> <span class="NLM_lpage">5887</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.07.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmcl.2011.07.091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5881-5887&author=T.+Mohamedauthor=J.+C.K.+Yeungauthor=P.+P.N.+Rao&title=Development+of+2-substituted-N-%28naphth-1-ylmethyl%29+and+N-benzhydrylpyrimidin-4-amines+as+dual+cholinesterase+and+A%CE%B2-aggregation+inhibitors%3A+Synthesis+and+biological+evaluation&doi=10.1016%2Fj.bmcl.2011.07.091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.091%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DYeung%26aufirst%3DJ.%2BC.K.%26aulast%3DRao%26aufirst%3DP.%2BP.N.%26atitle%3DDevelopment%2520of%25202-substituted-N-%2528naphth-1-ylmethyl%2529%2520and%2520N-benzhydrylpyrimidin-4-amines%2520as%2520dual%2520cholinesterase%2520and%2520A%25CE%25B2-aggregation%2520inhibitors%253A%2520Synthesis%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5881%26epage%3D5887%26doi%3D10.1016%2Fj.bmcl.2011.07.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3606</span><span class="NLM_x">–</span> <span class="NLM_lpage">3609</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmcl.2010.04.108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3606-3609&author=T.+Mohamedauthor=P.+P.+Rao&title=Design%2C+synthesis+and+evaluation+of+2%2C4-disubstituted+pyrimidines+as+cholinesterase+inhibitors&doi=10.1016%2Fj.bmcl.2010.04.108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.108%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DP.%2BP.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%25202%252C4-disubstituted%2520pyrimidines%2520as%2520cholinesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3606%26epage%3D3609%26doi%3D10.1016%2Fj.bmcl.2010.04.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Orysyk, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekhnyo, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zborovskii, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orysyk, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vovk, M. V.</span><span> </span><span class="NLM_article-title">Synthesis, structure and spectral characteristics of Ni(II), Pd(II) and Zn(II) complexes with N-(2-pyridinyl)morpholine-4-carbothioamide</span> <span class="citation_source-journal">Polyhedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.poly.2012.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.poly.2012.02.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=15-25&author=S.+I.+Orysykauthor=V.+V.+Bonauthor=V.+I.+Pekhnyoauthor=Y.+L.+Zborovskiiauthor=V.+V.+Orysykauthor=M.+V.+Vovk&title=Synthesis%2C+structure+and+spectral+characteristics+of+Ni%28II%29%2C+Pd%28II%29+and+Zn%28II%29+complexes+with+N-%282-pyridinyl%29morpholine-4-carbothioamide&doi=10.1016%2Fj.poly.2012.02.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2012.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2012.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DOrysyk%26aufirst%3DS.%2BI.%26aulast%3DBon%26aufirst%3DV.%2BV.%26aulast%3DPekhnyo%26aufirst%3DV.%2BI.%26aulast%3DZborovskii%26aufirst%3DY.%2BL.%26aulast%3DOrysyk%26aufirst%3DV.%2BV.%26aulast%3DVovk%26aufirst%3DM.%2BV.%26atitle%3DSynthesis%252C%2520structure%2520and%2520spectral%2520characteristics%2520of%2520Ni%2528II%2529%252C%2520Pd%2528II%2529%2520and%2520Zn%2528II%2529%2520complexes%2520with%2520N-%25282-pyridinyl%2529morpholine-4-carbothioamide%26jtitle%3DPolyhedron%26date%3D2012%26volume%3D38%26spage%3D15%26epage%3D25%26doi%3D10.1016%2Fj.poly.2012.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Krivenko, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibgatullin, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezova, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galkin, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukmeneva, N. A.</span><span> </span><span class="NLM_article-title">Correlation between the structure of thioureas and their reactivity toward hydroperoxides and peroxy radicals</span> <span class="citation_source-journal">Russ. J. Gen. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span><span class="refDoi"> DOI: 10.1023/B:RUGC.0000007616.03223.3a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1023%2FB%3ARUGC.0000007616.03223.3a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Khtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=1086-1090&author=L.+V.+Krivenkoauthor=I.+M.+Sibgatullinauthor=E.+N.+Cherezovaauthor=V.+I.+Galkinauthor=N.+A.+Mukmeneva&title=Correlation+between+the+structure+of+thioureas+and+their+reactivity+toward+hydroperoxides+and+peroxy+radicals&doi=10.1023%2FB%3ARUGC.0000007616.03223.3a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between the structure of thioureas and their reactivity toward hydroperoxides and peroxy radicals</span></div><div class="casAuthors">Krivenko, L. V.; Sibgatullin, I. M.; Cherezova, E. N.; Galkin, V. I.; Mukmeneva, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Journal of General Chemistry (Translation of Zhurnal Obshchei Khimii)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1086-1090</span>CODEN:
                <span class="NLM_cas:coden">RJGCEK</span>;
        ISSN:<span class="NLM_cas:issn">1070-3632</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">The behavior of thiourea derivs. in reactions simulating oxidative processes in carbon-chain polymers was studied.  Based on the kinetic data obtained (reaction rate consts.), correlations were revealed between the structures of thioureas and their reactivity in inhibition of oxidn. of org. substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_kWvaQZulm7Vg90H21EOLACvtfcHk0liJs-Cdi97OjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Khtbs%253D&md5=b547053a0259e61f9a1e19dabae46ae8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FB%3ARUGC.0000007616.03223.3a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ARUGC.0000007616.03223.3a%26sid%3Dliteratum%253Aachs%26aulast%3DKrivenko%26aufirst%3DL.%2BV.%26aulast%3DSibgatullin%26aufirst%3DI.%2BM.%26aulast%3DCherezova%26aufirst%3DE.%2BN.%26aulast%3DGalkin%26aufirst%3DV.%2BI.%26aulast%3DMukmeneva%26aufirst%3DN.%2BA.%26atitle%3DCorrelation%2520between%2520the%2520structure%2520of%2520thioureas%2520and%2520their%2520reactivity%2520toward%2520hydroperoxides%2520and%2520peroxy%2520radicals%26jtitle%3DRuss.%2520J.%2520Gen.%2520Chem.%26date%3D2003%26volume%3D73%26spage%3D1086%26epage%3D1090%26doi%3D10.1023%2FB%3ARUGC.0000007616.03223.3a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Zhu, B.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antholine, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, B.</span><span> </span><span class="NLM_article-title">Thiourea protects against copper-induced oxidative damage by formation of a redox-inactive thiourea-copper complex</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.1016/S0891-5849(02)00847-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0891-5849%2802%2900847-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12057771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFyhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=1333-1338&author=B.-Z.+Zhuauthor=W.+E.+Antholineauthor=B.+Frei&title=Thiourea+protects+against+copper-induced+oxidative+damage+by+formation+of+a+redox-inactive+thiourea-copper+complex&doi=10.1016%2FS0891-5849%2802%2900847-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Thiourea protects against copper-induced oxidative damage by formation of a redox-inactive thiourea-copper complex</span></div><div class="casAuthors">Zhu, Ben-Zhan; Antholine, William E.; Frei, Balz</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1333-1338</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Although thiourea has been used widely to study the role of hydroxyl radicals in metal-mediated biol. damage, it is not a specific hydroxyl radical scavenger and may also exert antioxidant effects unrelated to hydroxyl radical scavenging.  Thus, the authors investigated the effects of thiourea on copper-induced oxidative damage to bovine serum albumin (1 mg/mL) in three different copper-contg. systems: Cu(II)/ascorbate, Cu(II)/H2O2, and Cu(II)/H2O2/ascorbate [Cu(II), 0.1 mM; ascorbate, 1 mM; H2O2, 1 mM].  Oxidative damage to albumin was measured as protein carbonyl formation.  Thiourea (0.1-10 mM) provided marked and dose-dependent protection against protein oxidn. in all three copper-contg. systems.  In contrast, only minor protection was obsd. with DMSO and mannitol, even at concns. as high as 100 mM.  Strong protection was also obsd. with dimethylthiourea, but not with urea or dimethylurea.  Thiourea also significantly inhibited copper-catalyzed oxidn. of ascorbate, and competed effectively with histidine and 1,10-phenanthroline for binding of cuprous, but not cupric, copper, as demonstrated by both UV-visible and low temp. ESR measurements.  The authors conclude that the protection by thiourea against copper-mediated protein oxidn. is not through scavenging of hydroxyl radicals, but rather through the chelation of cuprous copper and the formation of a redox-inactive thiourea-copper complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQVOEq2QRz27Vg90H21EOLACvtfcHk0lh37bnZ-9wNPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFyhsbk%253D&md5=68f86f822f4fe392fe1ed3fa44b56734</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2900847-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252900847-X%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.-Z.%26aulast%3DAntholine%26aufirst%3DW.%2BE.%26aulast%3DFrei%26aufirst%3DB.%26atitle%3DThiourea%2520protects%2520against%2520copper-induced%2520oxidative%2520damage%2520by%2520formation%2520of%2520a%2520redox-inactive%2520thiourea-copper%2520complex%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D32%26spage%3D1333%26epage%3D1338%26doi%3D10.1016%2FS0891-5849%2802%2900847-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Abbott, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isbell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momany, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlotta, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisleder, D.</span><span> </span><span class="NLM_article-title">1,3-di(3-Methoxybenzyl) thiourea and related lipid antioxidants</span> <span class="citation_source-journal">Ind. Crops Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/S0926-6690(02)00006-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0926-6690%2802%2900006-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Crsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=43-57&author=T.+P.+Abbottauthor=A.+Wohlmanauthor=T.+Isbellauthor=F.+A.+Momanyauthor=C.+Cantrellauthor=D.+V.+Garlottaauthor=D.+Weisleder&title=1%2C3-di%283-Methoxybenzyl%29+thiourea+and+related+lipid+antioxidants&doi=10.1016%2FS0926-6690%2802%2900006-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Di(3-Methoxybenzyl) thiourea and related lipid antioxidants</span></div><div class="casAuthors">Abbott, Thomas P.; Wohlman, Alan; Isbell, Terry; Momany, Frank A.; Cantrell, Charles; Garlotta, Donald V.; Weisleder, David</div><div class="citationInfo"><span class="NLM_cas:title">Industrial Crops and Products</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-57</span>CODEN:
                <span class="NLM_cas:coden">ICRDEW</span>;
        ISSN:<span class="NLM_cas:issn">0926-6690</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Natural lipids and oils are subject to oxidative degrdn. affecting color, odor, viscosity, and lubricity, which lowers the quality of the com. products contg. these lipids.  In the food, cosmetics and pharmaceutical industries, maintaining high quality color and odor of oils and other lipids is important.  Meadowfoam (Limnanthes alba) seed oil is more oxidatively stable than other vegetable oils and imparts this oxidative stability to other oils when mixed in combinations.  This study was conducted to identify antioxidants in meadowfoam oil and to det. their properties.  Structurally-related compds. were synthesized to compare to the antioxidant compd. in meadowfoam.  Compds. isolated from meadowfoam oil (L. alba), were concluded to be either a source of 1,3-di(3-methoxybenzyl) thiourea (3MBTU) or oxidn. products from it. 3-Methoxybenzyl isothiocyanate (3MBITC) and 3-methoxybenzyl amine (3MBAm), which were identified in the oil as degrdn. products of the glucosinolate glucolimnanthin, reacted readily to form 3MBTU in meadowfoam oil, water and ethanol. 1,3-di(3-methoxybenzyl) urea, the oxygenated form of 3MBTU, was isolated from crude meadowfoam oil. 3MBTU and other disubstituted thioureas contg. at least one 3-methoxybenzyl substituent were made from isothiocyanates and amines and the lipid soly., antioxidant properties, toxicity (LC50), stability and spectral absorbance properties were detd. 3MBTU was an effective antioxidant in two different oxidative stability tests for mono- and polyunsatd. oils at the 0.1% level.  It was also a stronger UVB absorber than most of the other disubstituted thioureas tested.  Mol. models and calcns. explained some of these results.  The toxicity of 3MBTU was also very low compared with other thioureas and some commonly used lipid antioxidants.  Soly. in meadowfoam oil was highest for 3MBTU, among those tested at 50°. In conclusion, 3MBTU, from meadowfoam oil, meadowfoam byproducts, or synthesized appears to meet many of the criteria for an effective lipid antioxidant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNf8rpSpcN37Vg90H21EOLACvtfcHk0lh37bnZ-9wNPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Crsbs%253D&md5=fbff5215f8783805c25736319ff8561d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0926-6690%2802%2900006-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0926-6690%252802%252900006-7%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DT.%2BP.%26aulast%3DWohlman%26aufirst%3DA.%26aulast%3DIsbell%26aufirst%3DT.%26aulast%3DMomany%26aufirst%3DF.%2BA.%26aulast%3DCantrell%26aufirst%3DC.%26aulast%3DGarlotta%26aufirst%3DD.%2BV.%26aulast%3DWeisleder%26aufirst%3DD.%26atitle%3D1%252C3-di%25283-Methoxybenzyl%2529%2520thiourea%2520and%2520related%2520lipid%2520antioxidants%26jtitle%3DInd.%2520Crops%2520Prod.%26date%3D2002%26volume%3D16%26spage%3D43%26epage%3D57%26doi%3D10.1016%2FS0926-6690%2802%2900006-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lh37bnZ-9wNPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Davalos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Cordoves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, B.</span><span> </span><span class="NLM_article-title">Extending applicability of the oxygen radical absorbance capacity (ORAC-Fluorescein) assay</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1021/jf0305231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&author=A.+Davalosauthor=C.+Gomez-Cordovesauthor=B.+Bartolome&title=Extending+applicability+of+the+oxygen+radical+absorbance+capacity+%28ORAC-Fluorescein%29+assay&doi=10.1021%2Fjf0305231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DGomez-Cordoves%26aufirst%3DC.%26aulast%3DBartolome%26aufirst%3DB.%26atitle%3DExtending%2520applicability%2520of%2520the%2520oxygen%2520radical%2520absorbance%2520capacity%2520%2528ORAC-Fluorescein%2529%2520assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26spage%3D48%26epage%3D54%26doi%3D10.1021%2Fjf0305231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Ou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampsch-Woodill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, R. L.</span><span> </span><span class="NLM_article-title">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4619</span><span class="NLM_x">–</span> <span class="NLM_lpage">4626</span><span class="refDoi"> DOI: 10.1021/jf010586o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+validation+of+an+improved+oxygen+radical+absorbance+capacity+assay+using+fluorescein+as+the+fluorescent+probe&doi=10.1021%2Fjf010586o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0lgsv6gwn4qC0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520an%2520improved%2520oxygen%2520radical%2520absorbance%2520capacity%2520assay%2520using%2520fluorescein%2520as%2520the%2520fluorescent%2520probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26spage%3D4619%26epage%3D4626%26doi%3D10.1021%2Fjf010586o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hatip, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suenaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, Y.</span><span> </span><span class="NLM_article-title">Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Aβ40, by the β-sheet breaker peptides 16–23 and 17–24</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00384.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1111%2Fj.1476-5381.2009.00384.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=19785651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1165-1172&author=F.+F.+Hatipauthor=M.+Suenagaauthor=T.+Yamadaauthor=Y.+Matsunaga&title=Reversal+of+temperature-induced+conformational+changes+in+the+amyloid-beta+peptide%2C+A%CE%B240%2C+by+the+%CE%B2-sheet+breaker+peptides+16%E2%80%9323+and+17%E2%80%9324&doi=10.1111%2Fj.1476-5381.2009.00384.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Aβ40, by the β-sheet breaker peptides 16-23 and 17-24</span></div><div class="casAuthors">Hatip, Funda F. Bolukbasi; Suenaga, Midori; Yamada, Tatsuo; Matsunaga, Yoichi</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1165-1172</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aggregates of the protein amyloid-beta (Aβ) play a crucial role in the pathogenesis of Alzheimer's disease (AD).  Most therapeutic approaches to AD do not target Aβ, so detn. of the factor(s) that facilitate aggregation and discovering agents that prevent aggregation have great potential therapeutic value.  We investigated ex vivo the temp.-sensitive regions of Aβ1-40 (Aβ40) and their interactions with octapeptides derived from sequences within Aβ40, β-sheet breaker peptides (βSBP), using ELISA, and dot blot and far-UV CD spectroscopy.  We measured changes within the physiol. limits of temp., using antibodies targeting epitopes 1-7, 5-10, 9-14, and 17-21 within Aβ40.  Temp.-dependent conformational changes were obsd. in Aβ40 at epitopes 9-14 and 17-21 at 36-38 and 36-40° resp.  The βSBPs 16-23 and 17-24, but not 15-22 and 18-25, could inhibit the changes.  Moreover, βSBPs 16-23 and 17-24 increased digestion of Aβ40 by protease K, indicating a decreased aggregation of Aβ40, whereas βSBPs 15-22 and 18-25 did not increase this digestion.  CD spectra revealed that β-sheet formation in Aβ40 at 38° was reduced with βSBPs 16-23 and 17-24.  The epitopes 9-14 and 17-21 are the temp.-sensitive regions within Aβ40.  The βSBPs, Aβ16-23 and 17-24 reversed temp.-induced β-sheet formation, and decreased Aβ40 aggregation.  The results suggest that the 17-23 epitope of Aβ40 is crucially involved in preventing Aβ40 aggregation and consequent deposition of Aβ40 in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxQ8bY265N6LVg90H21EOLACvtfcHk0lgsv6gwn4qC0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fN&md5=11c0322e1fdb2114d6452bfac86bd215</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00384.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00384.x%26sid%3Dliteratum%253Aachs%26aulast%3DHatip%26aufirst%3DF.%2BF.%26aulast%3DSuenaga%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DY.%26atitle%3DReversal%2520of%2520temperature-induced%2520conformational%2520changes%2520in%2520the%2520amyloid-beta%2520peptide%252C%2520A%25CE%25B240%252C%2520by%2520the%2520%25CE%25B2-sheet%2520breaker%2520peptides%252016%25E2%2580%259323%2520and%252017%25E2%2580%259324%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1165%26epage%3D1172%26doi%3D10.1111%2Fj.1476-5381.2009.00384.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begum, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubeda, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambegaokar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frautschy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span> </span><span class="NLM_article-title">Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5892</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span><span class="refDoi"> DOI: 10.1074/jbc.M404751200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1074%2Fjbc.M404751200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=15590663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=5892-5901&author=F.+Yangauthor=G.+P.+Limauthor=A.+N.+Begumauthor=O.+J.+Ubedaauthor=M.+R.+Simmonsauthor=S.+S.+Ambegaokarauthor=P.+P.+Chenauthor=R.+Kayedauthor=C.+G.+Glabeauthor=S.+A.+Frautschyauthor=G.+M.+Cole&title=Curcumin+inhibits+formation+of+amyloid+beta+oligomers+and+fibrils%2C+binds+plaques%2C+and+reduces+amyloid+in+vivo&doi=10.1074%2Fjbc.M404751200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo</span></div><div class="casAuthors">Yang, Fusheng; Lim, Giselle P.; Begum, Aynun N.; Ubeda, Oliver J.; Simmons, Mychica R.; Ambegaokar, Surendra S.; Chen, Pingping P.; Kayed, Rakez; Glabe, Charles G.; Frautschy, Sally A.; Cole, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5892-5901</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) involves amyloid β (Aβ) accumulation, oxidative damage, and inflammation, and risk is reduced with increased antioxidant and anti-inflammatory consumption.  The phenolic yellow curry pigment curcumin has potent anti-inflammatory and antioxidant activities and can suppress oxidative damage, inflammation, cognitive deficits, and amyloid accumulation.  Since the mol. structure of curcumin suggested potential Aβ binding, we investigated whether its efficacy in AD models could be explained by effects on Aβ aggregation.  Under aggregating conditions in vitro, curcumin inhibited aggregation (IC50 = 0.8 μM) as well as disaggregated fibrillar Aβ40 (IC50 = 1 μM), indicating favorable stoichiometry for inhibition.  Curcumin was a better Aβ40 aggregation inhibitor than ibuprofen and naproxen, and prevented Aβ42 oligomer formation and toxicity between 0.1 and 1.0 μM.  Under EM, curcumin decreased dose dependently Aβ fibril formation beginning with 0.125 μM.  The effects of curcumin did not depend on Aβ sequence but on fibril-related conformation.  AD and Tg2576 mice brain sections incubated with curcumin revealed preferential labeling of amyloid plaques.  In vivo studies showed that curcumin injected peripherally into aged Tg mice crossed the blood-brain barrier and bound plaques.  When fed to aged Tg2576 mice with advanced amyloid accumulation, curcumin labeled plaques and reduced amyloid levels and plaque burden.  Hence, curcumin directly binds small β-amyloid species to block aggregation and fibril formation in vitro and in vivo.  These data suggest that low dose curcumin effectively disaggregates Aβ as well as prevents fibril and oligomer formation, supporting the rationale for curcumin use in clin. trials preventing or treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTY2O8WLUVrVg90H21EOLACvtfcHk0lgsv6gwn4qC0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D&md5=5f8f6fb0c3529ba9dbeae5f8af096250</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404751200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404751200%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DG.%2BP.%26aulast%3DBegum%26aufirst%3DA.%2BN.%26aulast%3DUbeda%26aufirst%3DO.%2BJ.%26aulast%3DSimmons%26aufirst%3DM.%2BR.%26aulast%3DAmbegaokar%26aufirst%3DS.%2BS.%26aulast%3DChen%26aufirst%3DP.%2BP.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DFrautschy%26aufirst%3DS.%2BA.%26aulast%3DCole%26aufirst%3DG.%2BM.%26atitle%3DCurcumin%2520inhibits%2520formation%2520of%2520amyloid%2520beta%2520oligomers%2520and%2520fibrils%252C%2520binds%2520plaques%252C%2520and%2520reduces%2520amyloid%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D5892%26epage%3D5901%26doi%3D10.1074%2Fjbc.M404751200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aksenova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">3270</span><span class="NLM_x">–</span> <span class="NLM_lpage">3274</span><span class="refDoi"> DOI: 10.1073/pnas.91.8.3270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1073%2Fpnas.91.8.3270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=8159737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK2cXivFGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=3270-3274&author=K.+Hensleyauthor=J.+M.+Carneyauthor=M.+P.+Mattsonauthor=M.+Aksenovaauthor=M.+Harrisauthor=J.+F.+Wuauthor=R.+A.+Floydauthor=D.+A.+Butterfield&title=A+model+for+beta-amyloid+aggregation+and+neurotoxicity+based+on+free+radical+generation+by+the+peptide%3A+relevance+to+Alzheimer+disease&doi=10.1073%2Fpnas.91.8.3270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease</span></div><div class="casAuthors">Hensley, K.; Carney, J. M.; Mattson, M. P.; Aksenova, M.; Harris, M.; Wu, J. F.; Floyd, R. A.; Butterfield, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3270-4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">β-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-assocd. senile (amyloid) plaques.  No satisfactory hypothesis has yet been proposed to explain the mechanism of β-amyloid aggregation and toxicity.  The authors present mass spectrometric and ESR spin trapping evidence that β-amyloid, in aq. soln., fragments and generates free radical peptides.  β-Amyloid fragments, at concns. that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidn.-sensitive glutamine synthetase and creatine kinase enzymes.  Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the β-amyloid-(25-35) fragment during cell-free incubation.  These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of β-amyloid and are discussed with ref. to membrane mol. alterations in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmtrQ4YKCYbbVg90H21EOLACvtfcHk0lhZFNB4WE0mcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivFGrt7s%253D&md5=542820aa71efab3140773571ac4aab83</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.8.3270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.8.3270%26sid%3Dliteratum%253Aachs%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DAksenova%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%2BF.%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DA%2520model%2520for%2520beta-amyloid%2520aggregation%2520and%2520neurotoxicity%2520based%2520on%2520free%2520radical%2520generation%2520by%2520the%2520peptide%253A%2520relevance%2520to%2520Alzheimer%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D3270%26epage%3D3274%26doi%3D10.1073%2Fpnas.91.8.3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Dikalov, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitek, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maples, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span> </span><span class="NLM_article-title">Amyloid β peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">9392</span><span class="NLM_x">–</span> <span class="NLM_lpage">9399</span><span class="refDoi"> DOI: 10.1074/jbc.274.14.9392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1074%2Fjbc.274.14.9392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10092619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK1MXisVWlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=9392-9399&author=S.+I.+Dikalovauthor=M.+P.+Vitekauthor=K.+R.+Maplesauthor=R.+P.+Mason&title=Amyloid+%CE%B2+peptides+do+not+form+peptide-derived+free+radicals+spontaneously%2C+but+can+enhance+metal-catalyzed+oxidation+of+hydroxylamines+to+nitroxides&doi=10.1074%2Fjbc.274.14.9392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides</span></div><div class="casAuthors">Dikalov, Sergey I.; Vitek, Michael P.; Maples, Kirk R.; Mason, Ronald P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9392-9399</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) peptides play an important role in the pathogenesis of Alzheimer's disease.  Free radical generation by Aβ peptides was suggested to be a key mechanism of their neurotoxicity.  Reports that neurotoxic free radicals derived from Aβ-(1-40) and Aβ-(25-35) peptides react with the spin trap N-tert-butyl-α-phenylnitrone (PBN) to form a PBN/Aβ peptide radical adduct with a specific triplet ESR signal assert that the peptide itself was the source of free radicals.  The authors now report that three Aβ peptides, Aβ-(1-40), Aβ-(25-35), and Aβ-(40-1), do not yield radical adducts with PBN from the Oklahoma Medical Research Foundation (OMRF).  In contrast to OMRF PBN, incubation of Sigma PBN in phosphate buffer without Aβ peptides produced a three-line ESR spectrum.  It was shown that this nitroxide is di-tert-butylnitroxide and is formed in the Sigma PBN soln. as a result of transition metal-catalyzed auto-oxidn. of the resp. hydroxylamine present as an impurity in the Sigma PBN.  Under some conditions, incubation of PBN from Sigma with Aβ-(1-40) or Aβ-(25-35) can stimulate the formation of di-tert-butylnitroxide.  It was shown that Aβ peptides enhanced oxidn. of cyclic hydroxylamine 1-hydroxy-4-oxo-2,2,6,6-tetramethylpiperidine (TEMPONE-H), which was strongly inhibited by the treatment of phosphate buffer with Chelex-100.  It was shown that ferric and cupric ions are effective oxidants of TEMPONE-H.  The data obtained allow the authors to conclude that under some conditions toxic Aβ peptides Aβ-(1-40) and Aβ-(25-35) enhance metal-catalyzed oxidn. of hydroxylamine derivs., but do not spontaneously form peptide-derived free radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRXxQewfwb7Vg90H21EOLACvtfcHk0lhZFNB4WE0mcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVWlt7c%253D&md5=b091123b123af32ba6fce234cbdfa486</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.14.9392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.14.9392%26sid%3Dliteratum%253Aachs%26aulast%3DDikalov%26aufirst%3DS.%2BI.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DAmyloid%2520%25CE%25B2%2520peptides%2520do%2520not%2520form%2520peptide-derived%2520free%2520radicals%2520spontaneously%252C%2520but%2520can%2520enhance%2520metal-catalyzed%2520oxidation%2520of%2520hydroxylamines%2520to%2520nitroxides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D9392%26epage%3D9399%26doi%3D10.1074%2Fjbc.274.14.9392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Turnbull, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Agnaf, O. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twyman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span><span class="refDoi"> DOI: 10.1016/S0891-5849(01)00510-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0891-5849%2801%2900510-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=11369506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFegsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2001&pages=1154-1162&author=S.+Turnbullauthor=B.+J.+Tabnerauthor=O.+M.+A.+El-Agnafauthor=L.+J.+Twymanauthor=D.+Allsop&title=New+evidence+that+the+Alzheimer+%CE%B2-amyloid+peptide+does+not+spontaneously+form+free+radicals%3A+An+ESR+study+using+a+series+of+spin-traps&doi=10.1016%2FS0891-5849%2801%2900510-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps</span></div><div class="casAuthors">Turnbull, S.; Tabner, B. J.; El-Agnaf, O. M. A.; Twyman, L. J.; Allsop, D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1154-1162</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The direct formation of free radicals from Aβ has been suggested to be a key neurotoxic mechanism in Alzheimer's disease (AD).  We have explored the possibility of the spontaneous formation of peptide-derived free radicals during the incubation of Aβ 1-40 by ESR spectroscopy using N-tert-butyl-α-phenylnitrone (PBN), 5,5-dimethyl-1-pyrroline N-oxide (DMPO), α-(4-pyridyl-1-oxide)-N-tert-butylnitrone (POBN), and 3,5-dibromo-4-nitrosobenzenesulfonic acid sodium salt (DBNBS) as spin traps.  Employing PBN, we obsd. spectra during the incubation of β-amyloid peptide, at 37°, which included adducts of 2-methyl-2-nitrosopropane (MNP), despite rigorous purifn. of the PBN before incubation.  The formation of some of these adducts was found to be enhanced by ambient lab. light.  Our expts. have led us to propose a hypothesis that PBN undergoes hydrolysis and decompn. in the presence of oxidants, which explains the origin of all of the PBN and MNP adducts obsd. (even when the PBN is highly purified).  Hydrogen peroxide, formed during incubation, could play a major role as an oxidant in these expts.  Of the other three spin traps, only DMPO gave (very weak) spectra, but these could be assigned to its hydroxyl radical adduct, formed as an artifact by the nucleophilic addn. of water to DMPO, catalyzed by trace levels of iron ions.  Thus, while spectra are obsd. during our expts., none of them can be assigned to adducts of radicals derived from the peptide and, therefore, our data do not support the suggestion that radicals are spontaneously formed from β-amyloid peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrRyMutvQPLVg90H21EOLACvtfcHk0lgouTN_NR11LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFegsbY%253D&md5=82e8014774f8bace3343bc53cd89de9e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2801%2900510-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252801%252900510-X%26sid%3Dliteratum%253Aachs%26aulast%3DTurnbull%26aufirst%3DS.%26aulast%3DTabner%26aufirst%3DB.%2BJ.%26aulast%3DEl-Agnaf%26aufirst%3DO.%2BM.%2BA.%26aulast%3DTwyman%26aufirst%3DL.%2BJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DNew%2520evidence%2520that%2520the%2520Alzheimer%2520%25CE%25B2-amyloid%2520peptide%2520does%2520not%2520spontaneously%2520form%2520free%2520radicals%253A%2520An%2520ESR%2520study%2520using%2520a%2520series%2520of%2520spin-traps%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2001%26volume%3D30%26spage%3D1154%26epage%3D1162%26doi%3D10.1016%2FS0891-5849%2801%2900510-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span><span class="refDoi"> DOI: 10.1080/1071576021000049890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1080%2F1071576021000049890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12607822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=1307-1313&author=D.+A.+Butterfield&title=Amyloid+%CE%B2-peptide+%281%E2%80%9342%29-induced+oxidative+stress+and+neurotoxicity%3A+implications+for+neurodegeneration+in+Alzheimer%E2%80%99s+disease+brain.+A+review&doi=10.1080%2F1071576021000049890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review</span></div><div class="casAuthors">Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1307-1313</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, manifested by protein oxidn., lipid peroxidn., DNA oxidn. and 3-nitrotyrosine formation, among other indexes, is obsd. in Alzheimer's disease (AD) brain.  Amyloid β-peptide (1-42) [Aβ(1-42)] may be central to the pathogenesis of AD.  Our lab. and others have implicated Aβ(1-42)-induced free radical oxidative stress in the neurodegeneration obsd. in AD brain.  This paper reviews some of these studies from our lab.  Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Aβ(1-42) was crit. to its oxidative stress and neurotoxic properties.  Because the C-terminal region of Aβ(1-42) is helical, and invoking the i + 4 rule of helixes, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter.  This interaction could alter the susceptibility for oxidn. of Met-35, i.e. free radical formation.  Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Aβ(1-42).  Removal of the Met-35 residue from the lipid bilayer by substitution of the neg. charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Aβ(1-42).  The free radical scavenger vitamin E prevented Aβ (1-42)-induced ROS formation, protein oxidn., lipid peroxidn., and neurotoxicity in hippocampal neurons, consistent with our model for Aβ-assocd. free radical oxidative stress induced neurodegeneration in AD.  ApoE, allele 4, is a risk factor for AD.  Synaptosomes from apoE knock-out mice are more vulnerable to Aβ-induced oxidative stress (protein oxidn., lipid peroxidn., and ROS generation) than are those from wild-type mice.  We also studied synaptosomes from allele-specific human apoE knock-in mice.  Brain membranes from human apoE4 mice have greater vulnerability to Aβ(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indexes, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder.  Using immunopptn. of proteins from AD and control brain obtained no longer than 4 h PMI, selective oxidized proteins were identified in the AD brain.  Creatine kinase (CK) and β-actin have increased carbonyl groups, an index of protein oxidn., and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidn. product, 4-hydroxy-2-nonenal (HNE).  Aβ inhibits CK and causes lipid peroxidn., leading to HNE formation.  Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD.  Other oxidatively modified proteins have been identified in AD brain by proteomics anal., and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degrdn. of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy prodn. (α-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2).  Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Aβ(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Aβ(1-42)-induced oxidative stress and neurodegeneration in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovbtGvhIQlIrVg90H21EOLACvtfcHk0lgouTN_NR11LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D&md5=ad37b360cb8245ded7a9acad99e15b5e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1080%2F1071576021000049890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1071576021000049890%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DAmyloid%2520%25CE%25B2-peptide%2520%25281%25E2%2580%259342%2529-induced%2520oxidative%2520stress%2520and%2520neurotoxicity%253A%2520implications%2520for%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain.%2520A%2520review%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2002%26volume%3D36%26spage%3D1307%26epage%3D1313%26doi%3D10.1080%2F1071576021000049890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Goriya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, C. V.</span><span> </span><span class="NLM_article-title">The [Cu]-catalyzed SNAR reactions: direct amination of electron deficient aryl halides with sodium azide and the synthesis of arylthioethers under Cu(II)-ascorbate redox system</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">7642</span><span class="NLM_x">–</span> <span class="NLM_lpage">7650</span><span class="refDoi"> DOI: 10.1016/j.tet.2010.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.tet.2010.07.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=7642-7650&author=Y.+Goriyaauthor=C.+V.+Ramana&title=The+%5BCu%5D-catalyzed+SNAR+reactions%3A+direct+amination+of+electron+deficient+aryl+halides+with+sodium+azide+and+the+synthesis+of+arylthioethers+under+Cu%28II%29-ascorbate+redox+system&doi=10.1016%2Fj.tet.2010.07.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DGoriya%26aufirst%3DY.%26aulast%3DRamana%26aufirst%3DC.%2BV.%26atitle%3DThe%2520%255BCu%255D-catalyzed%2520SNAR%2520reactions%253A%2520direct%2520amination%2520of%2520electron%2520deficient%2520aryl%2520halides%2520with%2520sodium%2520azide%2520and%2520the%2520synthesis%2520of%2520arylthioethers%2520under%2520Cu%2528II%2529-ascorbate%2520redox%2520system%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D7642%26epage%3D7650%26doi%3D10.1016%2Fj.tet.2010.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Guilloreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combalbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sournia-Saquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, P.</span><span> </span><span class="NLM_article-title">Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1325</span><span class="refDoi"> DOI: 10.1002/cbic.200700111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fcbic.200700111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=17577900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos12rtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1317-1325&author=L.+Guilloreauauthor=S.+Combalbertauthor=A.+Sournia-Saquetauthor=H.+Mazarguilauthor=P.+Faller&title=Redox+chemistry+of+copper-amyloid-beta%3A+the+generation+of+hydroxyl+radical+in+the+presence+of+ascorbate+is+linked+to+redox-potentials+and+aggregation+state&doi=10.1002%2Fcbic.200700111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Redox chemistry of copper-amyloid-β: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state</span></div><div class="casAuthors">Guilloreau, Luc; Combalbert, Sarah; Sournia-Saquet, Alix; Mazarguil, Honore; Faller, Peter</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1317-1325</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Aggregation of the β-amyloid peptide (Aβ) to amyloid plaques is a key event in Alzheimer's disease.  According to the amyloid-cascade hypothesis, Aβ aggregates are toxic to neurons through the prodn. of reactive oxygen species (ROS).  Copper ions play an important role, because they are able to bind to Aβ and influence its aggregation properties.  Moreover, Cu-Aβ is supposed to be directly involved in ROS prodn.  To get a better understanding of these reactions, we measured the prodn. of HO· and the redox potential of Cu-Aβ.  The results were compared to other biol. copper-peptide complexes in order to get an insight into the biol. relevance.  Cu-Aβ produced more HO· than the complex of copper with Asp-Ala-His-Lys (Cu-DAHK), but less than with Gly-His-Lys (Cu-GHK).  Cyclic voltammetry revealed that the order for redn. potential is Cu-GHK > Cu-Aβ > Cu-DAHK, but for the oxidn. potential the order is reversed.  Thus, easier copper redox cycling correlated to higher HO· prodn.  The copper complex of the form Aβ1-42 showed a HO· prodn. five-times higher than that of the form Aβ1-40.  Time-dependence and aggregation studies suggest that an aggregation intermediate is responsible for this increased HO· prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCR9gIKLpQ7Vg90H21EOLACvtfcHk0lgmso5vy7yVCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos12rtrw%253D&md5=aa6d611f7f8aa40edcd72124521175db</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700111%26sid%3Dliteratum%253Aachs%26aulast%3DGuilloreau%26aufirst%3DL.%26aulast%3DCombalbert%26aufirst%3DS.%26aulast%3DSournia-Saquet%26aufirst%3DA.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DFaller%26aufirst%3DP.%26atitle%3DRedox%2520chemistry%2520of%2520copper-amyloid-beta%253A%2520the%2520generation%2520of%2520hydroxyl%2520radical%2520in%2520the%2520presence%2520of%2520ascorbate%2520is%2520linked%2520to%2520redox-potentials%2520and%2520aggregation%2520state%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1317%26epage%3D1325%26doi%3D10.1002%2Fcbic.200700111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lgmso5vy7yVCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">Computational methods for the prediction of "drug-likeness"</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/S1359-6446(99)01451-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1359-6446%2899%2901451-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=49-58&author=D.+E.+Clarkauthor=S.+D.+Pickett&title=Computational+methods+for+the+prediction+of+%22drug-likeness%22&doi=10.1016%2FS1359-6446%2899%2901451-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2899%2901451-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252899%252901451-8%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DComputational%2520methods%2520for%2520the%2520prediction%2520of%2520%2522drug-likeness%2522%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2000%26volume%3D5%26spage%3D49%26epage%3D58%26doi%3D10.1016%2FS1359-6446%2899%2901451-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lgO63ZsonLSOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1016/S1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2FS1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eYOm573X8mkR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2FS1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span><span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0lgO63ZsonLSOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Melting point distribution analysis of globally approved and discontinued drugs: A research for improving the chance of success of drug design and discovery</span> <span class="citation_source-journal">ChemistryOpen</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1002/open.201600015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fopen.201600015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=27547646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=357-368&author=F.+Maoauthor=Q.+Kongauthor=W.+Niauthor=X.+Xuauthor=D.+Lingauthor=Z.+Luauthor=J.+Li&title=Melting+point+distribution+analysis+of+globally+approved+and+discontinued+drugs%3A+A+research+for+improving+the+chance+of+success+of+drug+design+and+discovery&doi=10.1002%2Fopen.201600015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Melting Point Distribution Analysis of Globally Approved and Discontinued Drugs: A Research for Improving the Chance of Success of Drug Design and Discovery</span></div><div class="casAuthors">Mao, Fei; Kong, Qingya; Ni, Wei; Xu, Xiang; Ling, Dazheng; Lu, Zhengyu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ChemistryOpen</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-368</span>CODEN:
                <span class="NLM_cas:coden">CHOPCK</span>;
        ISSN:<span class="NLM_cas:issn">2191-1363</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The m.p. (MP), an easily accessible phys. parameter, has considerable potential for the judgment of drug-like properties.  However, to the best of our knowledge, there are no useful guidelines for understanding the relationship between the MP and drug-like properties.  To this end, we have constructed the largest MP database (exptl. value) of globally approved drugs (3164 org. small-mol. drugs) and discontinued drugs (417 org. small-mol. drugs) and subsequently extd. six subdatabases from the whole approved database and two subdatabases from the discontinued database.  The MP distribution statistics and anal. of approved drugs reveal five noteworthy observations; moreover, the MP distribution statistics and anal. of discontinued drugs further supplement these criteria.  In addn., the comparison of mol. wt. (MW) vs. MP and Clog P vs. MP distributions of different classes of approved drugs indicated that the MWs and Clog P values of most drugs in the optimal MP range were not more than 500 and 5, resp., implying the MP distribution criterion was in accordance with Lipinski's rule of five.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc6SJrc8pcs7Vg90H21EOLACvtfcHk0lgW2BmxfPZVWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eru7g%253D&md5=bf60d04bb54874439edaea537d1ab3b9</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fopen.201600015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fopen.201600015%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DQ.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DMelting%2520point%2520distribution%2520analysis%2520of%2520globally%2520approved%2520and%2520discontinued%2520drugs%253A%2520A%2520research%2520for%2520improving%2520the%2520chance%2520of%2520success%2520of%2520drug%2520design%2520and%2520discovery%26jtitle%3DChemistryOpen%26date%3D2016%26volume%3D5%26spage%3D357%26epage%3D368%26doi%3D10.1002%2Fopen.201600015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0lgW2BmxfPZVWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Safer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. P.</span><span> </span><span class="NLM_article-title">The central effects of scopolamine in man</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=4950489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADyaE2c7hs1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1971&pages=347-355&author=D.+J.+Saferauthor=R.+P.+Allen&title=The+central+effects+of+scopolamine+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The central effects of scopolamine in man</span></div><div class="casAuthors">Safer D J; Allen R P</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-55</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9k-R0AdOSfny-c-E1v-fmfW6udTcc2ebO7nf7PM_-p7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2c7hs1aqsA%253D%253D&md5=fb383f588bd7a211a1c05215d89f0484</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSafer%26aufirst%3DD.%2BJ.%26aulast%3DAllen%26aufirst%3DR.%2BP.%26atitle%3DThe%2520central%2520effects%2520of%2520scopolamine%2520in%2520man%26jtitle%3DBiol.%2520Psychiatry%26date%3D1971%26volume%3D3%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Klinkenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span> </span><span class="NLM_article-title">The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2010.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.neubiorev.2010.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=20398692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1307-1350&author=I.+Klinkenbergauthor=A.+Blokland&title=The+validity+of+scopolamine+as+a+pharmacological+model+for+cognitive+impairment%3A+A+review+of+animal+behavioral+studies&doi=10.1016%2Fj.neubiorev.2010.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies</span></div><div class="casAuthors">Klinkenberg, Inge; Blokland, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1307-1350</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Scopolamine is used as a std./ref. drug for inducing cognitive deficits in healthy humans and animals.  Effects are often interpreted in terms of a role of acetylcholine in mnemonic and/or attentional processes.  In this paper an overview is given of the effects of scopolamine on animal behavior.  Examn. of the dose-response curve of systemically administered scopolamine indicates that sensory discrimination and attention are most sensitive to disruption.  When higher doses (>0.03 mg/kg) are used, deficits in other cognitive and non-cognitive functions (e.g., learning and memory, locomotor activity) are reported.  Several behavioral processes (taste aversion, anxiety, short-term memory, attention) are found to be affected after intracerebral injections of scopolamine.  It is concluded that effects on learning and memory performance which are obsd. after higher doses of scopolamine are mediated by (1) primary effects on attention and sensory/stimulus discrimination, (2) non-specific effects on behavior (e.g., locomotor activity, anxiety), and (3) peripheral side-effects (e.g., pupil dilation, salivation).  Finally, the validity of scopolamine as a pharmacol. model for cognitive impairment is discussed.  The use of muscarinic M1 antagonists is suggested as a more selective and effective way of inducing cholinergic-induced cognitive deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kOHauaQ9u7Vg90H21EOLACvtfcHk0ljCf7Enjbu0iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWhs70%253D&md5=fa3e1e2c8fa117bbf04579b6a93747a7</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2010.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2010.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DKlinkenberg%26aufirst%3DI.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DThe%2520validity%2520of%2520scopolamine%2520as%2520a%2520pharmacological%2520model%2520for%2520cognitive%2520impairment%253A%2520A%2520review%2520of%2520animal%2520behavioral%2520studies%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2010%26volume%3D34%26spage%3D1307%26epage%3D1350%26doi%3D10.1016%2Fj.neubiorev.2010.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazor, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourashraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhakumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydserff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giguere, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groblewski, T.</span><span> </span><span class="NLM_article-title">Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span><span class="refDoi"> DOI: 10.1021/jm4014828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=733-758&author=D.+G.+Brownauthor=P.+R.+Bernsteinauthor=A.+Griffinauthor=S.+Wesolowskiauthor=D.+Labrecqueauthor=M.+C.+Tremblayauthor=M.+Sylvesterauthor=R.+Maugerauthor=P.+D.+Edwardsauthor=S.+R.+Thronerauthor=J.+J.+Folmerauthor=J.+Cacciolaauthor=C.+Scottauthor=L.+A.+Lazorauthor=M.+Pourashrafauthor=V.+Santhakumarauthor=W.+M.+Pottsauthor=S.+Sydserffauthor=P.+Giguereauthor=C.+Levesqueauthor=M.+Dasserauthor=T.+Groblewski&title=Discovery+of+spirofused+piperazine+and+diazepane+amides+as+selective+histamine-3+antagonists+with+in+vivo+efficacy+in+a+mouse+model+of+cognition&doi=10.1021%2Fjm4014828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Spirofused Piperazine and Diazepane Amides as Selective Histamine-3 Antagonists with in Vivo Efficacy in a Mouse Model of Cognition</span></div><div class="casAuthors">Brown, Dean G.; Bernstein, Peter R.; Griffin, Andrew; Wesolowski, Steve; Labrecque, Denis; Tremblay, Maxime C.; Sylvester, Mark; Mauger, Russell; Edwards, Phillip D.; Throner, Scott R.; Folmer, James J.; Cacciola, Joseph; Scott, Clay; Lazor, Lois A.; Pourashraf, Mehrnaz; Santhakumar, Vijayaratnam; Potts, William M.; Sydserff, Simon; Giguere, Pascall; Levesque, Carine; Dasser, Mohammed; Groblewski, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">733-758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of potent and selective histamine-3 receptor (H3R) antagonists was identified on the basis of an azaspiro[2.5]octane carboxamide scaffold.  Many scaffold modifications were largely tolerated, resulting in nanomolar-potent compds. in the H3R functional assay.  Exemplar compd. 6s demonstrated a selective profile against a panel of 144 secondary pharmacol. receptors, with activity at only σ2 (62% at 10 μM).  Compd. 6s demonstrated free-plasma exposures above the IC50 (∼50×) with a brain-to-plasma ratio of ∼3 following i.v. dosing in mice.  At three doses tested in the mouse novel object recognition model (1, 3, and 10 mg/kg s.c.), 6s demonstrated a statistically significant response compared with the control group.  This series represents a new scaffold of H3 receptor antagonists that demonstrates in vivo exposure and efficacy in an animal model of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTXWVp5QzxLVg90H21EOLACvtfcHk0ljCf7Enjbu0iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFWnsg%253D%253D&md5=7da2e8b7598cf69f64f7122efe660cff</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm4014828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014828%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DBernstein%26aufirst%3DP.%2BR.%26aulast%3DGriffin%26aufirst%3DA.%26aulast%3DWesolowski%26aufirst%3DS.%26aulast%3DLabrecque%26aufirst%3DD.%26aulast%3DTremblay%26aufirst%3DM.%2BC.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DMauger%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DThroner%26aufirst%3DS.%2BR.%26aulast%3DFolmer%26aufirst%3DJ.%2BJ.%26aulast%3DCacciola%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DC.%26aulast%3DLazor%26aufirst%3DL.%2BA.%26aulast%3DPourashraf%26aufirst%3DM.%26aulast%3DSanthakumar%26aufirst%3DV.%26aulast%3DPotts%26aufirst%3DW.%2BM.%26aulast%3DSydserff%26aufirst%3DS.%26aulast%3DGiguere%26aufirst%3DP.%26aulast%3DLevesque%26aufirst%3DC.%26aulast%3DDasser%26aufirst%3DM.%26aulast%3DGroblewski%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520spirofused%2520piperazine%2520and%2520diazepane%2520amides%2520as%2520selective%2520histamine-3%2520antagonists%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520cognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D733%26epage%3D758%26doi%3D10.1021%2Fjm4014828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Garcia-Barroso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricobaraza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual-Lucas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unceta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goicolea, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanciego, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado-Tejedor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Osta, A.</span><span> </span><span class="NLM_article-title">Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.neuropharm.2012.06.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=114-123&author=C.+Garcia-Barrosoauthor=A.+Ricobarazaauthor=M.+Pascual-Lucasauthor=N.+Uncetaauthor=A.+J.+Ricoauthor=M.+A.+Goicoleaauthor=J.+Sallesauthor=J.+L.+Lanciegoauthor=J.+Oyarzabalauthor=R.+Francoauthor=M.+Cuadrado-Tejedorauthor=A.+Garcia-Osta&title=Tadalafil+crosses+the+blood-brain+barrier+and+reverses+cognitive+dysfunction+in+a+mouse+model+of+AD&doi=10.1016%2Fj.neuropharm.2012.06.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DUnceta%26aufirst%3DN.%26aulast%3DRico%26aufirst%3DA.%2BJ.%26aulast%3DGoicolea%26aufirst%3DM.%2BA.%26aulast%3DSalles%26aufirst%3DJ.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DTadalafil%2520crosses%2520the%2520blood-brain%2520barrier%2520and%2520reverses%2520cognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520AD%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D114%26epage%3D123%26doi%3D10.1016%2Fj.neuropharm.2012.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Mensch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span> </span><span class="NLM_article-title">In vivo, in vitro and in silico methods for small molecule transfer across the BBB</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span><span class="refDoi"> DOI: 10.1002/jps.21745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fjps.21745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=4429-4468&author=J.+Menschauthor=J.+Oyarzabalauthor=C.+Mackieauthor=P.+Augustijns&title=In+vivo%2C+in+vitro+and+in+silico+methods+for+small+molecule+transfer+across+the+BBB&doi=10.1002%2Fjps.21745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fjps.21745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21745%26sid%3Dliteratum%253Aachs%26aulast%3DMensch%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAugustijns%26aufirst%3DP.%26atitle%3DIn%2520vivo%252C%2520in%2520vitro%2520and%2520in%2520silico%2520methods%2520for%2520small%2520molecule%2520transfer%2520across%2520the%2520BBB%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D4429%26epage%3D4468%26doi%3D10.1002%2Fjps.21745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Choi, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braymer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanga, R. P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">21990</span><span class="NLM_x">–</span> <span class="NLM_lpage">21995</span><span class="refDoi"> DOI: 10.1073/pnas.1006091107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1073%2Fpnas.1006091107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=21131570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVKk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21990-21995&author=J.+S.+Choiauthor=J.+J.+Braymerauthor=R.+P.+R.+Nangaauthor=A.+Ramamoorthyauthor=M.+H.+Lim&title=Design+of+small+molecules+that+target+metal-A%CE%B2+species+and+regulate+metal-induced+A%CE%B2+aggregation+and+neurotoxicity&doi=10.1073%2Fpnas.1006091107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity</span></div><div class="casAuthors">Choi, Jung-Suk; Braymer, Joseph J.; Nanga, Ravi P. R.; Ramamoorthy, Ayyalusamy; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21990-21995, S21990/1-S21990/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The accumulation of metal ions and amyloid-β (Aβ) aggregates found in the brain of patients with Alzheimer's disease (AD) has been suggested to be involved in AD pathogenesis.  To investigate metal-Aβ-assocd. pathways in AD, development of chem. tools to target metal-Aβ species is desired.  Only a few efforts, however, have been reported.  Here, bifunctional small mols., N-(pyridin-2-ylmethyl)aniline (L2-a) and N1,N1-dimethyl-N4-(pyridin-2-ylmethyl)benzene-1,4-diamine (L2-b) that can interact with both metal ions and Aβ species, as detd. by spectroscopic methods including high-resoln. NMR spectroscopy, are reported.  Using the bifunctional compd. L2-b, metal-induced Aβ aggregation and neurotoxicity were modulated in vitro as well as in human neuroblastoma cells.  Furthermore, treatment of human AD brain tissue homogenates contg. metal ions and Aβ species with L2-b showed disassembly of Aβ aggregates.  Therefore, the studies presented herein demonstrate the value of bifunctional compds. as chem. tools for investigating metal-Aβ-assocd. events and their mechanisms in the development and pathogenesis of AD and as potential therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDq-Ci1DofMbVg90H21EOLACvtfcHk0liFcvZGqgtxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVKk&md5=c039af9ec22cf5da7afb3bb1d7a40a56</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1006091107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1006091107%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DBraymer%26aufirst%3DJ.%2BJ.%26aulast%3DNanga%26aufirst%3DR.%2BP.%2BR.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DDesign%2520of%2520small%2520molecules%2520that%2520target%2520metal-A%25CE%25B2%2520species%2520and%2520regulate%2520metal-induced%2520A%25CE%25B2%2520aggregation%2520and%2520neurotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D21990%26epage%3D21995%26doi%3D10.1073%2Fpnas.1006091107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">New multi-target-directed small molecules against Alzheimer’s disease: a combination of resveratrol and clioquinol</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5936</span><span class="NLM_x">–</span> <span class="NLM_lpage">5944</span><span class="refDoi"> DOI: 10.1039/C4OB00998C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1039%2FC4OB00998C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=24986600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=5936-5944&author=F.+Maoauthor=J.+Yanauthor=J.+Liauthor=X.+Jiaauthor=H.+Miaoauthor=Y.+Sunauthor=L.+Huangauthor=X.+Li&title=New+multi-target-directed+small+molecules+against+Alzheimer%E2%80%99s+disease%3A+a+combination+of+resveratrol+and+clioquinol&doi=10.1039%2FC4OB00998C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol</span></div><div class="casAuthors">Mao, Fei; Yan, Jun; Li, Jianheng; Jia, Xian; Miao, Hui; Sun, Yang; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5936-5944</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is currently one of the most difficult and challenging diseases to treat.  Based on the 'multi-target-directed ligands' (MTDLs) strategy, we designed and synthesized a series of new compds. against AD by combining the pharmacophores of resveratrol and clioquinol.  The results of biol. activity tests showed that the hybrids exhibited excellent MTDL properties: a significant ability to inhibit self-induced β-amyloid (Aβ) aggregation and copper(II)-induced Aβ aggregation, potential antioxidant behavior (ORAC-FL value of 0.9-3.2 Trolox equiv.) and biometal chelation.  Among these compds., (E)-5-(4-hydroxystyryl)quinoline-8-ol (10c) showed the most potent ability to inhibit self-induced Aβ aggregation (IC50 = 8.50 μM) and copper(II)-induced Aβ aggregation and to disassemble the well-structured Aβ fibrils generated by self- and copper(II)-induced Aβ aggregation.  Note that 10c could also control Cu(I/II)-triggered hydroxyl radical (OH ) prodn. by halting copper redox cycling via metal complexation, as confirmed by a Cu-ascorbate redox system assay.  Importantly, 10c did not show acute toxicity in mice at doses of up to 2000 mg kg-1 and was able to cross the blood-brain barrier (BBB), according to a parallel artificial membrane permeation assay.  These results indicate that compd. 10c is a promising multifunctional compd. for the development of novel drugs for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRtZbIAMbCHrVg90H21EOLACvtfcHk0lg7h92W5oQ19A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjJ&md5=fe3cb0d409d2e6e1c7e716dc9b08fcbd</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1039%2FC4OB00998C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB00998C%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DNew%2520multi-target-directed%2520small%2520molecules%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520combination%2520of%2520resveratrol%2520and%2520clioquinol%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D5936%26epage%3D5944%26doi%3D10.1039%2FC4OB00998C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref66':['cit66'],'ref67':['cit67']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Huan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haiyan Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 852-862. <a href="https://doi.org/10.1021/acschemneuro.8b00391" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00391%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DReconsideration%252Bof%252BAnticholinesterase%252BTherapeutic%252BStrategies%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DHuan%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31072018%26date%3D20112018%26date%3D06122018%26volume%3D10%26issue%3D2%26spage%3D852%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Masha
G. Savelieff, Geewoo Nam, Juhye Kang, Hyuck Jin Lee, Misun Lee, <span class="NLM_string-name hlFld-ContribAuthor">Mi Hee Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1221-1322. <a href="https://doi.org/10.1021/acs.chemrev.8b00138" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00138%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDevelopment%252Bof%252BMultifunctional%252BMolecules%252Bas%252BPotential%252BTherapeutic%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252BParkinson%2525E2%252580%252599s%252BDisease%25252C%252Band%252BAmyotrophic%252BLateral%252BSclerosis%252Bin%252Bthe%252BLast%252BDecade%26aulast%3DSavelieff%26aufirst%3DMasha%2BG.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D02032018%26date%3D10082018%26volume%3D119%26issue%3D2%26spage%3D1221%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yixiang Xu, Jian Zhang, Huan Wang, Fei Mao, Keting Bao, Wenwen Liu, Jin Zhu, Xiaokang Li, Haiyan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jian Li</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer’s Disease Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 482-496. <a href="https://doi.org/10.1021/acschemneuro.8b00357" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRational%252BDesign%252Bof%252BNovel%252BSelective%252BDual-Target%252BInhibitors%252Bof%252BAcetylcholinesterase%252Band%252BMonoamine%252BOxidase%252BB%252Bas%252BPotential%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BAgents%26aulast%3DXu%26aufirst%3DYixiang%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15072018%26date%3D15082018%26date%3D29082018%26date%3D15082018%26volume%3D10%26issue%3D1%26spage%3D482%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huan Zhang, Xiaoyan Dong, <span class="NLM_string-name hlFld-ContribAuthor">Yan Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Carnosine-LVFFARK-NH2 Conjugate: A Moderate Chelator but Potent Inhibitor of Cu2+-Mediated Amyloid β-Protein Aggregation. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 2689-2700. <a href="https://doi.org/10.1021/acschemneuro.8b00133" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00133%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCarnosine-LVFFARK-NH2%252BConjugate%25253A%252BA%252BModerate%252BChelator%252Bbut%252BPotent%252BInhibitor%252Bof%252BCu2%25252B-Mediated%252BAmyloid%252B%2525CE%2525B2-Protein%252BAggregation%26aulast%3DZhang%26aufirst%3DHuan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21032018%26date%3D23072018%26date%3D06082018%26date%3D23072018%26volume%3D9%26issue%3D11%26spage%3D2689%26epage%3D2700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Roberta Giampietro, Francesco Spinelli, Marialessandra Contino, <span class="NLM_string-name hlFld-ContribAuthor">Nicola Antonio Colabufo</span>. </span><span class="cited-content_cbyCitation_article-title">The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (3)
                                     , 808-820. <a href="https://doi.org/10.1021/acs.molpharmaceut.7b00841" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.7b00841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.7b00841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.7b00841%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DThe%252BPivotal%252BRole%252Bof%252BCopper%252Bin%252BNeurodegeneration%25253A%252BA%252BNew%252BStrategy%252Bfor%252Bthe%252BTherapy%252Bof%252BNeurodegenerative%252BDisorders%26aulast%3DGiampietro%26aufirst%3DRoberta%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D25092017%26date%3D11012018%26date%3D10012018%26date%3D02022018%26date%3D11012018%26volume%3D15%26issue%3D3%26spage%3D808%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baolong  Xie</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xi  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Dong</span>, and <span class="hlFld-ContribAuthor ">Yan  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Iminodiacetic Acid-Modified Human Serum Albumin: A Multifunctional Agent against Metal-Associated Amyloid β-Protein Aggregation and Cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 2214-2224. <a href="https://doi.org/10.1021/acschemneuro.7b00128" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00128%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIminodiacetic%252BAcid-Modified%252BHuman%252BSerum%252BAlbumin%25253A%252BA%252BMultifunctional%252BAgent%252Bagainst%252BMetal-Associated%252BAmyloid%252B%2525CE%2525B2-Protein%252BAggregation%252Band%252BCytotoxicity%26aulast%3DXie%26aufirst%3DBaolong%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06042017%26date%3D02082017%26date%3D14082017%26date%3D18102017%26date%3D02082017%26volume%3D8%26issue%3D10%26spage%3D2214%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Tardiff</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Brown</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Yan</span>, <span class="hlFld-ContribAuthor ">Richard  Trilles</span>, <span class="hlFld-ContribAuthor ">Nathan T.  Jui</span>, <span class="hlFld-ContribAuthor ">M. Inmaculada  Barrasa</span>, <span class="hlFld-ContribAuthor ">Kim A.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Guy A.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Scott E.  Schaus</span>, and <span class="hlFld-ContribAuthor ">Susan  Lindquist</span>  . </span><span class="cited-content_cbyCitation_article-title">Dihydropyrimidine-Thiones and Clioquinol Synergize To Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 2039-2055. <a href="https://doi.org/10.1021/acschemneuro.7b00187" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00187%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDihydropyrimidine-Thiones%252Band%252BClioquinol%252BSynergize%252BTo%252BTarget%252B%2525CE%2525B2-Amyloid%252BCellular%252BPathologies%252Bthrough%252Ba%252BMetal-Dependent%252BMechanism%26aulast%3DTardiff%26aufirst%3DDaniel%2BF.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22052017%26date%3D19062017%26date%3D12072017%26date%3D20092017%26date%3D19062017%26volume%3D8%26issue%3D9%26spage%3D2039%26epage%3D2055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangjing  Lv</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105070. <a href="https://doi.org/10.1016/j.bioorg.2021.105070" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bexploration%252Bof%252Bmultifunctional%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChangjun%26date%3D2021%26volume%3D114%26spage%3D105070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Caiyi  Xing</span>, <span class="hlFld-ContribAuthor ">Yingming  Wang</span>, <span class="hlFld-ContribAuthor ">Weiping  Lyu</span>, <span class="hlFld-ContribAuthor ">Saisai  Wang</span>, <span class="hlFld-ContribAuthor ">Qihang  Li</span>, <span class="hlFld-ContribAuthor ">Tingkai  Chen</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>30 </em>, 115940. <a href="https://doi.org/10.1016/j.bmc.2020.115940" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115940%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Bglycogen%252Bsynthase%252Bkinase%252B3%25252Fcholinesterase%252Binhibitors%252Bwith%252Bneuroprotection%252Bas%252Bpotential%252Btherapeutic%252Bagent%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DJiang%26aufirst%3DXueyang%26date%3D2021%26volume%3D30%26spage%3D115940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfei  Wu</span>, <span class="hlFld-ContribAuthor ">Xingxing  Zhu</span>, <span class="hlFld-ContribAuthor ">Yilong  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Tongtong  Liu</span>, <span class="hlFld-ContribAuthor ">Jianfei  Han</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation of 7-O-amide hesperetin derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2021,</strong> <em>334 </em>, 109350. <a href="https://doi.org/10.1016/j.cbi.2020.109350" title="DOI URL">https://doi.org/10.1016/j.cbi.2020.109350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2020.109350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2020.109350%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DBiological%252Bevaluation%252Bof%252B7-O-amide%252Bhesperetin%252Bderivatives%252Bas%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DWu%26aufirst%3DMingfei%26date%3D2021%26volume%3D334%26spage%3D109350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinay  Kumar</span>, <span class="hlFld-ContribAuthor ">Achintya  Saha</span>, <span class="hlFld-ContribAuthor ">Kunal  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2020,</strong> <em>88 </em>, 107355. <a href="https://doi.org/10.1016/j.compbiolchem.2020.107355" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2020.107355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2020.107355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2020.107355%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DIn%252Bsilico%252Bmodeling%252Bfor%252Bdual%252Binhibition%252Bof%252Bacetylcholinesterase%252B%252528AChE%252529%252Band%252Bbutyrylcholinesterase%252B%252528BuChE%252529%252Benzymes%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKumar%26aufirst%3DVinay%26date%3D2020%26volume%3D88%26spage%3D107355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Chunli  Tang</span>, <span class="hlFld-ContribAuthor ">Chengyun  Pang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Yuelian  Qin</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Nong</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Guo</span>, <span class="hlFld-ContribAuthor ">Maojun  Cheng</span>, <span class="hlFld-ContribAuthor ">Weizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Ningsheng  Liang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112475. <a href="https://doi.org/10.1016/j.ejmech.2020.112475" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112475%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Brasagiline-clorgyline%252Bhybrids%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252Bmonoamine%252Boxidase-B%252Band%252Bamyloid-%2525CE%2525B2%252Baggregation%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DXie%26aufirst%3DSai-Sai%26date%3D2020%26volume%3D202%26spage%3D112475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Rana</span>, <span class="hlFld-ContribAuthor ">Abhishek  Pareek</span>, <span class="hlFld-ContribAuthor ">Shivani  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Geeta  Arya</span>, <span class="hlFld-ContribAuthor ">Surendra  Nimesh</span>, <span class="hlFld-ContribAuthor ">Hemant  Arya</span>, <span class="hlFld-ContribAuthor ">Tarun K.  Bhatt</span>, <span class="hlFld-ContribAuthor ">Srinivasarao  Yaragorla</span>, <span class="hlFld-ContribAuthor ">Anuj K.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Aryldiazoquinoline based multifunctional small molecules for modulating Aβ
              42
              aggregation and cholinesterase activity related to Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (48)
                                     , 28827-28837. <a href="https://doi.org/10.1039/D0RA05172A" title="DOI URL">https://doi.org/10.1039/D0RA05172A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA05172A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA05172A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAryldiazoquinoline%252Bbased%252Bmultifunctional%252Bsmall%252Bmolecules%252Bfor%252Bmodulating%252BA%2525CE%2525B2%252B42%252Baggregation%252Band%252Bcholinesterase%252Bactivity%252Brelated%252Bto%252BAlzheimer%252527s%252Bdisease%26aulast%3DRana%26aufirst%3DMonika%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D48%26spage%3D28827%26epage%3D28837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Anna  Jaromin</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3337. <a href="https://doi.org/10.3390/molecules25153337" title="DOI URL">https://doi.org/10.3390/molecules25153337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153337%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPerspectives%252Bfor%252BNew%252Band%252BMore%252BEfficient%252BMultifunctional%252BLigands%252Bfor%252BAlzheimer%2525E2%252580%2525B2s%252BDisease%252BTherapy%26aulast%3DZag%25C3%25B3rska%26aufirst%3DAgnieszka%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Adel  Youssef</span>, <span class="hlFld-ContribAuthor ">Siva S.  Panda</span>, <span class="hlFld-ContribAuthor ">Riham A.  El-Shiekh</span>, <span class="hlFld-ContribAuthor ">ElSayed M.  Shalaby</span>, <span class="hlFld-ContribAuthor ">Dalia R.  Aboshouk</span>, <span class="hlFld-ContribAuthor ">Walid  Fayad</span>, <span class="hlFld-ContribAuthor ">Nehmedo G.  Fawzy</span>, <span class="hlFld-ContribAuthor ">Adel S.  Girgis</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2′-pyrrolidine-3′,3′′-pyrrolidines]. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (37)
                                     , 21830-21838. <a href="https://doi.org/10.1039/D0RA03064C" title="DOI URL">https://doi.org/10.1039/D0RA03064C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03064C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03064C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bmolecular%252Bmodeling%252Bstudies%252Bof%252Bcholinesterase%252Binhibitor%252Bdispiro%25255Bindoline-3%25252C2%2525E2%252580%2525B2-pyrrolidine-3%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%2525E2%252580%2525B2-pyrrolidines%25255D%26aulast%3DYoussef%26aufirst%3DM.%2BAdel%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D37%26spage%3D21830%26epage%3D21838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chanjuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Likun  Hu</span>, <span class="hlFld-ContribAuthor ">Dong  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Wenhan  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Circumdatin D Exerts Neuroprotective Effects by Attenuating LPS-Induced Pro-Inflammatory Responses and Downregulating Acetylcholinesterase Activity In Vitro and In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00760" title="DOI URL">https://doi.org/10.3389/fphar.2020.00760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00760%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DCircumdatin%252BD%252BExerts%252BNeuroprotective%252BEffects%252Bby%252BAttenuating%252BLPS-Induced%252BPro-Inflammatory%252BResponses%252Band%252BDownregulating%252BAcetylcholinesterase%252BActivity%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DZhang%26aufirst%3DChanjuan%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Lu</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Jiaying  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Qiu</span>, <span class="hlFld-ContribAuthor ">Lei  Fan</span>, <span class="hlFld-ContribAuthor ">Baoli  Li</span>, <span class="hlFld-ContribAuthor ">Wenwen  Liu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Xu  Shen</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of nitazoxanide-based derivatives as autophagy activators for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 646-666. <a href="https://doi.org/10.1016/j.apsb.2019.07.006" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDiscovery%252Bof%252Bnitazoxanide-based%252Bderivatives%252Bas%2525C2%2525A0autophagy%252Bactivators%252Bfor%252Bthe%252Btreatment%252Bof%2525C2%2525A0Alzheimer%252527s%252Bdisease%26aulast%3DLi%26aufirst%3DXiaokang%26date%3D2020%26volume%3D10%26issue%3D4%26spage%3D646%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>, <span class="hlFld-ContribAuthor ">Xinfeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Gaofeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Yiling  Wang</span>, <span class="hlFld-ContribAuthor ">Yiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhanpin  Qiao</span>, <span class="hlFld-ContribAuthor ">Anguo  Wu</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112180. <a href="https://doi.org/10.1016/j.ejmech.2020.112180" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112180%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdevelopment%252Bof%252Badvanced%252Bstructural%252Bframework%252Bas%252Bmulti-target-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2020%26volume%3D192%26spage%3D112180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Xinfeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Gaofeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Rongrui  Wei</span>, <span class="hlFld-ContribAuthor ">Qinge  Ma</span>, <span class="hlFld-ContribAuthor ">Lintao  Yu</span>, <span class="hlFld-ContribAuthor ">Yiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111958. <a href="https://doi.org/10.1016/j.ejmech.2019.111958" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111958%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApigenin-rivastigmine%252Bhybrids%252Bas%252Bmulti-target-directed%252Bliagnds%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2020%26volume%3D187%26spage%3D111958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandre  LeBlanc</span>, <span class="hlFld-ContribAuthor ">Miroslava  Cuperlovic-Culf</span>, <span class="hlFld-ContribAuthor ">Pier Jr.  Morin</span>, <span class="hlFld-ContribAuthor ">Mohamed  Touaibia</span>. </span><span class="cited-content_cbyCitation_article-title">Structurally Related Edaravone Analogues: Synthesis, Antiradical, Antioxidant, and Copper-Chelating Properties. </span><span class="cited-content_cbyCitation_journal-name">CNS & Neurological Disorders - Drug Targets</span><span> <strong>2020,</strong> <em>18 </em>
                                    (10)
                                     , 779-790. <a href="https://doi.org/10.2174/1871527318666191114092007" title="DOI URL">https://doi.org/10.2174/1871527318666191114092007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871527318666191114092007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871527318666191114092007%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520%2526%2520Neurological%2520Disorders%2520-%2520Drug%2520Targets%26atitle%3DStructurally%252BRelated%252BEdaravone%252BAnalogues%25253A%252BSynthesis%25252C%252BAntiradical%25252C%252BAntioxidant%25252C%252Band%252BCopper-Chelating%252BProperties%26aulast%3DLeBlanc%26aufirst%3DAlexandre%26date%3D2020%26volume%3D18%26issue%3D10%26spage%3D779%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuaishuai  Ni</span>, <span class="hlFld-ContribAuthor ">Baoli  Li</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting virulence factors as an antimicrobial approach: Pigment inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 293-338. <a href="https://doi.org/10.1002/med.21621" title="DOI URL">https://doi.org/10.1002/med.21621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21621%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bvirulence%252Bfactors%252Bas%252Ban%252Bantimicrobial%252Bapproach%25253A%252BPigment%252Binhibitors%26aulast%3DNi%26aufirst%3DShuaishuai%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D293%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praveen P.N.  Rao</span>, <span class="hlFld-ContribAuthor ">Amy Trinh  Pham</span>, <span class="hlFld-ContribAuthor ">Arash  Shakeri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small molecules for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 289-322. <a href="https://doi.org/10.1016/B978-0-12-818349-6.00011-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-818349-6.00011-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818349-6.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818349-6.00011-X%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252Bsmall%252Bmolecules%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRao%26aufirst%3DPraveen%2BP.N.%26date%3D2020%26spage%3D289%26epage%3D322%26pub%3DElsevier%26atitle%3DSmall%252BMolecule%252BDrug%252BDiscovery%26date%3D2020%26volume%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naglaa F.  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Marwa  El-Hussieny</span>, <span class="hlFld-ContribAuthor ">Ewies F.  Ewies</span>, <span class="hlFld-ContribAuthor ">Marwa A.  Fouad</span>, <span class="hlFld-ContribAuthor ">Leila S.  Boulos</span>. </span><span class="cited-content_cbyCitation_article-title">New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103499. <a href="https://doi.org/10.1016/j.bioorg.2019.103499" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103499%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNew%252Bphosphazine%252Band%252Bphosphazide%252Bderivatives%252Bas%252Bmultifunctional%252Bligands%252Btargeting%252Bacetylcholinesterase%252Band%252B%2525CE%2525B2-Amyloid%252Baggregation%252Bfor%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DEl-Sayed%26aufirst%3DNaglaa%2BF.%26date%3D2020%26volume%3D95%26spage%3D103499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nehad Abou-Elmagd  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Awatef El-Said  Farag</span>, <span class="hlFld-ContribAuthor ">Manal Abdel Fattah  Ezzat</span>, <span class="hlFld-ContribAuthor ">Hulya  Akincioglu</span>, <span class="hlFld-ContribAuthor ">İlhami  Gülçin</span>, <span class="hlFld-ContribAuthor ">Sahar Mahmoud  Abou-Seri</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>93 </em>, 103312. <a href="https://doi.org/10.1016/j.bioorg.2019.103312" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103312%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252Bnovel%252Bpyrrolizine-based%252Bcompounds%252Bwith%252Bpotential%252Bactivity%252Bas%252Bcholinesterase%252Binhibitors%252Band%252Banti-Alzheimer%252527s%252Bagents%26aulast%3DEl-Sayed%26aufirst%3DNehad%2BAbou-Elmagd%26date%3D2019%26volume%3D93%26spage%3D103312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Xinfeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng  Zheng</span>, <span class="hlFld-ContribAuthor ">Yao  Cheng</span>, <span class="hlFld-ContribAuthor ">Jian  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Lu</span>, <span class="hlFld-ContribAuthor ">Zhipei  Sang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111737. <a href="https://doi.org/10.1016/j.ejmech.2019.111737" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111737%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bchalcone-O-alkylamine%252Bderivatives%252Bas%252Bmultifunctional%252Bagents%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DBai%26aufirst%3DPing%26date%3D2019%26volume%3D183%26spage%3D111737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zehui  Liu</span>, <span class="hlFld-ContribAuthor ">Wanyan  Wang</span>, <span class="hlFld-ContribAuthor ">Tingyu  Huang</span>, <span class="hlFld-ContribAuthor ">Cunfang  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Jin  Huang</span>, . </span><span class="cited-content_cbyCitation_article-title">CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , e0222757. <a href="https://doi.org/10.1371/journal.pone.0222757" title="DOI URL">https://doi.org/10.1371/journal.pone.0222757</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0222757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0222757%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DCH%252528II%252529%25252C%252Ba%252Bcerebroprotein%252Bhydrolysate%25252C%252Bexhibits%252Bpotential%252Bneuro-protective%252Beffect%252Bon%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLiu%26aufirst%3DZehui%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3De0222757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfei  Wu</span>, <span class="hlFld-ContribAuthor ">Jie  Ma</span>, <span class="hlFld-ContribAuthor ">Lijun  Ji</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jianfei  Han</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>177 </em>, 198-211. <a href="https://doi.org/10.1016/j.ejmech.2019.05.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Brutacecarpine%252Bderivatives%252Bas%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DWu%26aufirst%3DMingfei%26date%3D2019%26volume%3D177%26spage%3D198%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiaoli  Ding</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaona  Sun</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Mo</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Yin</span>, <span class="hlFld-ContribAuthor ">Weizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 103027. <a href="https://doi.org/10.1016/j.bioorg.2019.103027" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bchromanone-dithiocarbamate%252Bhybrids%252Bas%252Bmultifunctional%252BAChE%252Binhibitors%252Bwith%252B%2525CE%2525B2-amyloid%252Banti-aggregation%252Bproperties%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DJiang%26aufirst%3DNeng%26date%3D2019%26volume%3D89%26spage%3D103027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target design strategies for the improved treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 228-247. <a href="https://doi.org/10.1016/j.ejmech.2019.05.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulti-target%252Bdesign%252Bstrategies%252Bfor%252Bthe%252Bimproved%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DZhang%26aufirst%3DPengfei%26date%3D2019%26volume%3D176%26spage%3D228%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sneha R.  Sagar</span>, <span class="hlFld-ContribAuthor ">Devendra Pratap  Singh</span>, <span class="hlFld-ContribAuthor ">Rajesh D.  Das</span>, <span class="hlFld-ContribAuthor ">Nirupa B.  Panchal</span>, <span class="hlFld-ContribAuthor ">Vasudevan  Sudarsanam</span>, <span class="hlFld-ContribAuthor ">Manish  Nivsarkar</span>, <span class="hlFld-ContribAuthor ">Kamala K.  Vasu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 102992. <a href="https://doi.org/10.1016/j.bioorg.2019.102992" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.102992</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.102992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.102992%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPharmacological%252Binvestigation%252Bof%252Bquinoxaline-bisthiazoles%252Bas%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSagar%26aufirst%3DSneha%2BR.%26date%3D2019%26volume%3D89%26spage%3D102992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Long  Shi</span>, <span class="hlFld-ContribAuthor ">Jing-De  Wu</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 211-225. <a href="https://doi.org/10.1016/j.ejmech.2019.02.001" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252BGSK-3%2525CE%2525B2%252Binhibitors%252Bas%252Bmultifunctional%252Bagents%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DShi%26aufirst%3DXiao-Long%26date%3D2019%26volume%3D167%26spage%3D211%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Cong</span>, <span class="hlFld-ContribAuthor ">Xiyu  Dong</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yulin  Deng</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Rongji  Dai</span>. </span><span class="cited-content_cbyCitation_article-title">On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 11-21. <a href="https://doi.org/10.1016/j.ejmech.2019.01.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOn%252Bthe%252Brole%252Bof%252Bsynthesized%252Bhydroxylated%252Bchalcones%252Bas%252Bdual%252Bfunctional%252Bamyloid-%2525CE%2525B2%252Baggregation%252Band%252Bferroptosis%252Binhibitors%252Bfor%252Bpotential%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DCong%26aufirst%3DLin%26date%3D2019%26volume%3D166%26spage%3D11%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhui  Hu</span>, <span class="hlFld-ContribAuthor ">Tingting  Pan</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Zhengcunxiao  Li</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 512-526. <a href="https://doi.org/10.1016/j.ejmech.2018.12.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bclioquinol-rolipram%25252Froflumilast%252Bhybrids%252Bas%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DHu%26aufirst%3DJinhui%26date%3D2019%26volume%3D163%26spage%3D512%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Hong</span>, <span class="hlFld-ContribAuthor ">Hui-yan  Guo</span>, <span class="hlFld-ContribAuthor ">Shuai  Chen</span>, <span class="hlFld-ContribAuthor ">Jian-wu  Lv</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Ya-cheng  Yang</span>, <span class="hlFld-ContribAuthor ">Kang  Huang</span>, <span class="hlFld-ContribAuthor ">Yi-juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-yong  Tian</span>, <span class="hlFld-ContribAuthor ">Wen  Luo</span>, <span class="hlFld-ContribAuthor ">Yi-ping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of genistein-
              O
              -alkylamine derivatives as potential multifunctional anti-Alzheimer agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (2)
                                     , 188-200. <a href="https://doi.org/10.1111/cbdd.13414" title="DOI URL">https://doi.org/10.1111/cbdd.13414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13414%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bgenistein-%252BO%252B-alkylamine%252Bderivatives%252Bas%252Bpotential%252Bmultifunctional%252Banti-Alzheimer%252Bagents%26aulast%3DHong%26aufirst%3DChen%26date%3D2019%26date%3D2018%26volume%3D93%26issue%3D2%26spage%3D188%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  He</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Jiaoli  Ding</span>, <span class="hlFld-ContribAuthor ">Yongbing  Sun</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Liyuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 512-528. <a href="https://doi.org/10.1016/j.bioorg.2018.09.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCoumarin-dithiocarbamate%252Bhybrids%252Bas%252Bnovel%252Bmultitarget%252BAChE%252Band%252BMAO-B%252Binhibitors%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DHe%26aufirst%3DQi%26date%3D2018%26volume%3D81%26spage%3D512%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuelian  Yang</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Qiaohong  Liu</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wu</span>, <span class="hlFld-ContribAuthor ">Yong  Yin</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3191-3201. <a href="https://doi.org/10.1016/j.bmc.2018.04.043" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B8-hydroxyquinoline%252Bderivatives%252Btargeting%252B%2525CE%2525B2-amyloid%252Baggregation%25252C%252Bmetal%252Bchelation%252Band%252Boxidative%252Bstress%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DYang%26aufirst%3DXuelian%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3191%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Chong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Dong</span>, <span class="hlFld-ContribAuthor ">Jie  Zheng</span>, <span class="hlFld-ContribAuthor ">Yan  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu
              2+
              -mediated amyloid β-protein aggregation and cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2018,</strong> <em>31 </em>
                                    (6)
                                     , e2697. <a href="https://doi.org/10.1002/jmr.2697" title="DOI URL">https://doi.org/10.1002/jmr.2697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.2697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.2697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DDesign%252Bof%252Bnonapeptide%252BLVFFARKHH%25253A%252BA%252Bbifunctional%252Bagent%252Bagainst%252BCu%252B2%25252B%252B-mediated%252Bamyloid%252B%2525CE%2525B2-protein%252Baggregation%252Band%252Bcytotoxicity%26aulast%3DZhang%26aufirst%3DHuan%26date%3D2018%26date%3D2018%26volume%3D31%26issue%3D6%26spage%3De2697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Qichun  Huang</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Ningsheng  Liang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Qinghua  Li</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 287-298. <a href="https://doi.org/10.1016/j.ejmech.2018.01.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Bcoumarin-dithiocarbamate%252Bhybrids%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DJiang%26aufirst%3DNeng%26date%3D2018%26volume%3D146%26spage%3D287%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cindy Juliet Cristancho  Ortiz</span>, <span class="hlFld-ContribAuthor ">Matheus  de Freitas Silva</span>, <span class="hlFld-ContribAuthor ">Vanessa Silva  Gontijo</span>, <span class="hlFld-ContribAuthor ">Flávia Pereira Dias  Viegas</span>, <span class="hlFld-ContribAuthor ">Kris Simone Tranches  Dias</span>, <span class="hlFld-ContribAuthor ">Claudio  Viegas</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 255-351. <a href="https://doi.org/10.1007/7653_2018_2" title="DOI URL">https://doi.org/10.1007/7653_2018_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_2%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BMulti-target%252BDirected%252BLigands%252Bas%252Ba%252BModern%252BApproach%252Bfor%252Bthe%252BDevelopment%252Bof%252BInnovative%252BDrug%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DOrtiz%26aufirst%3DCindy%2BJuliet%2BCristancho%26date%3D2018%26date%3D2018%26spage%3D255%26epage%3D351%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-xiang  Xu</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-kang  Li</span>, <span class="hlFld-ContribAuthor ">Sheng-nan  Dong</span>, <span class="hlFld-ContribAuthor ">Wen-wen  Liu</span>, <span class="hlFld-ContribAuthor ">Qi  Gong</span>, <span class="hlFld-ContribAuthor ">Tian-duan-yi  Wang</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Hai-yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 33-47. <a href="https://doi.org/10.1016/j.ejmech.2017.08.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bpropargylamine-modified%252B4-aminoalkyl%252Bimidazole%252Bsubstituted%252Bpyrimidinylthiourea%252Bderivatives%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DXu%26aufirst%3DYi-xiang%26date%3D2018%26volume%3D143%26spage%3D33%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń </span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (15)
                                     , 1835-1854. <a href="https://doi.org/10.4155/fmc-2017-0094" title="DOI URL">https://doi.org/10.4155/fmc-2017-0094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0094%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Btoward%252Bmultifunctional%252Bcholinesterase%252Band%252B%2525CE%2525B2-amyloid%252Baggregation%252Binhibitors%26aulast%3DPanek%26aufirst%3DDawid%26date%3D2017%26volume%3D9%26issue%3D15%26spage%3D1835%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Grasso</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Santoro</span>, <span class="hlFld-ContribAuthor ">Valeria  Lanza</span>, <span class="hlFld-ContribAuthor ">Diego  Sbardella</span>, <span class="hlFld-ContribAuthor ">Grazia Raffaella  Tundo</span>, <span class="hlFld-ContribAuthor ">Chiara  Ciaccio</span>, <span class="hlFld-ContribAuthor ">Stefano  Marini</span>, <span class="hlFld-ContribAuthor ">Massimo  Coletta</span>, <span class="hlFld-ContribAuthor ">Danilo  Milardi</span>. </span><span class="cited-content_cbyCitation_article-title">The double faced role of copper in Aβ homeostasis: A survey on the interrelationship between metal dyshomeostasis, UPS functioning and autophagy in neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2017,</strong> <em>347 </em>, 1-22. <a href="https://doi.org/10.1016/j.ccr.2017.06.004" title="DOI URL">https://doi.org/10.1016/j.ccr.2017.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2017.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2017.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DThe%252Bdouble%252Bfaced%252Brole%252Bof%252Bcopper%252Bin%252BA%2525CE%2525B2%252Bhomeostasis%25253A%252BA%252Bsurvey%252Bon%252Bthe%252Binterrelationship%252Bbetween%252Bmetal%252Bdyshomeostasis%25252C%252BUPS%252Bfunctioning%252Band%252Bautophagy%252Bin%252Bneurodegeneration%26aulast%3DGrasso%26aufirst%3DGiuseppe%26date%3D2017%26volume%3D347%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Qiang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Zhongcheng  Cao</span>, <span class="hlFld-ContribAuthor ">Qing  Song</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of scutellarein- O -acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 307-323. <a href="https://doi.org/10.1016/j.ejmech.2017.04.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bscutellarein-%252BO%252B-acetamidoalkylbenzylamines%252Bas%252Bpotential%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2017%26volume%3D135%26spage%3D307%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Wanli  Pan</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Qinge  Ma</span>, <span class="hlFld-ContribAuthor ">Lintao  Yu</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 3,4-dihydro-2(1 H )-quinoline- O -alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (12)
                                     , 3006-3017. <a href="https://doi.org/10.1016/j.bmc.2017.03.070" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3%25252C4-dihydro-2%2525281%252BH%252B%252529-quinoline-%252BO%252B-alkylamine%252Bderivatives%252Bas%252Bnew%252Bmultipotent%252Bcholinesterase%25252Fmonoamine%252Boxidase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2017%26volume%3D25%26issue%3D12%26spage%3D3006%26epage%3D3017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Wanli  Pan</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Qinge  Ma</span>, <span class="hlFld-ContribAuthor ">Lintao  Yu</span>, <span class="hlFld-ContribAuthor ">Yan  Yang</span>, <span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Chaoliang  Leng</span>, <span class="hlFld-ContribAuthor ">Qian  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Li</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel ferulic acid- O -alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>130 </em>, 379-392. <a href="https://doi.org/10.1016/j.ejmech.2017.02.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bferulic%252Bacid-%252BO%252B-alkylamine%252Bderivatives%252Bas%252Bpotential%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2017%26volume%3D130%26spage%3D379%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative MTDLs bearing AChE and metal-chelating properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b> and <b>2a</b>–<b>o</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4,6-dichloropyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (b) 4-amino-6-chloropyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 12 h. (c) (i) For <b>1</b>, <b>2c</b>: RNH<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40–50 °C, overnight. (ii) For <b>2a</b>: CH<sub>3</sub>CH<sub>2</sub>OH, NaH, DMF, 4 h. (iii) For <b>2b</b>: <i>n</i>-propylmagnesium bromide, ferrous acetylacetonate, anhydrous THF, N<sub>2</sub>, −30 °C, 1 h. (d) (i) For <b>2e</b>: AcCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, overnight. (ii) For <b>2f</b>–<b>o</b>: RNCO or RNCS, NaH, DMF, rt, 0.5 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>3a</b>–<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) (i) For <b>7a</b>: pyrrole, NaH, DMF, rt, 2 h. (ii) For <b>7b</b>–<b>i</b>: aza-aromatic compounds or alicyclic amines, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100–120 °C, 12–24 h. (c) CH<sub>3</sub>CH<sub>2</sub>NCS, NaH, DMF, rt, 0.5 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>4a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CH<sub>2</sub>NCS, NaH, DMF, rt, 0.5 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>5a</b>–<b>x</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100–120 °C, rt, 12–24 h; (b) CH<sub>3</sub>CH<sub>2</sub>NCS, DMF, rt, 0.5 h; (c) NaBH<sub>4</sub>, MeOH/DCM = 1:1, rt, 5 h; (d) NaBH<sub>3</sub>(CN), MeOH/DCE = 1:1, AcOH, rt, 12 h.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Key transition compounds of the structural optimization and a brief summary of SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. UV spectra of compounds (40 μM) alone and in the presence of CuCl<sub>2</sub> (20 μM), FeSO<sub>4</sub> (20 μM), FeCl<sub>3</sub> (20 μM), or ZnCl<sub>2</sub> (20 μM) in buffer (20 mM HEPES, 150 mM NaCl, pH 7.4): (A) <b>5r</b>; (B) <b>5t</b>; (C) <b>5y</b>. (D) UV spectrum of compound CQ (40 μM) alone and in the presence of CuCl<sub>2</sub> (20 μM), FeSO<sub>4</sub> (20 μM), FeCl<sub>3</sub> (20 μM), or ZnCl<sub>2</sub> (20 μM) in ethanol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of compounds on Cu<sup>2+</sup>-induced Aβ<sub>1–42</sub> aggregation. (A) Scan and bar graph of the dot blot assay. Aggregated Aβ was detected by A11 antibody, and total Aβ was probed by 6E10 antibody. Data are shown as the mean ± SEM, ($) <i>p</i> < 0.05, ($$) <i>p</i> < 0.01 vs Aβ alone group; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs Aβ + Cu<sup>2+</sup> group; <i>N</i> = 3. (B) TEM image analysis of the inhibition of compounds on Cu<sup>2+</sup>-induced Aβ<sub>1–42</sub> aggregation. Serial numbers indicate the following: (1) fresh Aβ<sub>1–42</sub>, (2) Aβ<sub>1–42</sub> alone, (3) Aβ<sub>1–42</sub> + Cu<sup>2+</sup>, (4) Aβ<sub>1–42</sub> + Cu<sup>2+</sup> + <b>5r</b>, (4) Aβ<sub>1–42</sub> + Cu<sup>2+</sup> + <b>5t</b>, (6) Aβ<sub>1–42</sub> + Cu<sup>2+</sup> + CQ. Experimental conditions were the follwoing: Aβ<sub>1–42</sub> (25 μM); compound/Aβ<sub>1–42</sub>/Cu<sup>2+</sup> = 2:1:1; HEPES (20 μM) and NaCl (150 μM); pH 6.6; 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Oxygen reduction by copper redox cycling in the presence of ascorbate. (B) Fluorescence intensity of the copper–ascorbate–<b>5r</b>, copper–ascorbate–<b>5t</b>, copper–ascorbate–EDTA, copper–ascorbate, and ascorbate alone systems. CCA (50 μM) and ascorbate (150 μM) were incubated in each system. Cu(II) = 5 μM, <b>5r</b> = 10 μM, <b>5t</b> = 10 μM, EDTA = 10 μM. PBS buffer (20 mM KH<sub>2</sub>PO<sub>4</sub>, 150 mM NaCl); <i>N</i> = 3; pH = 7.4; 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Cell viability of SH-SY5Y cells exposed to compounds <b>5r</b>, <b>5t</b>, Hup A, and Don at different concentrations (range 10–100 μM) for 24 h. Vehicle-treated cells were used as control. The results are expressed as the percentage of viable cells observed after treatment with compounds vs vehicle-treated cells (100%) and are shown as the mean ± SEM; <i>N</i> = 4. (B) Protection of compounds <b>5r</b> and <b>5t</b> from Cu<sup>2+</sup>-induced Aβ<sub>1–42</sub> neurotoxicity. Data are shown as the mean ± SEM; <i>N</i> = 4. Experimental conditions: Aβ<sub>1–42</sub> (1 μM); compounds/Aβ<sub>1–42</sub>/Cu<sup>2+</sup> = 2:1:1, (##) <i>p</i> < 0.01, (###) <i>p</i> < 0.001 vs vehicle group; ($$$) <i>p</i> < 0.001 vs Aβ alone group; (∗∗∗)<i>p</i> < 0.001 vs Aβ + Cu<sup>2+</sup> group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/medium/jm-2016-00636p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compounds <b>5t·HCl</b> and <b>5r·HCl</b> (200 mg/kg) on scopolamine-induced cognitive deficits mice, with Hup A (0.1 mg/kg) as reference: (A) escape latency of mice in passageway water maze; (B) number of errors of mice in passageway water maze. Data are shown as the mean ± SEM: (###) <i>p</i> < 0.001 vs control group, (∗∗∗) <i>p</i> < 0.001 vs scopolamine group; <i>N</i> = 17.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00636/20160916/images/large/jm-2016-00636p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00636&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i127">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Prince, M.; Albanese, E.; Guerchet, M.</span><span> </span><span class="NLM_article-title">World Alzheimer Report 2014. Dementia and Risk Reduction: An Analaysis of Protective and Modifiable Factors</span>. <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prince%2C+M.%3B+Albanese%2C+E.%3B+Guerchet%2C+M.+World+Alzheimer+Report+2014.+Dementia+and+Risk+Reduction%3A+An+Analaysis+of+Protective+and+Modifiable+Factors.+Alzheimer%E2%80%99s+Disease+International%3A+London%2C+2014%3B+pp+1%E2%80%9399."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26atitle%3DWorld%2520Alzheimer%2520Report%25202014.%2520Dementia%2520and%2520Risk%2520Reduction%253A%2520An%2520Analaysis%2520of%2520Protective%2520and%2520Modifiable%2520Factors%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2014%26spage%3D1%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Emmerzaal, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiliaan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, D. R.</span><span> </span><span class="NLM_article-title">2003–2013: a decade of body mass index, Alzheimer’s disease, and dementia</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.3233/JAD-141086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.3233%2FJAD-141086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=25147111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FktlWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=739-755&author=T.+L.+Emmerzaalauthor=A.+J.+Kiliaanauthor=D.+R.+Gustafson&title=2003%E2%80%932013%3A+a+decade+of+body+mass+index%2C+Alzheimer%E2%80%99s+disease%2C+and+dementia&doi=10.3233%2FJAD-141086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">2003-2013: a decade of body mass index, Alzheimer's disease, and dementia</span></div><div class="casAuthors">Emmerzaal Tim L; Kiliaan Amanda J; Gustafson Deborah R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">739-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The occurrence of obesity, commonly estimated using body mass index (BMI), and the most common late-onset dementia, Alzheimer's disease (AD), are increasing globally.  The year 2013 marked a decade of epidemiologic observational reports on the association between BMI and late-onset dementias.  In this review, we highlight epidemiological studies that measured both mid- and late-life BMI in association with dementia.  Studies investigating the association between midlife BMI and risk for dementia demonstrated generally an increased risk among overweight and obese adults.  When measured in late-life, elevated BMI has been associated with lower risk.  In addition, being underweight and/or having a decrease in BMI in late-life are associated with higher dementia risk compared to BMI in the normal range or stable BMI.  In this review, a decade (2003-2013) of epidemiologic observational studies on associations between BMI and AD is highlighted.  These observations provide a strong base for addressing biological mechanisms underlying this complex association.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbhEAsl7zZDP69nzq6467DfW6udTcc2eYT5lIcjWVxr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FktlWlsA%253D%253D&md5=85551c5cbdf88ecce4179bacd5ea4f3d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3233%2FJAD-141086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141086%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerzaal%26aufirst%3DT.%2BL.%26aulast%3DKiliaan%26aufirst%3DA.%2BJ.%26aulast%3DGustafson%26aufirst%3DD.%2BR.%26atitle%3D2003%25E2%2580%25932013%253A%2520a%2520decade%2520of%2520body%2520mass%2520index%252C%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520and%2520dementia%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2015%26volume%3D43%26spage%3D739%26epage%3D755%26doi%3D10.3233%2FJAD-141086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=K.+Zhongauthor=T.+Morstorf&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+Few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eYT5lIcjWVxr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DMorstorf%26aufirst%3DT.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520Few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savelieff, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brender, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer’s disease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span><span class="refDoi"> DOI: 10.1021/ja409801p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja409801p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=299-310&author=S.+Leeauthor=X.+Zhengauthor=J.+Krishnamoorthyauthor=M.+G.+Savelieffauthor=H.+M.+Parkauthor=J.+R.+Brenderauthor=J.+H.+Kimauthor=J.+S.+Derrickauthor=A.+Kochiauthor=H.+J.+Leeauthor=C.+Kimauthor=A.+Ramamoorthyauthor=M.+T.+Bowersauthor=M.+H.+Lim&title=Rational+design+of+a+structural+framework+with+potential+use+to+develop+chemical+reagents+that+target+and+modulate+multiple+facets+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fja409801p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer's Disease</span></div><div class="casAuthors">Lee, Sanghyun; Zheng, Xueyun; Krishnamoorthy, Janarthanan; Savelieff, Masha G.; Park, Hyun Min; Brender, Jeffrey R.; Kim, Jin Hoon; Derrick, Jeffrey S.; Kochi, Akiko; Lee, Hyuck Jin; Kim, Cheal; Ramamoorthy, Ayyalusamy; Bowers, Michael T.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by multiple, intertwined pathol. features, including amyloid-β (Aβ) aggregation, metal ion dyshomeostasis, and oxidative stress.  The authors report a novel compd. (ML) prototype of a rationally designed mol. obtained by integrating structural elements for Aβ aggregation control, metal chelation, reactive oxygen species (ROS) regulation, and antioxidant activity within a single mol.  Chem., biochem., ion mobility mass spectrometric, and NMR studies indicate that the compd. ML targets metal-free and metal-bound Aβ (metal-Aβ) species, suppresses Aβ aggregation in vitro, and diminishes toxicity induced by Aβ and metal-treated Aβ in living cells.  Comparison of ML to its structural moieties (i.e., 4-(dimethylamino)-phenol (DAP) and (8-aminoquinolin-2-yl)-methanol ) for reactivity with Aβ and metal-Aβ suggests the synergy of incorporating structural components for both metal chelation and Aβ interaction.  Moreover, ML is water-sol. and potentially brain permeable, as well as regulates the formation and presence of free radicals.  Overall, the authors demonstrate that a rational structure-based design strategy can generate a small mol. that can target and modulate multiple factors, providing a new tool to uncover and address AD complexity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcx8TkzbV9U7Vg90H21EOLACvtfcHk0liqKrDWqqvLDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I&md5=808d231c5dca419453c176265d16bfe3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fja409801p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja409801p%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DKrishnamoorthy%26aufirst%3DJ.%26aulast%3DSavelieff%26aufirst%3DM.%2BG.%26aulast%3DPark%26aufirst%3DH.%2BM.%26aulast%3DBrender%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DBowers%26aufirst%3DM.%2BT.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DRational%2520design%2520of%2520a%2520structural%2520framework%2520with%2520potential%2520use%2520to%2520develop%2520chemical%2520reagents%2520that%2520target%2520and%2520modulate%2520multiple%2520facets%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D299%26epage%3D310%26doi%3D10.1021%2Fja409801p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earnest, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozbil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korshavn, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruotolo, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: In vitro and in vivo efficacy and molecular mechanisms</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">14785</span><span class="NLM_x">–</span> <span class="NLM_lpage">14797</span><span class="refDoi"> DOI: 10.1021/jacs.5b10043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b10043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=14785-14797&author=J.+S.+Derrickauthor=R.+A.+Kerrauthor=Y.+Namauthor=S.+B.+Ohauthor=H.+J.+Leeauthor=K.+G.+Earnestauthor=N.+Suhauthor=K.+L.+Peckauthor=M.+Ozbilauthor=K.+J.+Korshavnauthor=A.+Ramamoorthyauthor=R.+Prabhakarauthor=E.+J.+Merinoauthor=J.+Shearerauthor=J.-Y.+Leeauthor=B.+T.+Ruotoloauthor=M.+H.+Lim&title=A+redox-active%2C+compact+molecule+for+cross-linking+amyloidogenic+peptides+into+nontoxic%2C+off-pathway+aggregates%3A+In+vitro+and+in+vivo+efficacy+and+molecular+mechanisms&doi=10.1021%2Fjacs.5b10043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms</span></div><div class="casAuthors">Derrick, Jeffrey S.; Kerr, Richard A.; Nam, Younwoo; Oh, Shin Bi; Lee, Hyuck Jin; Earnest, Kaylin G.; Suh, Nayoung; Peck, Kristy L.; Ozbil, Mehmet; Korshavn, Kyle J.; Ramamoorthy, Ayyalusamy; Prabhakar, Rajeev; Merino, Edward J.; Shearer, Jason; Lee, Joo-Yong; Ruotolo, Brandon T.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">14785-14797</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. reagents targeting and controlling amyloidogenic peptides have received much attention for helping identify their roles in the pathogenesis of protein-misfolding disorders.  Herein, the authors report a novel strategy for redirecting amyloidogenic peptides into nontoxic, off-pathway aggregates, which utilizes redox properties of a small mol. (DMPD, N,N-dimethyl-p-phenylenediamine) to trigger covalent adduct formation with the peptide.  In addn., for the first time, biochem., biophys., and mol. dynamics simulation studies have been performed to demonstrate a mechanistic understanding for such an interaction between a small mol. (DMPD) and amyloid-β (Aβ) and its subsequent anti-amyloidogenic activity, which, upon its transformation, generates ligand-peptide adducts via primary amine-dependent intramol. crosslinking correlated with structural compaction.  Furthermore, in vivo efficacy of DMPD toward amyloid pathol. and cognitive impairment was evaluated employing 5xFAD mice of Alzheimer's disease (AD).  Such a small mol. (DMPD) is indicated to noticeably reduce the overall cerebral amyloid load of sol. Aβ forms and amyloid deposits as well as significantly improve cognitive defects in the AD mouse model.  Overall, the authors' in vitro and in vivo studies of DMPD toward Aβ with the first mol.-level mechanistic investigations present the feasibility of developing new, innovative approaches that employ redox-active compds. without the structural complexity as next-generation chem. tools for amyloid management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVgBBoRUmXObVg90H21EOLACvtfcHk0liqKrDWqqvLDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmt7fL&md5=f95a3cad02c9a2752ea0389e69820943</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b10043%26sid%3Dliteratum%253Aachs%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DKerr%26aufirst%3DR.%2BA.%26aulast%3DNam%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DS.%2BB.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DEarnest%26aufirst%3DK.%2BG.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DPeck%26aufirst%3DK.%2BL.%26aulast%3DOzbil%26aufirst%3DM.%26aulast%3DKorshavn%26aufirst%3DK.%2BJ.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DR.%26aulast%3DMerino%26aufirst%3DE.%2BJ.%26aulast%3DShearer%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.-Y.%26aulast%3DRuotolo%26aufirst%3DB.%2BT.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DA%2520redox-active%252C%2520compact%2520molecule%2520for%2520cross-linking%2520amyloidogenic%2520peptides%2520into%2520nontoxic%252C%2520off-pathway%2520aggregates%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520efficacy%2520and%2520molecular%2520mechanisms%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D14785%26epage%3D14797%26doi%3D10.1021%2Fjacs.5b10043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Baptista, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Cruz e Silva, O. A. B.</span><span> </span><span class="NLM_article-title">Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer’s disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1021/cn400213r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400213r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaltLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=83-92&author=F.+I.+Baptistaauthor=A.+G.+Henriquesauthor=A.+M.+S.+Silvaauthor=J.+Wiltfangauthor=O.+A.+B.+da+Cruz+e+Silva&title=Flavonoids+as+therapeutic+compounds+targeting+key+proteins+involved+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn400213r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer's Disease</span></div><div class="casAuthors">Baptista, Filipa I.; Henriques, Ana G.; Silva, Artur M. S.; Wiltfang, Jens; da Cruz e Silva, Odete A. B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-92</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is characterized by pathol. aggregation of protein tau and amyloid-β peptides, both of which are considered to be toxic to neurons.  Naturally occurring dietary flavonoids have received considerable attention as alternative candidates for Alzheimer's therapy taking into account their antiamyloidogenic, antioxidative, and anti-inflammatory properties.  Exptl. evidence supports the hypothesis that certain flavonoids may protect against Alzheimer's disease in part by interfering with the generation and assembly of amyloid-β peptides into neurotoxic oligomeric aggregates and also by reducing tau aggregation.  Several mechanisms have been proposed for the ability of flavonoids to prevent the onset or to slow the progression of the disease.  Some mechanisms include their interaction with important signaling pathways in the brain like the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways that regulate prosurvival transcription factors and gene expression.  Other processes include the disruption of amyloid-β aggregation and alterations in amyloid precursor protein processing through the inhibition of β-secretase and/or activation of α-secretase, and inhibiting cyclin-dependent kinase-5 and glycogen synthase kinase-3β activation, preventing abnormal tau phosphorylation.  The interaction of flavonoids with different signaling pathways put forward their therapeutic potential to prevent the onset and progression of Alzheimer's disease and to promote cognitive performance.  Nevertheless, further studies are needed to give addnl. insight into the specific mechanisms by which flavonoids exert their potential neuroprotective actions in the brain of Alzheimer's disease patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp4YgHRFlNqrVg90H21EOLACvtfcHk0lgJZDED4NHpCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaltLjL&md5=de814b1d8ce4bc863df6c89c6761a222</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcn400213r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400213r%26sid%3Dliteratum%253Aachs%26aulast%3DBaptista%26aufirst%3DF.%2BI.%26aulast%3DHenriques%26aufirst%3DA.%2BG.%26aulast%3DSilva%26aufirst%3DA.%2BM.%2BS.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3Dda%2BCruz%2Be%2BSilva%26aufirst%3DO.%2BA.%2BB.%26atitle%3DFlavonoids%2520as%2520therapeutic%2520compounds%2520targeting%2520key%2520proteins%2520involved%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D83%26epage%3D92%26doi%3D10.1021%2Fcn400213r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Li, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.ejmech.2013.09.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=632-646&author=S.-Y.+Liauthor=X.-B.+Wangauthor=S.-S.+Xieauthor=N.+Jiangauthor=K.+D.+G.+Wangauthor=H.-Q.+Yaoauthor=H.-B.+Sunauthor=L.-Y.+Kong&title=Multifunctional+tacrine-flavonoid+hybrids+with+cholinergic%2C+%CE%B2-amyloid-reducing%2C+and+metal+chelating+properties+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.09.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.-Y.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DYao%26aufirst%3DH.-Q.%26aulast%3DSun%26aufirst%3DH.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMultifunctional%2520tacrine-flavonoid%2520hybrids%2520with%2520cholinergic%252C%2520%25CE%25B2-amyloid-reducing%252C%2520and%2520metal%2520chelating%2520properties%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D632%26epage%3D646%26doi%3D10.1016%2Fj.ejmech.2013.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juarez-Jimenez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabateauthor=J.+Juarez-Jimenezauthor=B.+Perezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Munoz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lgJZDED4NHpCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DJuarez-Jimenez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena-Altamira, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesaresi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-beta aggregation and to exert anticholinesterase and antioxidant Effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8576</span><span class="NLM_x">–</span> <span class="NLM_lpage">8589</span><span class="refDoi"> DOI: 10.1021/jm5010804</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010804" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eju7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8576-8589&author=E.+Nepovimovaauthor=E.+Uliassiauthor=J.+Korabecnyauthor=L.+E.+Pena-Altamiraauthor=S.+Samezauthor=A.+Pesaresiauthor=G.+E.+Garciaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=C.+Bergaminiauthor=R.+Fatoauthor=D.+Lambaauthor=M.+Robertiauthor=K.+Kucaauthor=B.+Montiauthor=M.+L.+Bolognesi&title=Multitarget+drug+design+strategy%3A+quinone-tacrine+hybrids+designed+to+block+amyloid-beta+aggregation+and+to+exert+anticholinesterase+and+antioxidant+Effects&doi=10.1021%2Fjm5010804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Drug Design Strategy: Quinone-Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects</span></div><div class="casAuthors">Nepovimova, Eugenie; Uliassi, Elisa; Korabecny, Jan; Pena-Altamira, Luis Emiliano; Samez, Sarah; Pesaresi, Alessandro; Garcia, Gregory E.; Bartolini, Manuela; Andrisano, Vincenza; Bergamini, Christian; Fato, Romana; Lamba, Doriano; Roberti, Marinella; Kuca, Kamil; Monti, Barbara; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8576-8589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the identification of multitarget anti-Alzheimer compds. designed by combining a naphthoquinone function and a tacrine fragment.  In vitro, 15 compds. displayed excellent acetylcholinesterase (AChE) inhibitory potencies and interesting capabilities to block amyloid-β (Aβ) aggregation.  The X-ray anal. of one of those compds. in complex with AChE allowed rationalizing the outstanding activity data (IC50 = 0.72 nM).  Two of the compds. showed negligible toxicity in immortalized mouse cortical neurons Neuro2A and primary rat cerebellar granule neurons.  However, only one of them was less hepatotoxic than tacrine in HepG2 cells.  In T67 cells, both compds. showed antioxidant activity, following NQO1 induction.  Furthermore, in Neuro2A, they were able to completely revert the decrease in viability induced by Aβ.  Importantly, they crossed the blood-brain barrier, as demonstrated in ex vivo expts. with rats.  When ex vivo results were combined with in vitro studies, these two compds. emerged to be promising multitarget lead candidates worthy of further pursuit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6HUhlnJkHLrVg90H21EOLACvtfcHk0lhLbtye6ftzcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eju7bK&md5=2f58fc44a8a7044df7efc833e29c0880</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm5010804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010804%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DPena-Altamira%26aufirst%3DL.%2BE.%26aulast%3DSamez%26aufirst%3DS.%26aulast%3DPesaresi%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DRoberti%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DMultitarget%2520drug%2520design%2520strategy%253A%2520quinone-tacrine%2520hybrids%2520designed%2520to%2520block%2520amyloid-beta%2520aggregation%2520and%2520to%2520exert%2520anticholinesterase%2520and%2520antioxidant%2520Effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8576%26epage%3D8589%26doi%3D10.1021%2Fjm5010804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert-Freon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer’s disease: The design of donecopride</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3172</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3172-3187&author=C.+Rochaisauthor=C.+Lecouteyauthor=F.+Gavenauthor=P.+Giannoniauthor=K.+Hamidoucheauthor=D.+Hedouauthor=E.+Dubostauthor=D.+Genestauthor=S.+Yahiaouiauthor=T.+Freretauthor=V.+Bouetauthor=F.+Dauphinauthor=J.+Sopkova+de+Oliveira+Santosauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert-Freonauthor=R.+Legayauthor=M.+Boulouardauthor=S.+Claeysenauthor=P.+Dallemagne&title=Novel+multitarget-directed+ligands+%28MTDLs%29+with+acetylcholinesterase+%28AChE%29+inhibitory+and+serotonergic+subtype+4+receptor+%285-HT4R%29+agonist+activities+as+potential+agents+against+Alzheimer%E2%80%99s+disease%3A+The+design+of+donecopride&doi=10.1021%2Facs.jmedchem.5b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride</span></div><div class="casAuthors">Rochais, Christophe; Lecoutey, Cedric; Gaven, Florence; Giannoni, Patrizia; Hamidouche, Katia; Hedou, Damien; Dubost, Emmanuelle; Genest, David; Yahiaoui, Samir; Freret, Thomas; Bouet, Valentine; Dauphin, Francois; Sopkova de Oliveira Santos, Jana; Ballandonne, Celine; Corvaisier, Sophie; Malzert-Freon, Aurelie; Legay, Remi; Boulouard, Michel; Claeysen, Sylvie; Dallemagne, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3172-3187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice.  The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfqjY4Tl4ObVg90H21EOLACvtfcHk0li5o70lbxefRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D&md5=435652a2503e322ad880bd9607838103</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DHamidouche%26aufirst%3DK.%26aulast%3DHedou%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DSopkova%2Bde%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert-Freon%26aufirst%3DA.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DNovel%2520multitarget-directed%2520ligands%2520%2528MTDLs%2529%2520with%2520acetylcholinesterase%2520%2528AChE%2529%2520inhibitory%2520and%2520serotonergic%2520subtype%25204%2520receptor%2520%25285-HT4R%2529%2520agonist%2520activities%2520as%2520potential%2520agents%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520design%2520of%2520donecopride%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3172%26epage%3D3187%26doi%3D10.1021%2Facs.jmedchem.5b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03163-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands&doi=10.1016%2FS1359-6446%2804%2903163-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0li5o70lbxefRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651%26doi%3D10.1016%2FS1359-6446%2804%2903163-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0li5o70lbxefRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8616</span><span class="NLM_x">–</span> <span class="NLM_lpage">8637</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8616-8637&author=Z.+Wangauthor=Y.+Wangauthor=B.+Wangauthor=W.+Liauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+evaluation+of+orally+available+clioquinol-moracin+M+hybrids+as+multitarget-directed+ligands+for+cognitive+improvement+in+a+rat+model+of+neurodegeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b01222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease</span></div><div class="casAuthors">Wang, Zhiren; Wang, Yali; Wang, Bo; Li, Wenrui; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8616-8637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of clioquinol-moracin hybrids were designed and synthesized by fusing the pharmacophores of clioquinol and moracin M, and their activities as multitarget-directed ligands against Alzheimer's disease were evaluated.  Biol. activity results demonstrated that these hybrids possessed significant inhibitory activities against phosphodiesterase 4D (PDE4D) and Aβ aggregation as well as remarkable antioxidant effects and excellent blood-brain barrier permeability.  The optimal compd., I (WBQ5187), exhibited excellent PDE4D inhibitory potency (IC50 = 0.32 μM), significant antioxidant effects, appropriate biometal chelating functions, and interesting properties that modulated self- and metal-induced Aβ aggregation.  Two-dimensional NMR studies revealed that I had significant interactions with Aβ1-42 at the R5, H6, H14, Q15, and F20 residues.  Furthermore, this typical hybrid possessed preeminent neuroprotective effects against inflammation in microglial cells.  Most importantly, oral administration of I·HCl demonstrated marked improvements in cognitive and spatial memory in a rat model of Alzheimer's disease and protected hippocampal neurons from necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcLe7jrheic7Vg90H21EOLACvtfcHk0lht728ze259Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI&md5=1230163c53dc646777185602d9fa9643</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01222%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520available%2520clioquinol-moracin%2520M%2520hybrids%2520as%2520multitarget-directed%2520ligands%2520for%2520cognitive%2520improvement%2520in%2520a%2520rat%2520model%2520of%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8616%26epage%3D8637%26doi%3D10.1021%2Facs.jmedchem.5b01222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bartus, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. L.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">The cholinergic hypothesis of geriatric memory dysfunction</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span><span class="refDoi"> DOI: 10.1126/science.7046051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1126%2Fscience.7046051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=7046051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaL38XkslShur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1982&pages=408-414&author=R.+T.+Bartusauthor=R.+L.+Deanauthor=B.+Beerauthor=A.+S.+Lippa&title=The+cholinergic+hypothesis+of+geriatric+memory+dysfunction&doi=10.1126%2Fscience.7046051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of geriatric memory dysfunction</span></div><div class="casAuthors">Bartus, Raymond T.; Dean, Reginald L., III; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">4558</span>),
    <span class="NLM_cas:pages">408-17</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 93 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC5hLTTFFYoLVg90H21EOLACvtfcHk0lht728ze259Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslShur4%253D&md5=ff0661ed096b9cb45406dd159c88e15e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.7046051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7046051%26sid%3Dliteratum%253Aachs%26aulast%3DBartus%26aufirst%3DR.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BL.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DThe%2520cholinergic%2520hypothesis%2520of%2520geriatric%2520memory%2520dysfunction%26jtitle%3DScience%26date%3D1982%26volume%3D217%26spage%3D408%26epage%3D414%26doi%3D10.1126%2Fscience.7046051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Perry, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R.</span><span> </span><span class="NLM_article-title">Acetylcholine in mind: a neurotransmitter correlate of consciousness?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1016/S0166-2236(98)01361-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0166-2236%2898%2901361-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=273-280&author=E.+Perryauthor=M.+Walkerauthor=J.+Graceauthor=R.+Perry&title=Acetylcholine+in+mind%3A+a+neurotransmitter+correlate+of+consciousness%3F&doi=10.1016%2FS0166-2236%2898%2901361-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2898%2901361-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252898%252901361-7%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DE.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DGrace%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DR.%26atitle%3DAcetylcholine%2520in%2520mind%253A%2520a%2520neurotransmitter%2520correlate%2520of%2520consciousness%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D273%26epage%3D280%26doi%3D10.1016%2FS0166-2236%2898%2901361-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, M. R.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: a disorder of cortical cholinergic innervation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span><span class="refDoi"> DOI: 10.1126/science.6338589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1126%2Fscience.6338589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=6338589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADyaL3s7ks1egsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1983&pages=1184-1190&author=J.+T.+Coyleauthor=D.+L.+Priceauthor=M.+R.+DeLong&title=Alzheimer%E2%80%99s+disease%3A+a+disorder+of+cortical+cholinergic+innervation&doi=10.1126%2Fscience.6338589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: a disorder of cortical cholinergic innervation</span></div><div class="casAuthors">Coyle J T; Price D L; DeLong M R</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">4589</span>),
    <span class="NLM_cas:pages">1184-90</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Great emphasis is being placed on identification of neurotransmitter systems involved in the symptomatic manifestations of neurological and psychiatric disorders.  In the case of Alzheimer's disease, which now seems to be one of the most common causes of mental deterioration in the elderly, compelling evidence has been developed that acetylcholine-releasing neurons, whose cell bodies lie in the basal forebrain, selectively degenerate.  These cholinergic neurons provide widespread innervation of the cerebral cortex and related structures and appear to play an important role in cognitive functions, especially memory.  These advances reflect a close interaction between experimental and clinical neuroscientists in which information derived from basic neurobiology is rapidly utilized to analyze disorders of the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqtu7Bwk96tP69nzq6467DfW6udTcc2eZhW-8d8CULa7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7ks1egsg%253D%253D&md5=40217992dc463498c596ce10976ea557</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.6338589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6338589%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DDeLong%26aufirst%3DM.%2BR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520disorder%2520of%2520cortical%2520cholinergic%2520innervation%26jtitle%3DScience%26date%3D1983%26volume%3D219%26spage%3D1184%26epage%3D1190%26doi%3D10.1126%2Fscience.6338589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Francis, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snape, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, G. K.</span><span> </span><span class="NLM_article-title">The cholinergic hypothesis of Alzheimer’s disease: a review of progress</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1136/jnnp.66.2.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1136%2Fjnnp.66.2.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10071091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADyaK1M7mvVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1999&pages=137-147&author=P.+T.+Francisauthor=A.+M.+Palmerauthor=M.+Snapeauthor=G.+K.+Wilcock&title=The+cholinergic+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+a+review+of+progress&doi=10.1136%2Fjnnp.66.2.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of Alzheimer's disease: a review of progress</span></div><div class="casAuthors">Francis P T; Palmer A M; Snape M; Wilcock G K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-47</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Alzheimer's disease is one of the most common causes of mental deterioration in elderly people, accounting for around 50%-60% of the overall cases of dementia among persons over 65 years of age.  The past two decades have witnessed a considerable research effort directed towards discovering the cause of Alzheimer's disease with the ultimate hope of developing safe and effective pharmacological treatments.  This article examines the existing scientific applicability of the original cholinergic hypothesis of Alzheimer's disease by describing the biochemical and histopathological changes of neurotransmitter markers that occur in the brains of patients with Alzheimer's disease both at postmortem and neurosurgical cerebral biopsy and the behavioural consequences of cholinomimetic drugs and cholinergic lesions.  Such studies have resulted in the discovery of an association between a decline in learning and memory, and a deficit in excitatory amino acid (EAA) neurotransmission, together with important roles for the cholinergic system in attentional processing and as a modulator of EAA neurotransmission.  Accordingly, although there is presently no "cure" for Alzheimer's disease, a large number of potential therapeutic interventions have emerged that are designed to correct loss of presynaptic cholinergic function.  A few of these compounds have confirmed efficacy in delaying the deterioration of symptoms of Alzheimer's disease, a valuable treatment target considering the progressive nature of the disease.  Indeed, three compounds have received European approval for the treatment of the cognitive symptoms of Alzheimer's disease, first tacrine and more recently, donepezil and rivastigmine, all of which are cholinesterase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnFJROHH3HoJagfuraLLzSfW6udTcc2eZhW-8d8CULa7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7mvVKnuw%253D%253D&md5=3c06fbfd49488233c971bb735a2410fd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.66.2.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.66.2.137%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26aulast%3DSnape%26aufirst%3DM.%26aulast%3DWilcock%26aufirst%3DG.%2BK.%26atitle%3DThe%2520cholinergic%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520of%2520progress%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D1999%26volume%3D66%26spage%3D137%26epage%3D147%26doi%3D10.1136%2Fjnnp.66.2.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Green, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span> </span><span class="NLM_article-title">hChAT: A Tool for the chemoenzymatic generation of potential acetyl/butyrylcholinesterase inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2191</span><span class="NLM_x">–</span> <span class="NLM_lpage">2194</span><span class="refDoi"> DOI: 10.1002/cbic.200900309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fcbic.200900309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2191-2194&author=K.+D.+Greenauthor=M.+Fridmanauthor=S.+Garneau-Tsodikova&title=hChAT%3A+A+Tool+for+the+chemoenzymatic+generation+of+potential+acetyl%2Fbutyrylcholinesterase+inhibitors&doi=10.1002%2Fcbic.200900309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900309%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DK.%2BD.%26aulast%3DFridman%26aufirst%3DM.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DhChAT%253A%2520A%2520Tool%2520for%2520the%2520chemoenzymatic%2520generation%2520of%2520potential%2520acetyl%252Fbutyrylcholinesterase%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D2191%26epage%3D2194%26doi%3D10.1002%2Fcbic.200900309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ballard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarsland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)61349-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0140-6736%2810%2961349-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=21371747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=1019-1031&author=C.+Ballardauthor=S.+Gauthierauthor=A.+Corbettauthor=C.+Brayneauthor=D.+Aarslandauthor=E.+Jones&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2810%2961349-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Ballard Clive; Gauthier Serge; Corbett Anne; Brayne Carol; Aarsland Dag; Jones Emma</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">9770</span>),
    <span class="NLM_cas:pages">1019-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease.  Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority.  Although there are licensed treatments that can alleviate symptoms of Alzheimer's disease, there is a pressing need to improve our understanding of pathogenesis to enable development of disease-modifying treatments.  Methods for improving diagnosis are also moving forward, but a better consensus is needed for development of a panel of biological and neuroimaging biomarkers that support clinical diagnosis.  There is now strong evidence of potential risk and protective factors for Alzheimer's disease, dementia, and cognitive decline, but further work is needed to understand these better and to establish whether interventions can substantially lower these risks.  In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPHrxmEUcI2DdblLE_E9PWfW6udTcc2eaO5BIn80jwoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D&md5=e37ee3fb78a85dfc774b372d0a9af0c5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2961349-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252961349-9%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DC.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DCorbett%26aufirst%3DA.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DAarsland%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DE.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D1019%26epage%3D1031%26doi%3D10.1016%2FS0140-6736%2810%2961349-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Holzgrabe, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alptuezuen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmann, E.</span><span> </span><span class="NLM_article-title">Targeting acetylcholinesterase to treat neurodegeneration</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1517/14728222.11.2.161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1517%2F14728222.11.2.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=17227232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=161-179&author=U.+Holzgrabeauthor=P.+Kapkovaauthor=V.+Alptuezuenauthor=J.+Scheiberauthor=E.+Kugelmann&title=Targeting+acetylcholinesterase+to+treat+neurodegeneration&doi=10.1517%2F14728222.11.2.161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase to treat neurodegeneration</span></div><div class="casAuthors">Holzgrabe, Ulrike; Kapkova, Petra; Alptuezuen, Vildan; Scheiber, Josef; Kugelmann, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-179</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders, such as Alzheimer's disease, are often characterized by the degeneration of the cholinergic system.  Thus, the aim of many treatment regimens is to support this system either by means of muscarinic agonists or by inhibitors of acetylcholinesterase (AChE), the latter being able to increase the concn. of acetylcholine.  However, both pharmacol. groups of drugs can only help in the beginning of the progressive disease.  The finding that the occupation of the peripheral anionic site of AChE is able to stop the formation of the amyloid plaque led to the development of bivalent ligands that occupy both the active and the peripheral site.  This dual action might be more beneficial for treatment of Alzheimer's disease than simple inhibition of the acetylcholine hydrolysis.  Thus, the new bivalent ligands are the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfJ1Ef8XjB3LVg90H21EOLACvtfcHk0lj4a6y-TZrjNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D&md5=e38fa01804094ae9ed273d68f0e74a50</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.2.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.2.161%26sid%3Dliteratum%253Aachs%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DKapkova%26aufirst%3DP.%26aulast%3DAlptuezuen%26aufirst%3DV.%26aulast%3DScheiber%26aufirst%3DJ.%26aulast%3DKugelmann%26aufirst%3DE.%26atitle%3DTargeting%2520acetylcholinesterase%2520to%2520treat%2520neurodegeneration%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D161%26epage%3D179%26doi%3D10.1517%2F14728222.11.2.161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span> </span><span class="NLM_article-title">A review on cholinesterase inhibitors for Alzheimer’s disease. Arch</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1007/s12272-013-0036-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1007%2Fs12272-013-0036-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=23435942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=375-399&author=P.+Anandauthor=B.+Singh&title=A+review+on+cholinesterase+inhibitors+for+Alzheimer%E2%80%99s+disease.+Arch&doi=10.1007%2Fs12272-013-0036-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A review on cholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Anand, Preet; Singh, Baldev</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-399</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is characterized by the deficits in the cholinergic system and deposition of beta amyloid (Aβ) in the form of neurofibrillary tangles and amyloid plaques.  Since the cholinergic system plays an important role in the regulation of learning and memory processes, it has been targetted for the design of anti-Alzheimer's drugs.  Cholinesterase inhibitors enhance cholinergic transmission directly by inhibiting the enzyme acetylcholinesterase (AChE) which hydrolyzes acetylcholine.  Furthermore, it has been also demonstrated that both acetylcholinesterase and butrylcholinesterase (BuChE) play an important role in Aβ-aggregation during the early stages of senile plaque formation.  Therefore, AChE and BuChE inhibition have been documented as crit. targets for the effective management of AD by an increase in the availability of acetylcholine in the brain regions and decrease in the Aβ deposition.  This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogs developed for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe8p6U3r94ubVg90H21EOLACvtfcHk0li0PE1polcNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D&md5=a8b48dbf6a7e7b988759182ad8cd9b6a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs12272-013-0036-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-013-0036-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26atitle%3DA%2520review%2520on%2520cholinesterase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease.%2520Arch%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2013%26volume%3D36%26spage%3D375%26epage%3D399%26doi%3D10.1007%2Fs12272-013-0036-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossberg, G. T.</span><span> </span><span class="NLM_article-title">Use of memantine for the treatment of dementia</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.1586/ern.11.132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1586%2Fern.11.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=21955192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1359-1370&author=D.+Loauthor=G.+T.+Grossberg&title=Use+of+memantine+for+the+treatment+of+dementia&doi=10.1586%2Fern.11.132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Use of memantine for the treatment of dementia</span></div><div class="casAuthors">Lo, Daphne; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1359-1370</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The term dementia'' encompasses a no. of neurodegenerative diseases of which Alzheimer''s disease (AD) is the most common.  Prior to 2003, cholinesterase inhibitors, such as donezepil, were the only class of drugs approved to treat mild-to-moderate AD.  In 2003, memantine became the first drug approved by the US FDA to treat moderate-to-severe AD.  Currently, both memantine and donepezil are FDA approved for the treatment of moderate-to-severe AD.  This article examines the pharmacol. profile of memantine, evidence for memantine''s efficacy in moderate-to-severe AD and other dementias, its novel use in other neuropsychiatric disorders and future implications and research directions for memantine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGdBuGdnw3bVg90H21EOLACvtfcHk0li0PE1polcNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM&md5=1108b2e6b6328bbafa7394f43205e450</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1586%2Fern.11.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.11.132%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DD.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DUse%2520of%2520memantine%2520for%2520the%2520treatment%2520of%2520dementia%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2011%26volume%3D11%26spage%3D1359%26epage%3D1370%26doi%3D10.1586%2Fern.11.132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Scarpini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelterns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease; current status and new perspectives</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1016/S1474-4422(03)00502-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1474-4422%2803%2900502-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12941576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=539-547&author=E.+Scarpiniauthor=P.+Schelternsauthor=H.+Feldman&title=Treatment+of+Alzheimer%E2%80%99s+disease%3B+current+status+and+new+perspectives&doi=10.1016%2FS1474-4422%2803%2900502-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's disease: current status and new perspectives</span></div><div class="casAuthors">Scarpini, Elio; Scheltens, Philip; Feldman, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">539-547</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing.  Pharmacol. treatment of AD is based on the use of acetylcholinesterase inhibitors, which have beneficial effects on cognitive, functional, and behavioral symptoms of the disease, but their role in AD pathogenesis is unknown.  Other pharmacol. therapies are becoming available-including the recently approved drug memantine, an NMDA channel blocker indicated for advanced AD.  Here, we review clin. features of the available cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) including their pharmacol. properties, the evidence for switching from one agent to another, "head to head" studies, and the emerging evidence for the use of memantine in AD.  New therapeutic approaches-including those more closely targeted to the pathogenesis of the disease-will also be reviewed.  These potentially disease modifying treatments include amyloid-β-peptide vaccination, secretase inhibitors, cholesterol-lowering drugs, metal chelators, and anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcyZp4rgEiurVg90H21EOLACvtfcHk0li0PE1polcNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D&md5=f7d73fefb0cfce13bf8c93eebf60a4dd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2803%2900502-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252803%252900502-7%26sid%3Dliteratum%253Aachs%26aulast%3DScarpini%26aufirst%3DE.%26aulast%3DSchelterns%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DH.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253B%2520current%2520status%2520and%2520new%2520perspectives%26jtitle%3DLancet%2520Neurol.%26date%3D2003%26volume%3D2%26spage%3D539%26epage%3D547%26doi%3D10.1016%2FS1474-4422%2803%2900502-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span><span class="refDoi"> DOI: 10.1016/S0140-6736(06)69113-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0140-6736%2806%2969113-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=16876668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFymsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2806%2969113-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Blennow, Kaj; de Leon, Mony J.; Zetterberg, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">9533</span>),
    <span class="NLM_cas:pages">387-403</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most common cause of dementia.  Research advances have enabled detailed understanding of the mol. pathogenesis of the hallmarks of the disease-ie, plaques, composed of amyloid β (Aβ), and tangles, composed of hyperphosphorylated tau.  However, as our knowledge increases so does our appreciation for the pathogenic complexity of the disorder.  Alzheimer's disease is a very rare autosomal dominant disease with early onset, caused by mutations in the amyloid precursor protein and presenilin genes, both linked to Aβ metab.  By contrast with familial disease, sporadic Alzheimer's disease is very common with more than 15 million people affected worldwide.  The cause of the sporadic form of the disease is unknown, probably because the disease is heterogeneous, caused by aging in concert with a complex interaction of both genetic and environmental risk factors.  This seminar reviews the key aspects of the disease, including epidemiol., genetics, pathogenesis, diagnosis, and treatment, as well as recent developments and controversies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOIYvvzbyybVg90H21EOLACvtfcHk0ljMLZsGr5Jvyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFymsbY%253D&md5=f70c374fbe01be1953bd0eea290745bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2806%2969113-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252806%252969113-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403%26doi%3D10.1016%2FS0140-6736%2806%2969113-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Yankner, B. A.</span><span> </span><span class="NLM_article-title">Mechanisms of neuronal degeneration in Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80115-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0896-6273%2800%2980115-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=8630250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK28XjsVKgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=921-932&author=B.+A.+Yankner&title=Mechanisms+of+neuronal+degeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0896-6273%2800%2980115-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of neuronal degeneration in Alzheimer's disease</span></div><div class="casAuthors">Yankner, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">921-932</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with ∼200 refs. on recent advances in the mol. genetics and cell biol. of Alzheimer's disease and the potential pathogenic mechanisms that emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnQiMvbx7gXrVg90H21EOLACvtfcHk0ljMLZsGr5Jvyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsVKgs7o%253D&md5=2c5ec5c4a5b18550f6a0c2abff3fc0c0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980115-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980115-4%26sid%3Dliteratum%253Aachs%26aulast%3DYankner%26aufirst%3DB.%2BA.%26atitle%3DMechanisms%2520of%2520neuronal%2520degeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D921%26epage%3D932%26doi%3D10.1016%2FS0896-6273%2800%2980115-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kepp, K. P.</span><span> </span><span class="NLM_article-title">Bioinorganic chemistry of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5193</span><span class="NLM_x">–</span> <span class="NLM_lpage">5239</span><span class="refDoi"> DOI: 10.1021/cr300009x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300009x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVejtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=5193-5239&author=K.+P.+Kepp&title=Bioinorganic+chemistry+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcr300009x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioinorganic Chemistry of Alzheimer's Disease</span></div><div class="casAuthors">Kepp, Kasper P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5193-5239</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The role of genetic and environmental risk factors as exogenous metal exposure-mediated neuronal accumulation in brain of β-amyloid peptides in pathogenesis of Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrksapTjHoTvrVg90H21EOLACvtfcHk0ljMLZsGr5Jvyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVejtbnK&md5=e9eaffc178654ba1c0ecc0393ca2bc8d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcr300009x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300009x%26sid%3Dliteratum%253Aachs%26aulast%3DKepp%26aufirst%3DK.%2BP.%26atitle%3DBioinorganic%2520chemistry%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D5193%26epage%3D5239%26doi%3D10.1021%2Fcr300009x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korshavn, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Cholesterol and metal ions in Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6682</span><span class="refDoi"> DOI: 10.1039/C4CS00005F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1039%2FC4CS00005F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=24710074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6672-6682&author=H.+J.+Leeauthor=K.+J.+Korshavnauthor=A.+Kochiauthor=J.+S.+Derrickauthor=M.+H.+Lim&title=Cholesterol+and+metal+ions+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CS00005F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol and metal ions in Alzheimer's disease</span></div><div class="casAuthors">Lee, Hyuck Jin; Korshavn, Kyle J.; Kochi, Akiko; Derrick, Jeffrey S.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cholesterol and metal ions have been suggested to be assocd. with the onset and progression of Alzheimer's disease (AD).  Moreover, recent findings have demonstrated a potential interconnection between these two factors.  For example, (a) cholesterol has been shown to be misregulated in AD-afflicted brains, and the aberrant activity of proteins (particularly, apolipoprotein E (ApoE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase (HMGR)) has been linked to cholesterol-related AD exacerbation; (b) dyshomeostasis of metal ions assocd. with misfolded proteins (i.e., amyloid-β (Aβ) aggregates) found in the brains of AD patients is shown to promote oxidative stress leading to the malfunction of multiple proteins, including cytochrome c oxidase (CcO), and Cu/Zn superoxide dismutase (SOD1); (c) metal ion misregulation has also been obsd. to disrupt the activity of proteins (e.g., HMGR, low-d. lipoproteins (LDL)), required for cholesterol prodn. and regulation.  Herein, we briefly discuss the potential involvement of cholesterol and metal ions in AD neuropathogenesis in both individual and interrelated manners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIRcNDCbM9ELVg90H21EOLACvtfcHk0lhd8Z6ph3zyYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nL&md5=9ce6cc08f84ed8d07deb6fe5518b66c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC4CS00005F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00005F%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKorshavn%26aufirst%3DK.%2BJ.%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DCholesterol%2520and%2520metal%2520ions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6672%26epage%3D6682%26doi%3D10.1039%2FC4CS00005F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Savelieff, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeToma, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer’s disease</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2482</span><span class="refDoi"> DOI: 10.1021/ar500152x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar500152x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GlurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=2475-2482&author=M.+G.+Savelieffauthor=A.+S.+DeTomaauthor=J.+S.+Derrickauthor=M.+H.+Lim&title=The+ongoing+search+for+small+molecules+to+study+metal-associated+amyloid-%CE%B2+species+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Far500152x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer's Disease</span></div><div class="casAuthors">Savelieff, Masha G.; DeToma, Alaina S.; Derrick, Jeffrey S.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2475-2482</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of a cure for Alzheimer's disease (AD) has been impeded by an inability to pinpoint the root cause of this disorder.  Although numerous potential pathol. factors have been indicated, acting either individually or mutually, the mol. mechanisms leading to disease onset and progression have not been clear.  Amyloid-β (Aβ), generated from proteolytic processing of the amyloid precursor protein (APP), and its aggregated forms, particularly oligomers, are suggested as key pathol. features in AD-affected brains.  Historically, highly concd. metals are found colocalized within Aβ plaques.  Metal binding to Aβ (metal-Aβ) generates/stabilizes potentially toxic Aβ oligomers, and produces reactive oxygen species (ROS) in vitro (redox active metal ions; plausible contribution to oxidative stress).  Consequently, clarification of the relationship between Aβ, metal ions, and toxicity, including oxidative stress via metal-Aβ, can lead to a deeper understanding of AD development.  To probe the involvement of metal-Aβ in AD pathogenesis, rationally designed and naturally occurring mols. have been examd. as chem. tools to target metal-Aβ species, modulate the interaction between the metal and Aβ, and subsequently redirect their aggregation into nontoxic, off-pathway unstructured aggregates.  These ligands are also capable of attenuating the generation of redox active metal-Aβ-induced ROS to mitigate oxidative stress.  One rational design concept, the incorporation approach, installs a metal binding site into a framework known to interact with Aβ.  This approach affords compds. with the simultaneous ability to chelate metal ions and interact with Aβ.  Natural products capable of Aβ interaction have been investigated for their influence on metal-induced Aβ aggregation and have inspired the construction of synthetic analogs.  Systematic studies of these synthetic or natural mols. could uncover relationships between chem. structures, metal/Aβ/metal-Aβ interactions, and inhibition of Aβ/metal-Aβ reactivity (i.e., aggregation modes of Aβ/metal-Aβ; assocd. ROS prodn.), suggesting mechanisms to refine the design strategy.  Interdisciplinary investigations have demonstrated that the designed mols. and natural products control the aggregation pathways of metal-Aβ species transforming their size/conformation distribution.  The aptitude of these mols. to impact metal-Aβ aggregation pathways, either via inhibition of Aβ aggregate formation, most importantly of oligomers, or disaggregation of preformed fibrils, could originate from their formation of complexes with metal-Aβ.  Potentially, these mols. could direct metal-Aβ size/conformational states into alternative nontoxic unstructured oligomers, and control the geometry at the Aβ-ligated metal center for limited ROS formation to lessen the overall toxicity induced by metal-Aβ.  Complexation between small mols. and Aβ/metal-Aβ has been obsd. by NMR spectroscopy (NMR) and ion mobility-mass spectrometry (IM-MS) pointing to mol. level interactions, validating the design strategy.  In addn., these mols. exhibit other attractive properties, such as antioxidant capacity, prevention of ROS prodn., potential blood-brain barrier (BBB) permeability, and redn. of Aβ-/metal-Aβ-induced cytotoxicity, making them desirable tools for unraveling AD complexity.  In this Account, we summarize the recent development of small mols., via both rational design and the selection and modification of natural products, as tools for investigating metal-Aβ complexes, to advance our understanding of their relation to AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonOeVndqFambVg90H21EOLACvtfcHk0lhd8Z6ph3zyYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GlurvF&md5=26cb7b5ff0499e657046f99776f48010</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Far500152x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far500152x%26sid%3Dliteratum%253Aachs%26aulast%3DSavelieff%26aufirst%3DM.%2BG.%26aulast%3DDeToma%26aufirst%3DA.%2BS.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DThe%2520ongoing%2520search%2520for%2520small%2520molecules%2520to%2520study%2520metal-associated%2520amyloid-%25CE%25B2%2520species%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2014%26volume%3D47%26spage%3D2475%26epage%3D2482%26doi%3D10.1021%2Far500152x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Duce, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Biological metals and Alzheimer’s disease: Implications for therapeutics and diagnostics</span> <span class="citation_source-journal">Prog. Neurobiol. (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.pneurobio.2010.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=20444428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1-18&author=J.+A.+Duceauthor=A.+I.+Bush&title=Biological+metals+and+Alzheimer%E2%80%99s+disease%3A+Implications+for+therapeutics+and+diagnostics&doi=10.1016%2Fj.pneurobio.2010.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics</span></div><div class="casAuthors">Duce, James A.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The equil. of metal ions is crit. for many physiol. functions, particularly in the central nervous system, where metals are essential for development and maintenance of enzymic activities, mitochondrial function, myelination, neurotransmission as well as learning and memory.  Due to their importance, cells have evolved complex machinery for controlling metal-ion homeostasis.  However, disruption of these mechanisms, or absorption of detrimental metals with no known biol. function, alter the ionic balance and can result in a disease state, including several neurodegenerative disorders such as Alzheimer's disease.  Understanding the complex structural and functional interactions of metal ions with the various intracellular and extracellular components of the central nervous system, under normal conditions and during neurodegeneration, is essential for the development of effective therapies.  Accordingly, assisting the balance of metal ions back to homeostatic levels has been proposed as a disease-modifying therapeutic strategy for Alzheimer's disease as well as other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHRXNaNohExLVg90H21EOLACvtfcHk0lj4ZoY_YTyPHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D&md5=2aa9da17774b3da9f6118f0ce3f122ae</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DBiological%2520metals%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Implications%2520for%2520therapeutics%2520and%2520diagnostics%26jtitle%3DProg.%2520Neurobiol.%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2010%26volume%3D92%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.pneurobio.2010.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Metallostasis in Alzheimer’s disease</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2012.10.558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.freeradbiomed.2012.10.558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=23142767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslymtrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=76-89&author=S.+Aytonauthor=P.+Leiauthor=A.+I.+Bush&title=Metallostasis+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.freeradbiomed.2012.10.558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Metallostasis in Alzheimer's disease</span></div><div class="casAuthors">Ayton, Scott; Lei, Peng; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-89</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  2012 Has been another year in which multiple large-scale clin. trials for Alzheimer's disease (AD) have failed to meet their clin. endpoints.  With the social and financial burden of this disease increasing every year, the onus is now on the field of AD researchers to investigate alternative ideas to deliver outcomes for patients.  Although several major clin. trials targeting Aβ have failed, three smaller clin. trials targeting metal interactions with Aβ have all shown benefit for patients.  Here we review the genetic, pathol., biochem., and pharmacol. evidence that underlies the metal hypothesis of AD.  The AD-affected brain suffers from metallostasis, or fatigue of metal trafficking, resulting in redistribution of metals into inappropriate compartments.  The metal hypothesis is built upon a triad of transition elements: iron, copper, and zinc.  The hypothesis has matured from early investigations showing amyloidogenic and oxidative stress consequences of these metals; recently, disease-related proteins, APP, tau, and presenilin, have been shown to have major roles in metal regulation, which provides insight into the pathway of neurodegeneration in AD and illuminates potential new therapeutic avenues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokaWTzAem-GbVg90H21EOLACvtfcHk0lj4ZoY_YTyPHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslymtrnN&md5=4228fa48389e53a4b44c85786c0d2aa3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.10.558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.10.558%26sid%3Dliteratum%253Aachs%26aulast%3DAyton%26aufirst%3DS.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DMetallostasis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2013%26volume%3D62%26spage%3D76%26epage%3D89%26doi%3D10.1016%2Fj.freeradbiomed.2012.10.558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Praticò, D.</span><span> </span><span class="NLM_article-title">Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1016/j.tips.2008.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.tips.2008.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=609-615&author=D.+Pratic%C3%B2&title=Oxidative+stress+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+a+reappraisal&doi=10.1016%2Fj.tips.2008.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DPratic%25C3%25B2%26aufirst%3DD.%26atitle%3DOxidative%2520stress%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520reappraisal%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D609%26epage%3D615%26doi%3D10.1016%2Fj.tips.2008.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lee, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadesus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunomura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span> </span><span class="NLM_article-title">Antioxidant approaches for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span><span class="refDoi"> DOI: 10.1586/ern.10.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1586%2Fern.10.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=20586698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BC3cnjsFKgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1201-1208&author=H.+P.+Leeauthor=X.+Zhuauthor=G.+Casadesusauthor=R.+J.+Castellaniauthor=A.+Nunomuraauthor=M.+A.+Smithauthor=H.+G.+Leeauthor=G.+Perry&title=Antioxidant+approaches+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1586%2Fern.10.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant approaches for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Lee Hyun Pil; Zhu Xiongwei; Casadesus Gemma; Castellani Rudy J; Nunomura Akihiko; Smith Mark A; Lee Hyoung-gon; Perry George</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of neurotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1201-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxidative stress is an important factor, and one that acts in the earliest stages, of Alzheimer's disease (AD) pathogenesis.  The reduction of oxidative stress has been tested as a therapy for AD.  While the trial of vitamin E supplementation in moderately severe AD is the most promising so far, it also reveals the limitations of general antioxidant therapies that simply lower oxidative stress and, therefore, the complexity of the redox system.  The multiple contributing factors that foster the clinical manifestations of AD should be considered when designing antioxidative stress therapy.  In this article, we discuss the multiple pathogenic mechanisms of oxidative stress in AD and the potential targeting approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs7JD-wMaBKZw7prLlxLOzfW6udTcc2eYXJT7RIpnfrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnjsFKgsw%253D%253D&md5=3b10b89e2f26322dc333aba247c66b4d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1586%2Fern.10.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.10.74%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCasadesus%26aufirst%3DG.%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DNunomura%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DH.%2BG.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DAntioxidant%2520approaches%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2010%26volume%3D10%26spage%3D1201%26epage%3D1208%26doi%3D10.1586%2Fern.10.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">Novel tacrine–8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span><span class="refDoi"> DOI: 10.1021/jm100329q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100329q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4927-4937&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=S.+Condeauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Novel+tacrine%E2%80%938-hydroxyquinoline+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+neuroprotective%2C+cholinergic%2C+antioxidant%2C+and+copper-complexing+properties&doi=10.1021%2Fjm100329q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100329q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100329q%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNovel%2520tacrine%25E2%2580%25938-hydroxyquinoline%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520neuroprotective%252C%2520cholinergic%252C%2520antioxidant%252C%2520and%2520copper-complexing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4927%26epage%3D4937%26doi%3D10.1021%2Fjm100329q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckroat, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhoub, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span> </span><span class="NLM_article-title">A novel hybrid of 6-chlorotacrine and metal-amyloid-β modulator for inhibition of acetylcholinesterase and metal-induced amyloid-β aggregation</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">4137</span><span class="NLM_x">–</span> <span class="NLM_lpage">4145</span><span class="refDoi"> DOI: 10.1039/c3sc51902c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1039%2Fc3sc51902c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFegsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=4137-4145&author=A.+Kochiauthor=T.+J.+Eckroatauthor=K.+D.+Greenauthor=A.+S.+Mayhoubauthor=M.+H.+Limauthor=S.+Garneau-Tsodikova&title=A+novel+hybrid+of+6-chlorotacrine+and+metal-amyloid-%CE%B2+modulator+for+inhibition+of+acetylcholinesterase+and+metal-induced+amyloid-%CE%B2+aggregation&doi=10.1039%2Fc3sc51902c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A novel hybrid of 6-chlorotacrine and metal-amyloid-β modulator for inhibition of acetylcholinesterase and metal-induced amyloid-β aggregation</span></div><div class="casAuthors">Kochi, Akiko; Eckroat, Todd J.; Green, Keith D.; Mayhoub, Abdelrahman S.; Lim, Mi Hee; Garneau-Tsodikova, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4137-4145</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The no. of people suffering from Alzheimer's disease (AD) is expected to increase dramatically in the coming decades.  Currently, acetylcholinesterase inhibitors (AChEis) provide some relief of cognitive symptoms, while newer approaches, such as amyloid-β (Aβ)-targeted metal chelation, offer potential hope for slowing and/or reversing disease progression.  This work details the synthesis and biochem. evaluation of a novel hybrid of 6-chlorotacrine and a metal-Aβ modulator that chem. combines an AChEi and an Aβ-targeted metal chelator into a single mol.  This hybrid shows potent inhibition of AChE under various conditions, interaction with Cu2+ and Zn2+, control of metal-free and metal-induced Aβ aggregate assembly, and disaggregation of preformed metal-free and metal-assocd. Aβ aggregates.  As such, the hybrid described herein represents a promising, new multifunctional compd. for AD studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5evGjzbS4a7Vg90H21EOLACvtfcHk0ljjlzJz_s5mzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFegsr3O&md5=679a47d182cc7fc9c4d24e95e7bc7e6b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fc3sc51902c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc51902c%26sid%3Dliteratum%253Aachs%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DEckroat%26aufirst%3DT.%2BJ.%26aulast%3DGreen%26aufirst%3DK.%2BD.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DA%2520novel%2520hybrid%2520of%25206-chlorotacrine%2520and%2520metal-amyloid-%25CE%25B2%2520modulator%2520for%2520inhibition%2520of%2520acetylcholinesterase%2520and%2520metal-induced%2520amyloid-%25CE%25B2%2520aggregation%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D4137%26epage%3D4145%26doi%3D10.1039%2Fc3sc51902c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wu, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shionoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inokuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.ejmech.2015.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=26471320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=864-879&author=M.-Y.+Wuauthor=G.+Estebanauthor=S.+Brogiauthor=M.+Shionoyaauthor=L.+Wangauthor=G.+Campianiauthor=M.+Unzetaauthor=T.+Inokuchiauthor=S.+Butiniauthor=J.+Marco-Contelles&title=Donepezil-like+multifunctional+agents%3A+Design%2C+synthesis%2C+molecular+modeling+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2015.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation</span></div><div class="casAuthors">Wu, Ming-Yu; Esteban, Gerard; Brogi, Simone; Shionoya, Masahi; Wang, Li; Campiani, Giuseppe; Unzeta, Mercedes; Inokuchi, Tsutomu; Butini, Stefania; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">864-879</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Currently available drugs against Alzheimer's disease (AD) are only able to ameliorate the disease symptoms resulting in a moderate improvement in memory and cognitive function without any efficacy in preventing and inhibiting the progression of the pathol.  In an effort to obtain disease-modifying anti-Alzheimer's drugs (DMAADs) following the multifactorial nature of AD, we have recently developed multifunctional compds.  We herein describe the design, synthesis, mol. modeling and biol. evaluation of a new series of donepezil-related compds. possessing metal chelating properties, and being capable of targeting different enzymic systems related to AD (cholinesterases, ChEs, and monoamine oxidase A, MAO-A).  Among this set of analogs compd. I showed excellent ChEs inhibition potency and a selective MAO-A inhibition (vs MAO-B) coupled to strong complexing properties for zinc and copper ions, both known to be involved in the progression of AD.  Moreover, I exhibited moderate antioxidant properties as found by in vitro assessment.  This compd. represents a novel donepezil-hydroxyquinoline hybrid with DMAAD profile paving the way to the development of a novel class of drugs potentially able to treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCOvmO6AroXrVg90H21EOLACvtfcHk0lhLgTSSeFoXFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GktL%252FM&md5=7bf3ba2586578a39287a0aacbbe3f672</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.-Y.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DShionoya%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DInokuchi%26aufirst%3DT.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDonepezil-like%2520multifunctional%2520agents%253A%2520Design%252C%2520synthesis%252C%2520molecular%2520modeling%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D864%26epage%3D879%26doi%3D10.1016%2Fj.ejmech.2015.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Li, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.ejmech.2013.09.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=632-646&author=S.-Y.+Liauthor=X.-B.+Wangauthor=S.-S.+Xieauthor=N.+Jiangauthor=K.+D.+G.+Wangauthor=H.-Q.+Yaoauthor=H.-B.+Sunauthor=L.-Y.+Kong&title=Multifunctional+tacrine-flavonoid+hybrids+with+cholinergic%2C+%CE%B2-amyloid-reducing%2C+and+metal+chelating+properties+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.09.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.-Y.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DYao%26aufirst%3DH.-Q.%26aulast%3DSun%26aufirst%3DH.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMultifunctional%2520tacrine-flavonoid%2520hybrids%2520with%2520cholinergic%252C%2520%25CE%25B2-amyloid-reducing%252C%2520and%2520metal%2520chelating%2520properties%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D632%26epage%3D646%26doi%3D10.1016%2Fj.ejmech.2013.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1007/s00702-012-0948-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1007%2Fs00702-012-0948-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=23238976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosl2qurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2013&pages=893-902&author=I.+Boleaauthor=A.+Gellaauthor=M.+Unzeta&title=Propargylamine-derived+multitarget-directed+ligands%3A+fighting+Alzheimer%E2%80%99s+disease+with+monoamine+oxidase+inhibitors&doi=10.1007%2Fs00702-012-0948-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors</span></div><div class="casAuthors">Bolea, Irene; Gella, Alejandro; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">893-902</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a complex neurodegenerative disorder with a multifaceted pathogenesis.  There are at present three Food and Drug Administration-approved drugs based on the "one drug, one target" paradigm (donepezil, galantamine and rivastigmine) that improve symptoms by inhibiting acetylcholinesterase.  However, apart from the beneficial palliative properties, cholinergic drugs have shown little efficacy to prevent the progression of the disease evidencing the unsuitability of this strategy for the complex nature of AD.  By contrast, the multifactorial nature of this neurodegenerative disorder supports the most current innovative therapeutic approach based on the "one drug, multiple targets" paradigm, which suggests the use of compds. with multiple activities at different target sites.  Accordingly, the also called multitarget-directed ligand (MTDL) approach has been the subject of increasing attention by many research groups, which have developed a variety of hybrid compds. acting on very diverse targets.  The therapeutic potential of monoamine oxidase inhibitors (MAOI) in AD has been suggested due to their demonstrated neuroprotective properties besides their enhancing effect on monoaminergic transmission.  Esp., those contg. a propargylamine moiety are of particular interest due to their reported beneficial actions.  Therefore, targeting MAO enzymes should be considered in therapeutic interventions.  This review makes a special emphasis on MTDLs that commonly target MAO enzymes.  There is at present an urgent need for real disease-modifying therapies for AD and the MTDL approach makes a breakthrough for the development of new drugs capable of addressing the biol. complexity of this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8SaG-kY0_7Vg90H21EOLACvtfcHk0ljr13pJ1trlBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosl2qurY%253D&md5=bf146b3d399378b7defd06c8d1bb1058</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00702-012-0948-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-012-0948-y%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DPropargylamine-derived%2520multitarget-directed%2520ligands%253A%2520fighting%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2013%26volume%3D120%26spage%3D893%26epage%3D902%26doi%3D10.1007%2Fs00702-012-0948-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, J. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasefi, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beazely, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P. N.</span><span> </span><span class="NLM_article-title">Development and evaluation of multifunctional agents for potential treatment of Alzheimer’s disease: Application to a pyrimidine-2,4-diamine template</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4707</span><span class="NLM_x">–</span> <span class="NLM_lpage">4712</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmcl.2012.05.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=22704921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslSlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4707-4712&author=T.+Mohamedauthor=J.+C.+K.+Yeungauthor=M.+S.+Vasefiauthor=M.+A.+Beazelyauthor=P.+P.+N.+Rao&title=Development+and+evaluation+of+multifunctional+agents+for+potential+treatment+of+Alzheimer%E2%80%99s+disease%3A+Application+to+a+pyrimidine-2%2C4-diamine+template&doi=10.1016%2Fj.bmcl.2012.05.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: Application to a pyrimidine-2,4-diamine template</span></div><div class="casAuthors">Mohamed, Tarek; Yeung, Jacky C. K.; Vasefi, Maryam S.; Beazely, Michael A.; Rao, Praveen P. N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4707-4712</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated a group of 2-benzylpiperidin-N-benzylpyrimidin-4-amines with various electron-withdrawing or electron-donating groups (EWGs or EDGs, resp.) as multi-targeted Alzheimer's disease (AD) therapeutics.  The synthesized derivs. were screened for anti-cholinesterase (AChE and BuChE), anti-Aβ-aggregation (AChE- and self-induced) and anti-β-secretase (BACE-1) activities in an effort to identify lead, multifunctional candidates as part of our multi-targeted approach to treat AD.  Biol. assessment revealed that the nature of the substituent on the C-4 benzylamine group (e.g., halogen vs methoxy-based) greatly affected the biol. profile.  In vitro screening identified N2-(1-benzylpiperidin-4-yl)-N4-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamine (7h) as the lead candidate with a dual ChE (AChE IC50 = 9.9 μM; BuChE IC50 = 11.4 μM), Aβ-aggregation (AChE-induced = 59.3%; self-induced = 17.4% at 100 μM) and BACE-1 (34% inhibition at 10 μM) inhibitory profile along with good cell viability (% neuroblastoma cell viability at 40 μM = 81.0%).  Mol. modeling studies indicate that a central pyrimidine-2,4-diamine ring serves as a suitable template to develop novel small mol. candidates to target multiple pathol. routes in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFR2oGdjFsjbVg90H21EOLACvtfcHk0ljr13pJ1trlBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslSlurw%253D&md5=0aa3c060e101470c2951d260427b218c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.077%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DYeung%26aufirst%3DJ.%2BC.%2BK.%26aulast%3DVasefi%26aufirst%3DM.%2BS.%26aulast%3DBeazely%26aufirst%3DM.%2BA.%26aulast%3DRao%26aufirst%3DP.%2BP.%2BN.%26atitle%3DDevelopment%2520and%2520evaluation%2520of%2520multifunctional%2520agents%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Application%2520to%2520a%2520pyrimidine-2%252C4-diamine%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4707%26epage%3D4712%26doi%3D10.1016%2Fj.bmcl.2012.05.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P. N.</span><span> </span><span class="NLM_article-title">Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: Dual activity as cholinesterase and Aβ-aggregation inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2281</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmc.2011.02.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2269-2281&author=T.+Mohamedauthor=X.+Zhaoauthor=L.+K.+Habibauthor=J.+Yangauthor=P.+P.+N.+Rao&title=Design%2C+synthesis+and+structure-activity+relationship+%28SAR%29+studies+of+2%2C4-disubstituted+pyrimidine+derivatives%3A+Dual+activity+as+cholinesterase+and+A%CE%B2-aggregation+inhibitors&doi=10.1016%2Fj.bmc.2011.02.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHabib%26aufirst%3DL.%2BK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DP.%2BP.%2BN.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%25202%252C4-disubstituted%2520pyrimidine%2520derivatives%253A%2520Dual%2520activity%2520as%2520cholinesterase%2520and%2520A%25CE%25B2-aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2269%26epage%3D2281%26doi%3D10.1016%2Fj.bmc.2011.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, J. C.K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P.N.</span><span> </span><span class="NLM_article-title">Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5881</span><span class="NLM_x">–</span> <span class="NLM_lpage">5887</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.07.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmcl.2011.07.091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5881-5887&author=T.+Mohamedauthor=J.+C.K.+Yeungauthor=P.+P.N.+Rao&title=Development+of+2-substituted-N-%28naphth-1-ylmethyl%29+and+N-benzhydrylpyrimidin-4-amines+as+dual+cholinesterase+and+A%CE%B2-aggregation+inhibitors%3A+Synthesis+and+biological+evaluation&doi=10.1016%2Fj.bmcl.2011.07.091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.091%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DYeung%26aufirst%3DJ.%2BC.K.%26aulast%3DRao%26aufirst%3DP.%2BP.N.%26atitle%3DDevelopment%2520of%25202-substituted-N-%2528naphth-1-ylmethyl%2529%2520and%2520N-benzhydrylpyrimidin-4-amines%2520as%2520dual%2520cholinesterase%2520and%2520A%25CE%25B2-aggregation%2520inhibitors%253A%2520Synthesis%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5881%26epage%3D5887%26doi%3D10.1016%2Fj.bmcl.2011.07.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Mohamed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. P.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3606</span><span class="NLM_x">–</span> <span class="NLM_lpage">3609</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.bmcl.2010.04.108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3606-3609&author=T.+Mohamedauthor=P.+P.+Rao&title=Design%2C+synthesis+and+evaluation+of+2%2C4-disubstituted+pyrimidines+as+cholinesterase+inhibitors&doi=10.1016%2Fj.bmcl.2010.04.108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.108%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DP.%2BP.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%25202%252C4-disubstituted%2520pyrimidines%2520as%2520cholinesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3606%26epage%3D3609%26doi%3D10.1016%2Fj.bmcl.2010.04.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Orysyk, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekhnyo, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zborovskii, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orysyk, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vovk, M. V.</span><span> </span><span class="NLM_article-title">Synthesis, structure and spectral characteristics of Ni(II), Pd(II) and Zn(II) complexes with N-(2-pyridinyl)morpholine-4-carbothioamide</span> <span class="citation_source-journal">Polyhedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.poly.2012.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.poly.2012.02.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=15-25&author=S.+I.+Orysykauthor=V.+V.+Bonauthor=V.+I.+Pekhnyoauthor=Y.+L.+Zborovskiiauthor=V.+V.+Orysykauthor=M.+V.+Vovk&title=Synthesis%2C+structure+and+spectral+characteristics+of+Ni%28II%29%2C+Pd%28II%29+and+Zn%28II%29+complexes+with+N-%282-pyridinyl%29morpholine-4-carbothioamide&doi=10.1016%2Fj.poly.2012.02.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2012.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2012.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DOrysyk%26aufirst%3DS.%2BI.%26aulast%3DBon%26aufirst%3DV.%2BV.%26aulast%3DPekhnyo%26aufirst%3DV.%2BI.%26aulast%3DZborovskii%26aufirst%3DY.%2BL.%26aulast%3DOrysyk%26aufirst%3DV.%2BV.%26aulast%3DVovk%26aufirst%3DM.%2BV.%26atitle%3DSynthesis%252C%2520structure%2520and%2520spectral%2520characteristics%2520of%2520Ni%2528II%2529%252C%2520Pd%2528II%2529%2520and%2520Zn%2528II%2529%2520complexes%2520with%2520N-%25282-pyridinyl%2529morpholine-4-carbothioamide%26jtitle%3DPolyhedron%26date%3D2012%26volume%3D38%26spage%3D15%26epage%3D25%26doi%3D10.1016%2Fj.poly.2012.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Krivenko, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibgatullin, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezova, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galkin, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukmeneva, N. A.</span><span> </span><span class="NLM_article-title">Correlation between the structure of thioureas and their reactivity toward hydroperoxides and peroxy radicals</span> <span class="citation_source-journal">Russ. J. Gen. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span><span class="refDoi"> DOI: 10.1023/B:RUGC.0000007616.03223.3a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1023%2FB%3ARUGC.0000007616.03223.3a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Khtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=1086-1090&author=L.+V.+Krivenkoauthor=I.+M.+Sibgatullinauthor=E.+N.+Cherezovaauthor=V.+I.+Galkinauthor=N.+A.+Mukmeneva&title=Correlation+between+the+structure+of+thioureas+and+their+reactivity+toward+hydroperoxides+and+peroxy+radicals&doi=10.1023%2FB%3ARUGC.0000007616.03223.3a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between the structure of thioureas and their reactivity toward hydroperoxides and peroxy radicals</span></div><div class="casAuthors">Krivenko, L. V.; Sibgatullin, I. M.; Cherezova, E. N.; Galkin, V. I.; Mukmeneva, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Journal of General Chemistry (Translation of Zhurnal Obshchei Khimii)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1086-1090</span>CODEN:
                <span class="NLM_cas:coden">RJGCEK</span>;
        ISSN:<span class="NLM_cas:issn">1070-3632</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">The behavior of thiourea derivs. in reactions simulating oxidative processes in carbon-chain polymers was studied.  Based on the kinetic data obtained (reaction rate consts.), correlations were revealed between the structures of thioureas and their reactivity in inhibition of oxidn. of org. substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_kWvaQZulm7Vg90H21EOLACvtfcHk0lhw9Wb73SkCmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Khtbs%253D&md5=b547053a0259e61f9a1e19dabae46ae8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FB%3ARUGC.0000007616.03223.3a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ARUGC.0000007616.03223.3a%26sid%3Dliteratum%253Aachs%26aulast%3DKrivenko%26aufirst%3DL.%2BV.%26aulast%3DSibgatullin%26aufirst%3DI.%2BM.%26aulast%3DCherezova%26aufirst%3DE.%2BN.%26aulast%3DGalkin%26aufirst%3DV.%2BI.%26aulast%3DMukmeneva%26aufirst%3DN.%2BA.%26atitle%3DCorrelation%2520between%2520the%2520structure%2520of%2520thioureas%2520and%2520their%2520reactivity%2520toward%2520hydroperoxides%2520and%2520peroxy%2520radicals%26jtitle%3DRuss.%2520J.%2520Gen.%2520Chem.%26date%3D2003%26volume%3D73%26spage%3D1086%26epage%3D1090%26doi%3D10.1023%2FB%3ARUGC.0000007616.03223.3a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Zhu, B.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antholine, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, B.</span><span> </span><span class="NLM_article-title">Thiourea protects against copper-induced oxidative damage by formation of a redox-inactive thiourea-copper complex</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.1016/S0891-5849(02)00847-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0891-5849%2802%2900847-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12057771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFyhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=1333-1338&author=B.-Z.+Zhuauthor=W.+E.+Antholineauthor=B.+Frei&title=Thiourea+protects+against+copper-induced+oxidative+damage+by+formation+of+a+redox-inactive+thiourea-copper+complex&doi=10.1016%2FS0891-5849%2802%2900847-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Thiourea protects against copper-induced oxidative damage by formation of a redox-inactive thiourea-copper complex</span></div><div class="casAuthors">Zhu, Ben-Zhan; Antholine, William E.; Frei, Balz</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1333-1338</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Although thiourea has been used widely to study the role of hydroxyl radicals in metal-mediated biol. damage, it is not a specific hydroxyl radical scavenger and may also exert antioxidant effects unrelated to hydroxyl radical scavenging.  Thus, the authors investigated the effects of thiourea on copper-induced oxidative damage to bovine serum albumin (1 mg/mL) in three different copper-contg. systems: Cu(II)/ascorbate, Cu(II)/H2O2, and Cu(II)/H2O2/ascorbate [Cu(II), 0.1 mM; ascorbate, 1 mM; H2O2, 1 mM].  Oxidative damage to albumin was measured as protein carbonyl formation.  Thiourea (0.1-10 mM) provided marked and dose-dependent protection against protein oxidn. in all three copper-contg. systems.  In contrast, only minor protection was obsd. with DMSO and mannitol, even at concns. as high as 100 mM.  Strong protection was also obsd. with dimethylthiourea, but not with urea or dimethylurea.  Thiourea also significantly inhibited copper-catalyzed oxidn. of ascorbate, and competed effectively with histidine and 1,10-phenanthroline for binding of cuprous, but not cupric, copper, as demonstrated by both UV-visible and low temp. ESR measurements.  The authors conclude that the protection by thiourea against copper-mediated protein oxidn. is not through scavenging of hydroxyl radicals, but rather through the chelation of cuprous copper and the formation of a redox-inactive thiourea-copper complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQVOEq2QRz27Vg90H21EOLACvtfcHk0lh0ddSVFjCYrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFyhsbk%253D&md5=68f86f822f4fe392fe1ed3fa44b56734</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2900847-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252900847-X%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.-Z.%26aulast%3DAntholine%26aufirst%3DW.%2BE.%26aulast%3DFrei%26aufirst%3DB.%26atitle%3DThiourea%2520protects%2520against%2520copper-induced%2520oxidative%2520damage%2520by%2520formation%2520of%2520a%2520redox-inactive%2520thiourea-copper%2520complex%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D32%26spage%3D1333%26epage%3D1338%26doi%3D10.1016%2FS0891-5849%2802%2900847-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Abbott, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isbell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momany, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlotta, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisleder, D.</span><span> </span><span class="NLM_article-title">1,3-di(3-Methoxybenzyl) thiourea and related lipid antioxidants</span> <span class="citation_source-journal">Ind. Crops Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/S0926-6690(02)00006-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0926-6690%2802%2900006-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Crsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=43-57&author=T.+P.+Abbottauthor=A.+Wohlmanauthor=T.+Isbellauthor=F.+A.+Momanyauthor=C.+Cantrellauthor=D.+V.+Garlottaauthor=D.+Weisleder&title=1%2C3-di%283-Methoxybenzyl%29+thiourea+and+related+lipid+antioxidants&doi=10.1016%2FS0926-6690%2802%2900006-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Di(3-Methoxybenzyl) thiourea and related lipid antioxidants</span></div><div class="casAuthors">Abbott, Thomas P.; Wohlman, Alan; Isbell, Terry; Momany, Frank A.; Cantrell, Charles; Garlotta, Donald V.; Weisleder, David</div><div class="citationInfo"><span class="NLM_cas:title">Industrial Crops and Products</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-57</span>CODEN:
                <span class="NLM_cas:coden">ICRDEW</span>;
        ISSN:<span class="NLM_cas:issn">0926-6690</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Natural lipids and oils are subject to oxidative degrdn. affecting color, odor, viscosity, and lubricity, which lowers the quality of the com. products contg. these lipids.  In the food, cosmetics and pharmaceutical industries, maintaining high quality color and odor of oils and other lipids is important.  Meadowfoam (Limnanthes alba) seed oil is more oxidatively stable than other vegetable oils and imparts this oxidative stability to other oils when mixed in combinations.  This study was conducted to identify antioxidants in meadowfoam oil and to det. their properties.  Structurally-related compds. were synthesized to compare to the antioxidant compd. in meadowfoam.  Compds. isolated from meadowfoam oil (L. alba), were concluded to be either a source of 1,3-di(3-methoxybenzyl) thiourea (3MBTU) or oxidn. products from it. 3-Methoxybenzyl isothiocyanate (3MBITC) and 3-methoxybenzyl amine (3MBAm), which were identified in the oil as degrdn. products of the glucosinolate glucolimnanthin, reacted readily to form 3MBTU in meadowfoam oil, water and ethanol. 1,3-di(3-methoxybenzyl) urea, the oxygenated form of 3MBTU, was isolated from crude meadowfoam oil. 3MBTU and other disubstituted thioureas contg. at least one 3-methoxybenzyl substituent were made from isothiocyanates and amines and the lipid soly., antioxidant properties, toxicity (LC50), stability and spectral absorbance properties were detd. 3MBTU was an effective antioxidant in two different oxidative stability tests for mono- and polyunsatd. oils at the 0.1% level.  It was also a stronger UVB absorber than most of the other disubstituted thioureas tested.  Mol. models and calcns. explained some of these results.  The toxicity of 3MBTU was also very low compared with other thioureas and some commonly used lipid antioxidants.  Soly. in meadowfoam oil was highest for 3MBTU, among those tested at 50°. In conclusion, 3MBTU, from meadowfoam oil, meadowfoam byproducts, or synthesized appears to meet many of the criteria for an effective lipid antioxidant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNf8rpSpcN37Vg90H21EOLACvtfcHk0lh0ddSVFjCYrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Crsbs%253D&md5=fbff5215f8783805c25736319ff8561d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0926-6690%2802%2900006-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0926-6690%252802%252900006-7%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DT.%2BP.%26aulast%3DWohlman%26aufirst%3DA.%26aulast%3DIsbell%26aufirst%3DT.%26aulast%3DMomany%26aufirst%3DF.%2BA.%26aulast%3DCantrell%26aufirst%3DC.%26aulast%3DGarlotta%26aufirst%3DD.%2BV.%26aulast%3DWeisleder%26aufirst%3DD.%26atitle%3D1%252C3-di%25283-Methoxybenzyl%2529%2520thiourea%2520and%2520related%2520lipid%2520antioxidants%26jtitle%3DInd.%2520Crops%2520Prod.%26date%3D2002%26volume%3D16%26spage%3D43%26epage%3D57%26doi%3D10.1016%2FS0926-6690%2802%2900006-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lh0ddSVFjCYrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Davalos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Cordoves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, B.</span><span> </span><span class="NLM_article-title">Extending applicability of the oxygen radical absorbance capacity (ORAC-Fluorescein) assay</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1021/jf0305231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&author=A.+Davalosauthor=C.+Gomez-Cordovesauthor=B.+Bartolome&title=Extending+applicability+of+the+oxygen+radical+absorbance+capacity+%28ORAC-Fluorescein%29+assay&doi=10.1021%2Fjf0305231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DGomez-Cordoves%26aufirst%3DC.%26aulast%3DBartolome%26aufirst%3DB.%26atitle%3DExtending%2520applicability%2520of%2520the%2520oxygen%2520radical%2520absorbance%2520capacity%2520%2528ORAC-Fluorescein%2529%2520assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26spage%3D48%26epage%3D54%26doi%3D10.1021%2Fjf0305231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Ou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampsch-Woodill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, R. L.</span><span> </span><span class="NLM_article-title">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4619</span><span class="NLM_x">–</span> <span class="NLM_lpage">4626</span><span class="refDoi"> DOI: 10.1021/jf010586o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+validation+of+an+improved+oxygen+radical+absorbance+capacity+assay+using+fluorescein+as+the+fluorescent+probe&doi=10.1021%2Fjf010586o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0liAMZiUSB0Ejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520an%2520improved%2520oxygen%2520radical%2520absorbance%2520capacity%2520assay%2520using%2520fluorescein%2520as%2520the%2520fluorescent%2520probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26spage%3D4619%26epage%3D4626%26doi%3D10.1021%2Fjf010586o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hatip, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suenaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, Y.</span><span> </span><span class="NLM_article-title">Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Aβ40, by the β-sheet breaker peptides 16–23 and 17–24</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00384.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1111%2Fj.1476-5381.2009.00384.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=19785651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1165-1172&author=F.+F.+Hatipauthor=M.+Suenagaauthor=T.+Yamadaauthor=Y.+Matsunaga&title=Reversal+of+temperature-induced+conformational+changes+in+the+amyloid-beta+peptide%2C+A%CE%B240%2C+by+the+%CE%B2-sheet+breaker+peptides+16%E2%80%9323+and+17%E2%80%9324&doi=10.1111%2Fj.1476-5381.2009.00384.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Aβ40, by the β-sheet breaker peptides 16-23 and 17-24</span></div><div class="casAuthors">Hatip, Funda F. Bolukbasi; Suenaga, Midori; Yamada, Tatsuo; Matsunaga, Yoichi</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1165-1172</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aggregates of the protein amyloid-beta (Aβ) play a crucial role in the pathogenesis of Alzheimer's disease (AD).  Most therapeutic approaches to AD do not target Aβ, so detn. of the factor(s) that facilitate aggregation and discovering agents that prevent aggregation have great potential therapeutic value.  We investigated ex vivo the temp.-sensitive regions of Aβ1-40 (Aβ40) and their interactions with octapeptides derived from sequences within Aβ40, β-sheet breaker peptides (βSBP), using ELISA, and dot blot and far-UV CD spectroscopy.  We measured changes within the physiol. limits of temp., using antibodies targeting epitopes 1-7, 5-10, 9-14, and 17-21 within Aβ40.  Temp.-dependent conformational changes were obsd. in Aβ40 at epitopes 9-14 and 17-21 at 36-38 and 36-40° resp.  The βSBPs 16-23 and 17-24, but not 15-22 and 18-25, could inhibit the changes.  Moreover, βSBPs 16-23 and 17-24 increased digestion of Aβ40 by protease K, indicating a decreased aggregation of Aβ40, whereas βSBPs 15-22 and 18-25 did not increase this digestion.  CD spectra revealed that β-sheet formation in Aβ40 at 38° was reduced with βSBPs 16-23 and 17-24.  The epitopes 9-14 and 17-21 are the temp.-sensitive regions within Aβ40.  The βSBPs, Aβ16-23 and 17-24 reversed temp.-induced β-sheet formation, and decreased Aβ40 aggregation.  The results suggest that the 17-23 epitope of Aβ40 is crucially involved in preventing Aβ40 aggregation and consequent deposition of Aβ40 in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxQ8bY265N6LVg90H21EOLACvtfcHk0lhrLvejDGOqpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fN&md5=11c0322e1fdb2114d6452bfac86bd215</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00384.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00384.x%26sid%3Dliteratum%253Aachs%26aulast%3DHatip%26aufirst%3DF.%2BF.%26aulast%3DSuenaga%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DY.%26atitle%3DReversal%2520of%2520temperature-induced%2520conformational%2520changes%2520in%2520the%2520amyloid-beta%2520peptide%252C%2520A%25CE%25B240%252C%2520by%2520the%2520%25CE%25B2-sheet%2520breaker%2520peptides%252016%25E2%2580%259323%2520and%252017%25E2%2580%259324%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1165%26epage%3D1172%26doi%3D10.1111%2Fj.1476-5381.2009.00384.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begum, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubeda, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambegaokar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frautschy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span> </span><span class="NLM_article-title">Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5892</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span><span class="refDoi"> DOI: 10.1074/jbc.M404751200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1074%2Fjbc.M404751200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=15590663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=5892-5901&author=F.+Yangauthor=G.+P.+Limauthor=A.+N.+Begumauthor=O.+J.+Ubedaauthor=M.+R.+Simmonsauthor=S.+S.+Ambegaokarauthor=P.+P.+Chenauthor=R.+Kayedauthor=C.+G.+Glabeauthor=S.+A.+Frautschyauthor=G.+M.+Cole&title=Curcumin+inhibits+formation+of+amyloid+beta+oligomers+and+fibrils%2C+binds+plaques%2C+and+reduces+amyloid+in+vivo&doi=10.1074%2Fjbc.M404751200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo</span></div><div class="casAuthors">Yang, Fusheng; Lim, Giselle P.; Begum, Aynun N.; Ubeda, Oliver J.; Simmons, Mychica R.; Ambegaokar, Surendra S.; Chen, Pingping P.; Kayed, Rakez; Glabe, Charles G.; Frautschy, Sally A.; Cole, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5892-5901</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) involves amyloid β (Aβ) accumulation, oxidative damage, and inflammation, and risk is reduced with increased antioxidant and anti-inflammatory consumption.  The phenolic yellow curry pigment curcumin has potent anti-inflammatory and antioxidant activities and can suppress oxidative damage, inflammation, cognitive deficits, and amyloid accumulation.  Since the mol. structure of curcumin suggested potential Aβ binding, we investigated whether its efficacy in AD models could be explained by effects on Aβ aggregation.  Under aggregating conditions in vitro, curcumin inhibited aggregation (IC50 = 0.8 μM) as well as disaggregated fibrillar Aβ40 (IC50 = 1 μM), indicating favorable stoichiometry for inhibition.  Curcumin was a better Aβ40 aggregation inhibitor than ibuprofen and naproxen, and prevented Aβ42 oligomer formation and toxicity between 0.1 and 1.0 μM.  Under EM, curcumin decreased dose dependently Aβ fibril formation beginning with 0.125 μM.  The effects of curcumin did not depend on Aβ sequence but on fibril-related conformation.  AD and Tg2576 mice brain sections incubated with curcumin revealed preferential labeling of amyloid plaques.  In vivo studies showed that curcumin injected peripherally into aged Tg mice crossed the blood-brain barrier and bound plaques.  When fed to aged Tg2576 mice with advanced amyloid accumulation, curcumin labeled plaques and reduced amyloid levels and plaque burden.  Hence, curcumin directly binds small β-amyloid species to block aggregation and fibril formation in vitro and in vivo.  These data suggest that low dose curcumin effectively disaggregates Aβ as well as prevents fibril and oligomer formation, supporting the rationale for curcumin use in clin. trials preventing or treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTY2O8WLUVrVg90H21EOLACvtfcHk0lhrLvejDGOqpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D&md5=5f8f6fb0c3529ba9dbeae5f8af096250</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404751200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404751200%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DG.%2BP.%26aulast%3DBegum%26aufirst%3DA.%2BN.%26aulast%3DUbeda%26aufirst%3DO.%2BJ.%26aulast%3DSimmons%26aufirst%3DM.%2BR.%26aulast%3DAmbegaokar%26aufirst%3DS.%2BS.%26aulast%3DChen%26aufirst%3DP.%2BP.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DFrautschy%26aufirst%3DS.%2BA.%26aulast%3DCole%26aufirst%3DG.%2BM.%26atitle%3DCurcumin%2520inhibits%2520formation%2520of%2520amyloid%2520beta%2520oligomers%2520and%2520fibrils%252C%2520binds%2520plaques%252C%2520and%2520reduces%2520amyloid%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D5892%26epage%3D5901%26doi%3D10.1074%2Fjbc.M404751200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hensley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aksenova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">3270</span><span class="NLM_x">–</span> <span class="NLM_lpage">3274</span><span class="refDoi"> DOI: 10.1073/pnas.91.8.3270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1073%2Fpnas.91.8.3270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=8159737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK2cXivFGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=3270-3274&author=K.+Hensleyauthor=J.+M.+Carneyauthor=M.+P.+Mattsonauthor=M.+Aksenovaauthor=M.+Harrisauthor=J.+F.+Wuauthor=R.+A.+Floydauthor=D.+A.+Butterfield&title=A+model+for+beta-amyloid+aggregation+and+neurotoxicity+based+on+free+radical+generation+by+the+peptide%3A+relevance+to+Alzheimer+disease&doi=10.1073%2Fpnas.91.8.3270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease</span></div><div class="casAuthors">Hensley, K.; Carney, J. M.; Mattson, M. P.; Aksenova, M.; Harris, M.; Wu, J. F.; Floyd, R. A.; Butterfield, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3270-4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">β-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-assocd. senile (amyloid) plaques.  No satisfactory hypothesis has yet been proposed to explain the mechanism of β-amyloid aggregation and toxicity.  The authors present mass spectrometric and ESR spin trapping evidence that β-amyloid, in aq. soln., fragments and generates free radical peptides.  β-Amyloid fragments, at concns. that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidn.-sensitive glutamine synthetase and creatine kinase enzymes.  Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the β-amyloid-(25-35) fragment during cell-free incubation.  These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of β-amyloid and are discussed with ref. to membrane mol. alterations in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmtrQ4YKCYbbVg90H21EOLACvtfcHk0lhrLvejDGOqpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivFGrt7s%253D&md5=542820aa71efab3140773571ac4aab83</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.8.3270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.8.3270%26sid%3Dliteratum%253Aachs%26aulast%3DHensley%26aufirst%3DK.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DAksenova%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%2BF.%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DA%2520model%2520for%2520beta-amyloid%2520aggregation%2520and%2520neurotoxicity%2520based%2520on%2520free%2520radical%2520generation%2520by%2520the%2520peptide%253A%2520relevance%2520to%2520Alzheimer%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D3270%26epage%3D3274%26doi%3D10.1073%2Fpnas.91.8.3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Dikalov, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitek, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maples, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span> </span><span class="NLM_article-title">Amyloid β peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">9392</span><span class="NLM_x">–</span> <span class="NLM_lpage">9399</span><span class="refDoi"> DOI: 10.1074/jbc.274.14.9392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1074%2Fjbc.274.14.9392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10092619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK1MXisVWlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=9392-9399&author=S.+I.+Dikalovauthor=M.+P.+Vitekauthor=K.+R.+Maplesauthor=R.+P.+Mason&title=Amyloid+%CE%B2+peptides+do+not+form+peptide-derived+free+radicals+spontaneously%2C+but+can+enhance+metal-catalyzed+oxidation+of+hydroxylamines+to+nitroxides&doi=10.1074%2Fjbc.274.14.9392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides</span></div><div class="casAuthors">Dikalov, Sergey I.; Vitek, Michael P.; Maples, Kirk R.; Mason, Ronald P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9392-9399</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) peptides play an important role in the pathogenesis of Alzheimer's disease.  Free radical generation by Aβ peptides was suggested to be a key mechanism of their neurotoxicity.  Reports that neurotoxic free radicals derived from Aβ-(1-40) and Aβ-(25-35) peptides react with the spin trap N-tert-butyl-α-phenylnitrone (PBN) to form a PBN/Aβ peptide radical adduct with a specific triplet ESR signal assert that the peptide itself was the source of free radicals.  The authors now report that three Aβ peptides, Aβ-(1-40), Aβ-(25-35), and Aβ-(40-1), do not yield radical adducts with PBN from the Oklahoma Medical Research Foundation (OMRF).  In contrast to OMRF PBN, incubation of Sigma PBN in phosphate buffer without Aβ peptides produced a three-line ESR spectrum.  It was shown that this nitroxide is di-tert-butylnitroxide and is formed in the Sigma PBN soln. as a result of transition metal-catalyzed auto-oxidn. of the resp. hydroxylamine present as an impurity in the Sigma PBN.  Under some conditions, incubation of PBN from Sigma with Aβ-(1-40) or Aβ-(25-35) can stimulate the formation of di-tert-butylnitroxide.  It was shown that Aβ peptides enhanced oxidn. of cyclic hydroxylamine 1-hydroxy-4-oxo-2,2,6,6-tetramethylpiperidine (TEMPONE-H), which was strongly inhibited by the treatment of phosphate buffer with Chelex-100.  It was shown that ferric and cupric ions are effective oxidants of TEMPONE-H.  The data obtained allow the authors to conclude that under some conditions toxic Aβ peptides Aβ-(1-40) and Aβ-(25-35) enhance metal-catalyzed oxidn. of hydroxylamine derivs., but do not spontaneously form peptide-derived free radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRXxQewfwb7Vg90H21EOLACvtfcHk0lhPBa_QnPuwXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVWlt7c%253D&md5=b091123b123af32ba6fce234cbdfa486</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.14.9392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.14.9392%26sid%3Dliteratum%253Aachs%26aulast%3DDikalov%26aufirst%3DS.%2BI.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DAmyloid%2520%25CE%25B2%2520peptides%2520do%2520not%2520form%2520peptide-derived%2520free%2520radicals%2520spontaneously%252C%2520but%2520can%2520enhance%2520metal-catalyzed%2520oxidation%2520of%2520hydroxylamines%2520to%2520nitroxides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D9392%26epage%3D9399%26doi%3D10.1074%2Fjbc.274.14.9392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Turnbull, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Agnaf, O. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twyman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span><span class="refDoi"> DOI: 10.1016/S0891-5849(01)00510-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0891-5849%2801%2900510-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=11369506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFegsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2001&pages=1154-1162&author=S.+Turnbullauthor=B.+J.+Tabnerauthor=O.+M.+A.+El-Agnafauthor=L.+J.+Twymanauthor=D.+Allsop&title=New+evidence+that+the+Alzheimer+%CE%B2-amyloid+peptide+does+not+spontaneously+form+free+radicals%3A+An+ESR+study+using+a+series+of+spin-traps&doi=10.1016%2FS0891-5849%2801%2900510-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps</span></div><div class="casAuthors">Turnbull, S.; Tabner, B. J.; El-Agnaf, O. M. A.; Twyman, L. J.; Allsop, D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1154-1162</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The direct formation of free radicals from Aβ has been suggested to be a key neurotoxic mechanism in Alzheimer's disease (AD).  We have explored the possibility of the spontaneous formation of peptide-derived free radicals during the incubation of Aβ 1-40 by ESR spectroscopy using N-tert-butyl-α-phenylnitrone (PBN), 5,5-dimethyl-1-pyrroline N-oxide (DMPO), α-(4-pyridyl-1-oxide)-N-tert-butylnitrone (POBN), and 3,5-dibromo-4-nitrosobenzenesulfonic acid sodium salt (DBNBS) as spin traps.  Employing PBN, we obsd. spectra during the incubation of β-amyloid peptide, at 37°, which included adducts of 2-methyl-2-nitrosopropane (MNP), despite rigorous purifn. of the PBN before incubation.  The formation of some of these adducts was found to be enhanced by ambient lab. light.  Our expts. have led us to propose a hypothesis that PBN undergoes hydrolysis and decompn. in the presence of oxidants, which explains the origin of all of the PBN and MNP adducts obsd. (even when the PBN is highly purified).  Hydrogen peroxide, formed during incubation, could play a major role as an oxidant in these expts.  Of the other three spin traps, only DMPO gave (very weak) spectra, but these could be assigned to its hydroxyl radical adduct, formed as an artifact by the nucleophilic addn. of water to DMPO, catalyzed by trace levels of iron ions.  Thus, while spectra are obsd. during our expts., none of them can be assigned to adducts of radicals derived from the peptide and, therefore, our data do not support the suggestion that radicals are spontaneously formed from β-amyloid peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrRyMutvQPLVg90H21EOLACvtfcHk0lhPBa_QnPuwXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFegsbY%253D&md5=82e8014774f8bace3343bc53cd89de9e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2801%2900510-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252801%252900510-X%26sid%3Dliteratum%253Aachs%26aulast%3DTurnbull%26aufirst%3DS.%26aulast%3DTabner%26aufirst%3DB.%2BJ.%26aulast%3DEl-Agnaf%26aufirst%3DO.%2BM.%2BA.%26aulast%3DTwyman%26aufirst%3DL.%2BJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DNew%2520evidence%2520that%2520the%2520Alzheimer%2520%25CE%25B2-amyloid%2520peptide%2520does%2520not%2520spontaneously%2520form%2520free%2520radicals%253A%2520An%2520ESR%2520study%2520using%2520a%2520series%2520of%2520spin-traps%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2001%26volume%3D30%26spage%3D1154%26epage%3D1162%26doi%3D10.1016%2FS0891-5849%2801%2900510-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span><span class="refDoi"> DOI: 10.1080/1071576021000049890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1080%2F1071576021000049890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12607822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=1307-1313&author=D.+A.+Butterfield&title=Amyloid+%CE%B2-peptide+%281%E2%80%9342%29-induced+oxidative+stress+and+neurotoxicity%3A+implications+for+neurodegeneration+in+Alzheimer%E2%80%99s+disease+brain.+A+review&doi=10.1080%2F1071576021000049890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review</span></div><div class="casAuthors">Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1307-1313</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, manifested by protein oxidn., lipid peroxidn., DNA oxidn. and 3-nitrotyrosine formation, among other indexes, is obsd. in Alzheimer's disease (AD) brain.  Amyloid β-peptide (1-42) [Aβ(1-42)] may be central to the pathogenesis of AD.  Our lab. and others have implicated Aβ(1-42)-induced free radical oxidative stress in the neurodegeneration obsd. in AD brain.  This paper reviews some of these studies from our lab.  Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Aβ(1-42) was crit. to its oxidative stress and neurotoxic properties.  Because the C-terminal region of Aβ(1-42) is helical, and invoking the i + 4 rule of helixes, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter.  This interaction could alter the susceptibility for oxidn. of Met-35, i.e. free radical formation.  Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Aβ(1-42).  Removal of the Met-35 residue from the lipid bilayer by substitution of the neg. charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Aβ(1-42).  The free radical scavenger vitamin E prevented Aβ (1-42)-induced ROS formation, protein oxidn., lipid peroxidn., and neurotoxicity in hippocampal neurons, consistent with our model for Aβ-assocd. free radical oxidative stress induced neurodegeneration in AD.  ApoE, allele 4, is a risk factor for AD.  Synaptosomes from apoE knock-out mice are more vulnerable to Aβ-induced oxidative stress (protein oxidn., lipid peroxidn., and ROS generation) than are those from wild-type mice.  We also studied synaptosomes from allele-specific human apoE knock-in mice.  Brain membranes from human apoE4 mice have greater vulnerability to Aβ(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indexes, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder.  Using immunopptn. of proteins from AD and control brain obtained no longer than 4 h PMI, selective oxidized proteins were identified in the AD brain.  Creatine kinase (CK) and β-actin have increased carbonyl groups, an index of protein oxidn., and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidn. product, 4-hydroxy-2-nonenal (HNE).  Aβ inhibits CK and causes lipid peroxidn., leading to HNE formation.  Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD.  Other oxidatively modified proteins have been identified in AD brain by proteomics anal., and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degrdn. of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy prodn. (α-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2).  Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Aβ(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Aβ(1-42)-induced oxidative stress and neurodegeneration in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovbtGvhIQlIrVg90H21EOLACvtfcHk0lirxzhRL_bv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D&md5=ad37b360cb8245ded7a9acad99e15b5e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1080%2F1071576021000049890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1071576021000049890%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DAmyloid%2520%25CE%25B2-peptide%2520%25281%25E2%2580%259342%2529-induced%2520oxidative%2520stress%2520and%2520neurotoxicity%253A%2520implications%2520for%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain.%2520A%2520review%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2002%26volume%3D36%26spage%3D1307%26epage%3D1313%26doi%3D10.1080%2F1071576021000049890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Goriya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, C. V.</span><span> </span><span class="NLM_article-title">The [Cu]-catalyzed SNAR reactions: direct amination of electron deficient aryl halides with sodium azide and the synthesis of arylthioethers under Cu(II)-ascorbate redox system</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">7642</span><span class="NLM_x">–</span> <span class="NLM_lpage">7650</span><span class="refDoi"> DOI: 10.1016/j.tet.2010.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.tet.2010.07.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=7642-7650&author=Y.+Goriyaauthor=C.+V.+Ramana&title=The+%5BCu%5D-catalyzed+SNAR+reactions%3A+direct+amination+of+electron+deficient+aryl+halides+with+sodium+azide+and+the+synthesis+of+arylthioethers+under+Cu%28II%29-ascorbate+redox+system&doi=10.1016%2Fj.tet.2010.07.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DGoriya%26aufirst%3DY.%26aulast%3DRamana%26aufirst%3DC.%2BV.%26atitle%3DThe%2520%255BCu%255D-catalyzed%2520SNAR%2520reactions%253A%2520direct%2520amination%2520of%2520electron%2520deficient%2520aryl%2520halides%2520with%2520sodium%2520azide%2520and%2520the%2520synthesis%2520of%2520arylthioethers%2520under%2520Cu%2528II%2529-ascorbate%2520redox%2520system%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D7642%26epage%3D7650%26doi%3D10.1016%2Fj.tet.2010.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Guilloreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combalbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sournia-Saquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, P.</span><span> </span><span class="NLM_article-title">Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1325</span><span class="refDoi"> DOI: 10.1002/cbic.200700111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fcbic.200700111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=17577900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos12rtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1317-1325&author=L.+Guilloreauauthor=S.+Combalbertauthor=A.+Sournia-Saquetauthor=H.+Mazarguilauthor=P.+Faller&title=Redox+chemistry+of+copper-amyloid-beta%3A+the+generation+of+hydroxyl+radical+in+the+presence+of+ascorbate+is+linked+to+redox-potentials+and+aggregation+state&doi=10.1002%2Fcbic.200700111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Redox chemistry of copper-amyloid-β: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state</span></div><div class="casAuthors">Guilloreau, Luc; Combalbert, Sarah; Sournia-Saquet, Alix; Mazarguil, Honore; Faller, Peter</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1317-1325</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Aggregation of the β-amyloid peptide (Aβ) to amyloid plaques is a key event in Alzheimer's disease.  According to the amyloid-cascade hypothesis, Aβ aggregates are toxic to neurons through the prodn. of reactive oxygen species (ROS).  Copper ions play an important role, because they are able to bind to Aβ and influence its aggregation properties.  Moreover, Cu-Aβ is supposed to be directly involved in ROS prodn.  To get a better understanding of these reactions, we measured the prodn. of HO· and the redox potential of Cu-Aβ.  The results were compared to other biol. copper-peptide complexes in order to get an insight into the biol. relevance.  Cu-Aβ produced more HO· than the complex of copper with Asp-Ala-His-Lys (Cu-DAHK), but less than with Gly-His-Lys (Cu-GHK).  Cyclic voltammetry revealed that the order for redn. potential is Cu-GHK > Cu-Aβ > Cu-DAHK, but for the oxidn. potential the order is reversed.  Thus, easier copper redox cycling correlated to higher HO· prodn.  The copper complex of the form Aβ1-42 showed a HO· prodn. five-times higher than that of the form Aβ1-40.  Time-dependence and aggregation studies suggest that an aggregation intermediate is responsible for this increased HO· prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCR9gIKLpQ7Vg90H21EOLACvtfcHk0lirxzhRL_bv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos12rtrw%253D&md5=aa6d611f7f8aa40edcd72124521175db</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700111%26sid%3Dliteratum%253Aachs%26aulast%3DGuilloreau%26aufirst%3DL.%26aulast%3DCombalbert%26aufirst%3DS.%26aulast%3DSournia-Saquet%26aufirst%3DA.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DFaller%26aufirst%3DP.%26atitle%3DRedox%2520chemistry%2520of%2520copper-amyloid-beta%253A%2520the%2520generation%2520of%2520hydroxyl%2520radical%2520in%2520the%2520presence%2520of%2520ascorbate%2520is%2520linked%2520to%2520redox-potentials%2520and%2520aggregation%2520state%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1317%26epage%3D1325%26doi%3D10.1002%2Fcbic.200700111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lg0WA3_J-eOBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">Computational methods for the prediction of "drug-likeness"</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/S1359-6446(99)01451-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1359-6446%2899%2901451-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=49-58&author=D.+E.+Clarkauthor=S.+D.+Pickett&title=Computational+methods+for+the+prediction+of+%22drug-likeness%22&doi=10.1016%2FS1359-6446%2899%2901451-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2899%2901451-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252899%252901451-8%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DComputational%2520methods%2520for%2520the%2520prediction%2520of%2520%2522drug-likeness%2522%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2000%26volume%3D5%26spage%3D49%26epage%3D58%26doi%3D10.1016%2FS1359-6446%2899%2901451-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lg0WA3_J-eOBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1016/S1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2FS1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eZWudwHDv70Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2FS1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span><span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0ljCuJnEgsJA1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Melting point distribution analysis of globally approved and discontinued drugs: A research for improving the chance of success of drug design and discovery</span> <span class="citation_source-journal">ChemistryOpen</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1002/open.201600015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fopen.201600015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=27547646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=357-368&author=F.+Maoauthor=Q.+Kongauthor=W.+Niauthor=X.+Xuauthor=D.+Lingauthor=Z.+Luauthor=J.+Li&title=Melting+point+distribution+analysis+of+globally+approved+and+discontinued+drugs%3A+A+research+for+improving+the+chance+of+success+of+drug+design+and+discovery&doi=10.1002%2Fopen.201600015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Melting Point Distribution Analysis of Globally Approved and Discontinued Drugs: A Research for Improving the Chance of Success of Drug Design and Discovery</span></div><div class="casAuthors">Mao, Fei; Kong, Qingya; Ni, Wei; Xu, Xiang; Ling, Dazheng; Lu, Zhengyu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ChemistryOpen</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-368</span>CODEN:
                <span class="NLM_cas:coden">CHOPCK</span>;
        ISSN:<span class="NLM_cas:issn">2191-1363</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The m.p. (MP), an easily accessible phys. parameter, has considerable potential for the judgment of drug-like properties.  However, to the best of our knowledge, there are no useful guidelines for understanding the relationship between the MP and drug-like properties.  To this end, we have constructed the largest MP database (exptl. value) of globally approved drugs (3164 org. small-mol. drugs) and discontinued drugs (417 org. small-mol. drugs) and subsequently extd. six subdatabases from the whole approved database and two subdatabases from the discontinued database.  The MP distribution statistics and anal. of approved drugs reveal five noteworthy observations; moreover, the MP distribution statistics and anal. of discontinued drugs further supplement these criteria.  In addn., the comparison of mol. wt. (MW) vs. MP and Clog P vs. MP distributions of different classes of approved drugs indicated that the MWs and Clog P values of most drugs in the optimal MP range were not more than 500 and 5, resp., implying the MP distribution criterion was in accordance with Lipinski's rule of five.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc6SJrc8pcs7Vg90H21EOLACvtfcHk0liz0Hc2auDYVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eru7g%253D&md5=bf60d04bb54874439edaea537d1ab3b9</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fopen.201600015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fopen.201600015%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DQ.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DMelting%2520point%2520distribution%2520analysis%2520of%2520globally%2520approved%2520and%2520discontinued%2520drugs%253A%2520A%2520research%2520for%2520improving%2520the%2520chance%2520of%2520success%2520of%2520drug%2520design%2520and%2520discovery%26jtitle%3DChemistryOpen%26date%3D2016%26volume%3D5%26spage%3D357%26epage%3D368%26doi%3D10.1002%2Fopen.201600015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0liz0Hc2auDYVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Safer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. P.</span><span> </span><span class="NLM_article-title">The central effects of scopolamine in man</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=4950489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A280%3ADyaE2c7hs1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1971&pages=347-355&author=D.+J.+Saferauthor=R.+P.+Allen&title=The+central+effects+of+scopolamine+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The central effects of scopolamine in man</span></div><div class="casAuthors">Safer D J; Allen R P</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-55</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9k-R0AdOSfny-c-E1v-fmfW6udTcc2ebZjbFumtQ9E7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2c7hs1aqsA%253D%253D&md5=fb383f588bd7a211a1c05215d89f0484</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSafer%26aufirst%3DD.%2BJ.%26aulast%3DAllen%26aufirst%3DR.%2BP.%26atitle%3DThe%2520central%2520effects%2520of%2520scopolamine%2520in%2520man%26jtitle%3DBiol.%2520Psychiatry%26date%3D1971%26volume%3D3%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Klinkenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span> </span><span class="NLM_article-title">The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2010.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.neubiorev.2010.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=20398692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1307-1350&author=I.+Klinkenbergauthor=A.+Blokland&title=The+validity+of+scopolamine+as+a+pharmacological+model+for+cognitive+impairment%3A+A+review+of+animal+behavioral+studies&doi=10.1016%2Fj.neubiorev.2010.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies</span></div><div class="casAuthors">Klinkenberg, Inge; Blokland, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1307-1350</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Scopolamine is used as a std./ref. drug for inducing cognitive deficits in healthy humans and animals.  Effects are often interpreted in terms of a role of acetylcholine in mnemonic and/or attentional processes.  In this paper an overview is given of the effects of scopolamine on animal behavior.  Examn. of the dose-response curve of systemically administered scopolamine indicates that sensory discrimination and attention are most sensitive to disruption.  When higher doses (>0.03 mg/kg) are used, deficits in other cognitive and non-cognitive functions (e.g., learning and memory, locomotor activity) are reported.  Several behavioral processes (taste aversion, anxiety, short-term memory, attention) are found to be affected after intracerebral injections of scopolamine.  It is concluded that effects on learning and memory performance which are obsd. after higher doses of scopolamine are mediated by (1) primary effects on attention and sensory/stimulus discrimination, (2) non-specific effects on behavior (e.g., locomotor activity, anxiety), and (3) peripheral side-effects (e.g., pupil dilation, salivation).  Finally, the validity of scopolamine as a pharmacol. model for cognitive impairment is discussed.  The use of muscarinic M1 antagonists is suggested as a more selective and effective way of inducing cholinergic-induced cognitive deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kOHauaQ9u7Vg90H21EOLACvtfcHk0lje1v_58vfq6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWhs70%253D&md5=fa3e1e2c8fa117bbf04579b6a93747a7</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2010.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2010.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DKlinkenberg%26aufirst%3DI.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DThe%2520validity%2520of%2520scopolamine%2520as%2520a%2520pharmacological%2520model%2520for%2520cognitive%2520impairment%253A%2520A%2520review%2520of%2520animal%2520behavioral%2520studies%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2010%26volume%3D34%26spage%3D1307%26epage%3D1350%26doi%3D10.1016%2Fj.neubiorev.2010.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazor, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourashraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhakumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydserff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giguere, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groblewski, T.</span><span> </span><span class="NLM_article-title">Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span><span class="refDoi"> DOI: 10.1021/jm4014828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=733-758&author=D.+G.+Brownauthor=P.+R.+Bernsteinauthor=A.+Griffinauthor=S.+Wesolowskiauthor=D.+Labrecqueauthor=M.+C.+Tremblayauthor=M.+Sylvesterauthor=R.+Maugerauthor=P.+D.+Edwardsauthor=S.+R.+Thronerauthor=J.+J.+Folmerauthor=J.+Cacciolaauthor=C.+Scottauthor=L.+A.+Lazorauthor=M.+Pourashrafauthor=V.+Santhakumarauthor=W.+M.+Pottsauthor=S.+Sydserffauthor=P.+Giguereauthor=C.+Levesqueauthor=M.+Dasserauthor=T.+Groblewski&title=Discovery+of+spirofused+piperazine+and+diazepane+amides+as+selective+histamine-3+antagonists+with+in+vivo+efficacy+in+a+mouse+model+of+cognition&doi=10.1021%2Fjm4014828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Spirofused Piperazine and Diazepane Amides as Selective Histamine-3 Antagonists with in Vivo Efficacy in a Mouse Model of Cognition</span></div><div class="casAuthors">Brown, Dean G.; Bernstein, Peter R.; Griffin, Andrew; Wesolowski, Steve; Labrecque, Denis; Tremblay, Maxime C.; Sylvester, Mark; Mauger, Russell; Edwards, Phillip D.; Throner, Scott R.; Folmer, James J.; Cacciola, Joseph; Scott, Clay; Lazor, Lois A.; Pourashraf, Mehrnaz; Santhakumar, Vijayaratnam; Potts, William M.; Sydserff, Simon; Giguere, Pascall; Levesque, Carine; Dasser, Mohammed; Groblewski, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">733-758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of potent and selective histamine-3 receptor (H3R) antagonists was identified on the basis of an azaspiro[2.5]octane carboxamide scaffold.  Many scaffold modifications were largely tolerated, resulting in nanomolar-potent compds. in the H3R functional assay.  Exemplar compd. 6s demonstrated a selective profile against a panel of 144 secondary pharmacol. receptors, with activity at only σ2 (62% at 10 μM).  Compd. 6s demonstrated free-plasma exposures above the IC50 (∼50×) with a brain-to-plasma ratio of ∼3 following i.v. dosing in mice.  At three doses tested in the mouse novel object recognition model (1, 3, and 10 mg/kg s.c.), 6s demonstrated a statistically significant response compared with the control group.  This series represents a new scaffold of H3 receptor antagonists that demonstrates in vivo exposure and efficacy in an animal model of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTXWVp5QzxLVg90H21EOLACvtfcHk0lje1v_58vfq6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFWnsg%253D%253D&md5=7da2e8b7598cf69f64f7122efe660cff</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm4014828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014828%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DBernstein%26aufirst%3DP.%2BR.%26aulast%3DGriffin%26aufirst%3DA.%26aulast%3DWesolowski%26aufirst%3DS.%26aulast%3DLabrecque%26aufirst%3DD.%26aulast%3DTremblay%26aufirst%3DM.%2BC.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DMauger%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DThroner%26aufirst%3DS.%2BR.%26aulast%3DFolmer%26aufirst%3DJ.%2BJ.%26aulast%3DCacciola%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DC.%26aulast%3DLazor%26aufirst%3DL.%2BA.%26aulast%3DPourashraf%26aufirst%3DM.%26aulast%3DSanthakumar%26aufirst%3DV.%26aulast%3DPotts%26aufirst%3DW.%2BM.%26aulast%3DSydserff%26aufirst%3DS.%26aulast%3DGiguere%26aufirst%3DP.%26aulast%3DLevesque%26aufirst%3DC.%26aulast%3DDasser%26aufirst%3DM.%26aulast%3DGroblewski%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520spirofused%2520piperazine%2520and%2520diazepane%2520amides%2520as%2520selective%2520histamine-3%2520antagonists%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520cognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D733%26epage%3D758%26doi%3D10.1021%2Fjm4014828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Garcia-Barroso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricobaraza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual-Lucas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unceta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goicolea, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanciego, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado-Tejedor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Osta, A.</span><span> </span><span class="NLM_article-title">Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1016%2Fj.neuropharm.2012.06.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=114-123&author=C.+Garcia-Barrosoauthor=A.+Ricobarazaauthor=M.+Pascual-Lucasauthor=N.+Uncetaauthor=A.+J.+Ricoauthor=M.+A.+Goicoleaauthor=J.+Sallesauthor=J.+L.+Lanciegoauthor=J.+Oyarzabalauthor=R.+Francoauthor=M.+Cuadrado-Tejedorauthor=A.+Garcia-Osta&title=Tadalafil+crosses+the+blood-brain+barrier+and+reverses+cognitive+dysfunction+in+a+mouse+model+of+AD&doi=10.1016%2Fj.neuropharm.2012.06.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DUnceta%26aufirst%3DN.%26aulast%3DRico%26aufirst%3DA.%2BJ.%26aulast%3DGoicolea%26aufirst%3DM.%2BA.%26aulast%3DSalles%26aufirst%3DJ.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DTadalafil%2520crosses%2520the%2520blood-brain%2520barrier%2520and%2520reverses%2520cognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520AD%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D114%26epage%3D123%26doi%3D10.1016%2Fj.neuropharm.2012.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Mensch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span> </span><span class="NLM_article-title">In vivo, in vitro and in silico methods for small molecule transfer across the BBB</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span><span class="refDoi"> DOI: 10.1002/jps.21745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1002%2Fjps.21745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=4429-4468&author=J.+Menschauthor=J.+Oyarzabalauthor=C.+Mackieauthor=P.+Augustijns&title=In+vivo%2C+in+vitro+and+in+silico+methods+for+small+molecule+transfer+across+the+BBB&doi=10.1002%2Fjps.21745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fjps.21745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21745%26sid%3Dliteratum%253Aachs%26aulast%3DMensch%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAugustijns%26aufirst%3DP.%26atitle%3DIn%2520vivo%252C%2520in%2520vitro%2520and%2520in%2520silico%2520methods%2520for%2520small%2520molecule%2520transfer%2520across%2520the%2520BBB%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D4429%26epage%3D4468%26doi%3D10.1002%2Fjps.21745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Choi, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braymer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanga, R. P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">21990</span><span class="NLM_x">–</span> <span class="NLM_lpage">21995</span><span class="refDoi"> DOI: 10.1073/pnas.1006091107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1073%2Fpnas.1006091107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=21131570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVKk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21990-21995&author=J.+S.+Choiauthor=J.+J.+Braymerauthor=R.+P.+R.+Nangaauthor=A.+Ramamoorthyauthor=M.+H.+Lim&title=Design+of+small+molecules+that+target+metal-A%CE%B2+species+and+regulate+metal-induced+A%CE%B2+aggregation+and+neurotoxicity&doi=10.1073%2Fpnas.1006091107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity</span></div><div class="casAuthors">Choi, Jung-Suk; Braymer, Joseph J.; Nanga, Ravi P. R.; Ramamoorthy, Ayyalusamy; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21990-21995, S21990/1-S21990/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The accumulation of metal ions and amyloid-β (Aβ) aggregates found in the brain of patients with Alzheimer's disease (AD) has been suggested to be involved in AD pathogenesis.  To investigate metal-Aβ-assocd. pathways in AD, development of chem. tools to target metal-Aβ species is desired.  Only a few efforts, however, have been reported.  Here, bifunctional small mols., N-(pyridin-2-ylmethyl)aniline (L2-a) and N1,N1-dimethyl-N4-(pyridin-2-ylmethyl)benzene-1,4-diamine (L2-b) that can interact with both metal ions and Aβ species, as detd. by spectroscopic methods including high-resoln. NMR spectroscopy, are reported.  Using the bifunctional compd. L2-b, metal-induced Aβ aggregation and neurotoxicity were modulated in vitro as well as in human neuroblastoma cells.  Furthermore, treatment of human AD brain tissue homogenates contg. metal ions and Aβ species with L2-b showed disassembly of Aβ aggregates.  Therefore, the studies presented herein demonstrate the value of bifunctional compds. as chem. tools for investigating metal-Aβ-assocd. events and their mechanisms in the development and pathogenesis of AD and as potential therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDq-Ci1DofMbVg90H21EOLACvtfcHk0lhKqz7b-oPReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVKk&md5=c039af9ec22cf5da7afb3bb1d7a40a56</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1006091107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1006091107%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DBraymer%26aufirst%3DJ.%2BJ.%26aulast%3DNanga%26aufirst%3DR.%2BP.%2BR.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DDesign%2520of%2520small%2520molecules%2520that%2520target%2520metal-A%25CE%25B2%2520species%2520and%2520regulate%2520metal-induced%2520A%25CE%25B2%2520aggregation%2520and%2520neurotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D21990%26epage%3D21995%26doi%3D10.1073%2Fpnas.1006091107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">New multi-target-directed small molecules against Alzheimer’s disease: a combination of resveratrol and clioquinol</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5936</span><span class="NLM_x">–</span> <span class="NLM_lpage">5944</span><span class="refDoi"> DOI: 10.1039/C4OB00998C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=10.1039%2FC4OB00998C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=24986600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=5936-5944&author=F.+Maoauthor=J.+Yanauthor=J.+Liauthor=X.+Jiaauthor=H.+Miaoauthor=Y.+Sunauthor=L.+Huangauthor=X.+Li&title=New+multi-target-directed+small+molecules+against+Alzheimer%E2%80%99s+disease%3A+a+combination+of+resveratrol+and+clioquinol&doi=10.1039%2FC4OB00998C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol</span></div><div class="casAuthors">Mao, Fei; Yan, Jun; Li, Jianheng; Jia, Xian; Miao, Hui; Sun, Yang; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5936-5944</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is currently one of the most difficult and challenging diseases to treat.  Based on the 'multi-target-directed ligands' (MTDLs) strategy, we designed and synthesized a series of new compds. against AD by combining the pharmacophores of resveratrol and clioquinol.  The results of biol. activity tests showed that the hybrids exhibited excellent MTDL properties: a significant ability to inhibit self-induced β-amyloid (Aβ) aggregation and copper(II)-induced Aβ aggregation, potential antioxidant behavior (ORAC-FL value of 0.9-3.2 Trolox equiv.) and biometal chelation.  Among these compds., (E)-5-(4-hydroxystyryl)quinoline-8-ol (10c) showed the most potent ability to inhibit self-induced Aβ aggregation (IC50 = 8.50 μM) and copper(II)-induced Aβ aggregation and to disassemble the well-structured Aβ fibrils generated by self- and copper(II)-induced Aβ aggregation.  Note that 10c could also control Cu(I/II)-triggered hydroxyl radical (OH ) prodn. by halting copper redox cycling via metal complexation, as confirmed by a Cu-ascorbate redox system assay.  Importantly, 10c did not show acute toxicity in mice at doses of up to 2000 mg kg-1 and was able to cross the blood-brain barrier (BBB), according to a parallel artificial membrane permeation assay.  These results indicate that compd. 10c is a promising multifunctional compd. for the development of novel drugs for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRtZbIAMbCHrVg90H21EOLACvtfcHk0lhVCGwwSO-uhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjJ&md5=fe3cb0d409d2e6e1c7e716dc9b08fcbd</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1039%2FC4OB00998C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB00998C%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DNew%2520multi-target-directed%2520small%2520molecules%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520combination%2520of%2520resveratrol%2520and%2520clioquinol%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D5936%26epage%3D5944%26doi%3D10.1039%2FC4OB00998C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i122"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00636">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57608"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00636">10.1021/acs.jmedchem.6b00636</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC reports for the purity check of the target compounds and the synthesis of compounds <b>5r·HCl</b>, <b>5s·HCl</b>, <b>5t·HCl</b>, <b>5y</b> and intermediates <b>8a</b>–<b>e</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_001.pdf">jm6b00636_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00636/suppl_file/jm6b00636_si_002.csv">jm6b00636_si_002.csv (2.95 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00636&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00636%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-18" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00636" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679994538dfc32b5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
